[sentNum: 1]<Annotation Id="18769" Type="Sentence" StartNode="2" EndNode="57">the american college of obstetricians and gynecologists PreferredName:American College of Obstetricians and Gynecologists SemanticType:[pros] POS:DT POS:NN POS:NN POS:IN POS:NNS POS:CC POS:NNS 
[sentNum: 2]<Annotation Id="18770" Type="Sentence" StartNode="60" EndNode="90">women&#x2019;s health care physicians PreferredName:Physicians, Women SemanticType:[prog] PreferredName:Health Care SemanticType:[hlca] POS:NNS POS:VBP POS:NNS POS:NN POS:NN POS:NNS 
[sentNum: 3]<Annotation Id="18771" Type="Sentence" StartNode="93" EndNode="110">PRACTICE BULLETIN PreferredName:Practice Experience SemanticType:[menp] POS:NN POS:NN 
[sentNum: 4]<Annotation Id="18772" Type="Sentence" StartNode="116" EndNode="188">Number 122, August 2011 Replaces Practice Bulletin Number 42, April 2003 PreferredName:replaces - RoleLinkType SemanticType:[idcn] PreferredName:Numbers SemanticType:[qnco] PreferredName:Numbers SemanticType:[qnco] PreferredName:Practice Experience SemanticType:[menp] POS:NN POS:CD POS:, POS:NNP POS:CD POS:VBZ POS:NNP POS:NNP POS:NNP POS:CD POS:, POS:NNP POS:CD 
[sentNum: 5]<Annotation Id="18773" Type="Sentence" StartNode="191" EndNode="214">Breast Cancer Screening PreferredName:Screening for cancer SemanticType:[diap] PreferredName:Thoracic mammary region SemanticType:[blor] POS:NN POS:NN POS:NN 
[sentNum: 6]<Annotation Id="18774" Type="Sentence" StartNode="217" EndNode="412">Breast cancer is the most commonly diagnosed noncutaneous cancer in women in the United States, and the second leading cause of death from cancer in American women&#x2014;second only to lung cancer (1). PreferredName:Diagnosis SemanticType:[fndg] PreferredName:Most SemanticType:[qnco] PreferredName:Woman SemanticType:[popg] PreferredName:Primary malignant neoplasm SemanticType:[neop] PreferredName:Cause of death.secondary:Find:Pt:^Patient:Nom SemanticType:[clna] PreferredName:United States SemanticType:[geoa] PreferredName:From SemanticType:[qlco] PreferredName:Leading SemanticType:[ftcn] PreferredName:Woman SemanticType:[popg] PreferredName:American SemanticType:[popg] PreferredName:Singular SemanticType:[qnco] PreferredName:Second Primary Cancers SemanticType:[neop] PreferredName:1+ Score SemanticType:[qnco] PreferredName:Malignant neoplasm of lung SemanticType:[neop] POS:NN POS:NN POS:VBZ POS:DT POS:RBS POS:RB POS:VBN POS:JJ POS:NN POS:IN POS:NNS POS:IN POS:DT POS:NNP POS:NNPS POS:, POS:CC POS:DT POS:JJ POS:VBG POS:NN POS:IN POS:NN POS:IN POS:NN POS:IN POS:JJ POS:NN POS:RB POS:TO POS:NN POS:NN POS:CD POS:CD POS:NN POS:. 
[sentNum: 7]<Annotation Id="18775" Type="Sentence" StartNode="413" EndNode="482">Breast cancer mortality can be effectively reduced through screening. PreferredName:Mortality Vital Statistics SemanticType:[qnco] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:Reduced SemanticType:[qlco] POS:NN POS:NN POS:NN POS:MD POS:VB POS:RB POS:VBN POS:IN POS:NN POS:. 
[sentNum: 8]<Annotation Id="18776" Type="Sentence" StartNode="483" EndNode="669">The purpose of this Practice Bulletin is to review breast cancer screening guidelines and the evidence used to support the recommendations and highlight new screening modalities and con­PreferredName:Practice Experience SemanticType:[menp] PreferredName:Purpose SemanticType:[ftcn] PreferredName:Act Class - review SemanticType:[idcn] PreferredName:To SemanticType:[qlco] PreferredName:Guideline [Publication Type] SemanticType:[inpr] PreferredName:Screening for malignant neoplasm of breast SemanticType:[topp] PreferredName:Used by SemanticType:[fndg] PreferredName:Evidence of SemanticType:[ftcn] PreferredName:Supportive assistance SemanticType:[cnce] PreferredName:To SemanticType:[qlco] PreferredName:New SemanticType:[tmco] PreferredName:Recommendation SemanticType:[idcn] PreferredName:Modality SemanticType:[idcn] PreferredName:Aspects of disease screening SemanticType:[ftcn] POS:DT POS:NN POS:IN POS:DT POS:NN POS:NNP POS:VBZ POS:TO POS:VB POS:NN POS:NN POS:NN POS:NNS POS:CC POS:DT POS:NN POS:VBN POS:TO POS:VB POS:DT POS:NNS POS:CC POS:VB POS:JJ POS:NN POS:NNS POS:CC POS:NN 
[sentNum: 9]<Annotation Id="18777" Type="Sentence" StartNode="671" EndNode="704">troversies surrounding screening. PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:Surrounding (qualifier value) SemanticType:[spco] POS:NNS POS:VBG POS:NN POS:. 
[sentNum: 10]<Annotation Id="18778" Type="Sentence" StartNode="709" EndNode="719">Background PreferredName:Background SemanticType:[cnce] POS:NN 
[sentNum: 11]<Annotation Id="18779" Type="Sentence" StartNode="722" EndNode="731">Incidence PreferredName:incidence of cases SemanticType:[ftcn] POS:NN 
[sentNum: 12]<Annotation Id="18780" Type="Sentence" StartNode="734" EndNode="813">Breast cancer accounts for 27% of all new cases of can­cerdiagnosedin women(2).APreferredName:account - ActClass SemanticType:[idcn] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Case unit dose SemanticType:[qnco] PreferredName:New SemanticType:[tmco] PreferredName:2+ Score SemanticType:[qnco] PreferredName:Woman SemanticType:[popg] POS:NN POS:NN POS:NNS POS:IN POS:CD POS:NN POS:IN POS:DT POS:JJ POS:NNS POS:IN POS:NN POS:NNS POS:VBP POS:CD POS:CD POS:. 
[sentNum: 13]<Annotation Id="18781" Type="Sentence" StartNode="813" EndNode="901">A woman&#x2019;slifetime risk of developing breast cancer is 12.08%, or 1in 8(Table 1)	 (2, 3). PreferredName:Risk SemanticType:[qlco] PreferredName:Female Breast Carcinoma SemanticType:[neop] PreferredName:2+ Score SemanticType:[qnco] PreferredName:Table - furniture SemanticType:[mnob] PreferredName:3+ Score SemanticType:[qnco] POS:DT POS:NN POS:CD POS:NN POS:NN POS:IN POS:VBG POS:NN POS:NN POS:VBZ POS:CD POS:. POS:CD POS:NN POS:, POS:CC POS:CD POS:IN POS:CD POS:CD POS:NNP POS:CD POS:CD POS:NN POS:CD POS:, POS:CD POS:NN POS:. 
[sentNum: 14]<Annotation Id="18782" Type="Sentence" StartNode="902" EndNode="1042">In 2010, approximately 207,090 new cases of invasive breast cancer were diagnosed, and 39,840 deaths were attributable to breast cancer (2). PreferredName:2010s SemanticType:[tmco] PreferredName:New SemanticType:[tmco] PreferredName:Approximate SemanticType:[qlco] PreferredName:Invasive SemanticType:[qlco] PreferredName:Case unit dose SemanticType:[qnco] PreferredName:Diagnosis SemanticType:[fndg] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Attribution SemanticType:[menp] PreferredName:Cessation of life SemanticType:[orgf] PreferredName:Malignant neoplasm of breast SemanticType:[neop] POS:IN POS:CD POS:, POS:RB POS:CD POS:, POS:CD POS:JJ POS:NNS POS:IN POS:JJ POS:NN POS:NN POS:VBD POS:VBN POS:, POS:CC POS:CD POS:, POS:CD POS:NNS POS:VBD POS:JJ POS:TO POS:NN POS:NN POS:NN POS:CD POS:NN POS:. 
[sentNum: 15]<Annotation Id="18783" Type="Sentence" StartNode="1043" EndNode="1124">In addition, 54,010 new cases of in situ breast cancer were reported in 2010 (3). PreferredName:Add - instruction imperative SemanticType:[ftcn] PreferredName:Case unit dose SemanticType:[qnco] PreferredName:New SemanticType:[tmco] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:In situ SemanticType:[spco] PreferredName:2010s SemanticType:[tmco] PreferredName:Reporting SemanticType:[hlca] PreferredName:3+ Score SemanticType:[qnco] POS:IN POS:NN POS:, POS:CD POS:, POS:CD POS:JJ POS:NNS POS:IN POS:FW POS:FW POS:NN POS:NN POS:VBD POS:VBN POS:IN POS:CD POS:CD POS:CD POS:NN POS:. 
[sentNum: 16]<Annotation Id="18784" Type="Sentence" StartNode="1125" EndNode="1329">There was a 2% per year decrease in the incidence of breast cancer between 1999 and 2006, pos­sibly reflecting decreased use of menopausal hormone therapy and decreased use of screening mammography (3&#x2013;5). PreferredName:GPR162 gene SemanticType:[gngm] PreferredName:Decrease SemanticType:[qnco] PreferredName:per year SemanticType:[tmco] PreferredName:incidence of cases SemanticType:[ftcn] PreferredName:Within SemanticType:[spco] PreferredName:Body position SemanticType:[orga] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Decreased SemanticType:[qnco] PreferredName:Reflecting SemanticType:[menp] PreferredName:Hormone replacement therapy SemanticType:[topp] PreferredName:Use of SemanticType:[ftcn] PreferredName:Use of SemanticType:[ftcn] PreferredName:Decreased SemanticType:[qnco] PreferredName:3/5 SemanticType:[qnco] PreferredName:Screening mammography SemanticType:[topp] POS:EX POS:VBD POS:DT POS:CD POS:NN POS:IN POS:NN POS:NN POS:IN POS:DT POS:NN POS:IN POS:NN POS:NN POS:IN POS:CD POS:CC POS:CD POS:, POS:RB POS:VBG POS:VBN POS:NN POS:IN POS:JJ POS:NN POS:NN POS:CC POS:VBD POS:NN POS:IN POS:VBG POS:NN POS:NN POS:CD POS:NN POS:CD POS:NN POS:. 
[sentNum: 17]<Annotation Id="18785" Type="Sentence" StartNode="1330" EndNode="1482">Breast cancer-related mortality has been decreas­ing steadily since 1990, reflecting both earlier detection of breast cancer and improved treatment (3). PreferredName:Relationships SemanticType:[qlco] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Decreasing SemanticType:[qlco] PreferredName:Mortality Vital Statistics SemanticType:[qnco] PreferredName:Reflecting SemanticType:[menp] PreferredName:1990s SemanticType:[tmco] PreferredName:Screening for malignant neoplasm of breast SemanticType:[topp] PreferredName:Bilateral SemanticType:[spco] PreferredName:Therapeutic procedure SemanticType:[topp] PreferredName:Better SemanticType:[qlco] PreferredName:3+ Score SemanticType:[qnco] POS:NN POS:JJ POS:NN POS:VBZ POS:VBN POS:VBG POS:RB POS:IN POS:CD POS:, POS:VBG POS:CC POS:JJR POS:NN POS:IN POS:NN POS:NN POS:CC POS:VBD POS:NN POS:CD POS:CD POS:NN POS:. 
[sentNum: 18]<Annotation Id="18786" Type="Sentence" StartNode="1489" EndNode="1549">Components of Breast Cancer Screening and Current Guidelines PreferredName:Component object SemanticType:[mnob] PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Guideline [Publication Type] SemanticType:[inpr] PreferredName:Current (present time) SemanticType:[tmco] POS:NNP POS:IN POS:NN POS:NN POS:NN POS:CC POS:JJ POS:NNS 
[sentNum: 19]<Annotation Id="18787" Type="Sentence" StartNode="1552" EndNode="1721">Breast cancer screening has traditionally included three elements: 1) breast imaging (primarily mammography), 2) clinical breast examination, and 3) patient self-screen-PreferredName:Including (qualifier) SemanticType:[ftcn] PreferredName:Screening for malignant neoplasm of breast SemanticType:[topp] PreferredName:Elements SemanticType:[elii] PreferredName:Three SemanticType:[qnco] PreferredName:Entire breast SemanticType:[bpoc] PreferredName:1+ Score, WHO SemanticType:[clas] PreferredName:Mammography SemanticType:[diap] PreferredName:Diagnostic Imaging SemanticType:[diap] PreferredName:Clinical Breast Examination SemanticType:[topp] PreferredName:Integer +2 SemanticType:[qnco] PreferredName:Patients SemanticType:[podg] PreferredName:&lt;3 (qualifier value) SemanticType:[qnco] PreferredName:Screening - procedure intent SemanticType:[ftcn] PreferredName:subscriber - self SemanticType:[inpr] POS:NN POS:NN POS:NN POS:VBZ POS:RB POS:VBN POS:CD POS:NNS POS:: POS:CD POS:CD POS:NN POS:NN POS:CD POS:RB POS:NN POS:NN POS:, POS:CD POS:CD POS:JJ POS:NN POS:NN POS:, POS:CC POS:CD POS:NN POS:NN POS:NN 
[sentNum: 20]<Annotation Id="18788" Type="Sentence" StartNode="1723" EndNode="1731">Table 1. PreferredName:Table - furniture SemanticType:[mnob] POS:NNP POS:CD POS:. 
[sentNum: 21]<Annotation Id="18789" Type="Sentence" StartNode="1732" EndNode="1803">Age-Specific Probabilities of Developing Invasive Female Breast Cancer* PreferredName:Age SemanticType:[orga] PreferredName:Probability SemanticType:[qnco] PreferredName:Specific qualifier value SemanticType:[qlco] PreferredName:Invasive Breast Carcinoma SemanticType:[neop] POS:NN POS:JJ POS:NNS POS:IN POS:VBG POS:JJ POS:JJ POS:NN POS:NN POS:SYM 
[sentNum: 22]<Annotation Id="18790" Type="Sentence" StartNode="1806" EndNode="1824">The Probability of PreferredName:Probability SemanticType:[qnco] PreferredName:Malignant neoplasm of breast SemanticType:[neop] POS:DT POS:NN POS:IN 
[sentNum: 23]<Annotation Id="18791" Type="Sentence" StartNode="1828" EndNode="1852">Developing Breast Cancer POS:VBG POS:NN POS:NN 
[sentNum: 24]<Annotation Id="18792" Type="Sentence" StartNode="1856" EndNode="1907">If Current Age Is&#x2026;  in the Next 10 Years&#x2020;  Or 1 in: PreferredName:Current age SemanticType:[tmco] PreferredName:year SemanticType:[tmco] PreferredName:Following SemanticType:[tmco] PreferredName:1+ Score, WHO SemanticType:[clas] POS:IN POS:JJ POS:NN POS:VBZ POS:CD POS:IN POS:DT POS:JJ POS:CD POS:NNS POS:CD POS:CC POS:CD POS:IN POS:: 
[sentNum: 25]<Annotation Id="18793" Type="Sentence" StartNode="1911" EndNode="1929">20	  0.06%	  1,760 POS:CD POS:CD POS:. POS:CD POS:NN POS:CD POS:, POS:CD 
[sentNum: 26]<Annotation Id="18794" Type="Sentence" StartNode="1933" EndNode="1949">30	  0.44%	  229 POS:CD POS:CD POS:. POS:CD POS:NN POS:CD 
[sentNum: 27]<Annotation Id="18795" Type="Sentence" StartNode="1953" EndNode="1968">40	  1.44%	  69 PreferredName:/40 SemanticType:[tmco] PreferredName:Arabic numeral 69 SemanticType:[inpr] POS:CD POS:CD POS:. POS:CD POS:NN POS:CD 
[sentNum: 28]<Annotation Id="18796" Type="Sentence" StartNode="1972" EndNode="1987">50	  2.39%	  42 POS:CD POS:CD POS:. POS:CD POS:NN POS:CD 
[sentNum: 29]<Annotation Id="18797" Type="Sentence" StartNode="1991" EndNode="2006">60	  3.40%	  29 POS:CD POS:CD POS:. POS:CD POS:NN POS:CD 
[sentNum: 30]<Annotation Id="18798" Type="Sentence" StartNode="2010" EndNode="2025">70	  3.73%	  27 POS:CD POS:CD POS:. POS:CD POS:NN POS:CD 
[sentNum: 31]<Annotation Id="18799" Type="Sentence" StartNode="2029" EndNode="2055">Lifetime risk	  12.08%	  8 PreferredName:Lifetime Risk SemanticType:[qnco] POS:NN POS:NN POS:CD POS:. POS:CD POS:NN POS:CD 
[sentNum: 32]<Annotation Id="18800" Type="Sentence" StartNode="2061" EndNode="2126">*Among those free of cancer at the beginning of the age interval. PreferredName:Primary malignant neoplasm SemanticType:[neop] PreferredName:Free (available (qualifier)) SemanticType:[qlco] PreferredName:Beginning SemanticType:[tmco] PreferredName:At SemanticType:[spco] PreferredName:Data Type Interval SemanticType:[inpr] PreferredName:Age SemanticType:[orga] POS:SYM POS:IN POS:DT POS:JJ POS:IN POS:NN POS:IN POS:DT POS:NN POS:IN POS:DT POS:NN POS:NN POS:. 
[sentNum: 33]<Annotation Id="18801" Type="Sentence" StartNode="2127" EndNode="2162">Based on cases diagnosed 2004&#x2013;2006. PreferredName:Case unit dose SemanticType:[qnco] PreferredName:Base - General Qualifier SemanticType:[idcn] PreferredName:Diagnosis SemanticType:[fndg] POS:VBN POS:IN POS:NNS POS:VBD POS:CD POS:CD POS:CD POS:. 
[sentNum: 34]<Annotation Id="18802" Type="Sentence" StartNode="2163" EndNode="2248">Percentages and &#x201c;1 in&#x201d; numbers may not be numerically equivalent because of rounding. PreferredName:Money or percentage indicator - Percentage SemanticType:[idcn] PreferredName:Numbers SemanticType:[qnco] PreferredName:And SemanticType:[idcn] PreferredName:Equal SemanticType:[qlco] PreferredName:Negation SemanticType:[ftcn] PreferredName:Round shape SemanticType:[spco] POS:NNS POS:CC POS:NN POS:CD POS:IN POS:CD POS:NNS POS:MD POS:RB POS:VB POS:RB POS:JJ POS:IN POS:IN POS:VBG POS:. 
[sentNum: 35]<Annotation Id="18803" Type="Sentence" StartNode="2251" EndNode="2313">&#x2020;Probability derived using NCI DevCan Software, Version 6.4.0. PreferredName:Probability SemanticType:[qnco] PreferredName:Use of SemanticType:[ftcn] PreferredName:Derivation SemanticType:[qlco] PreferredName:Computer software SemanticType:[inpr, mnob] PreferredName:National Cancer Institute SemanticType:[hcro] PreferredName:Version SemanticType:[ftcn] POS:NN POS:NN POS:VBN POS:VBG POS:NNP POS:NNP POS:NNP POS:, POS:NNP POS:CD POS:. POS:LS POS:. POS:CD POS:. 
[sentNum: 36]<Annotation Id="18804" Type="Sentence" StartNode="2316" EndNode="2371">Reprinted with permission from American Cancer Society. PreferredName:Reprint SemanticType:[inpr] PreferredName:American Cancer Society SemanticType:[pros] PreferredName:Authorization documentation SemanticType:[inpr] POS:VBN POS:IN POS:NN POS:IN POS:NNP POS:NNP POS:NNP POS:. 
[sentNum: 37]<Annotation Id="18805" Type="Sentence" StartNode="2372" EndNode="2411">Breast Cancer Facts&amp; Figures 2009&#x2013;2010. PreferredName:2010s SemanticType:[tmco] PreferredName:Malignant neoplasm of breast SemanticType:[neop] POS:NN POS:NN POS:NNP POS:CC POS:NNS POS:CD POS:CD POS:CD POS:. 
[sentNum: 38]<Annotation Id="18806" Type="Sentence" StartNode="2412" EndNode="2450">Atlanta: American Cancer Society, Inc. PreferredName:American Cancer Society SemanticType:[pros] PreferredName:Atlanta SemanticType:[euka] POS:NNP POS:: POS:NNP POS:NNP POS:NNP POS:, POS:NNP POS:. 
[sentNum: 39]<Annotation Id="18807" Type="Sentence" StartNode="2453" EndNode="2508">ing (breast self-examination or breast self-awareness). PreferredName:Entire breast SemanticType:[bpoc] PreferredName:Breast Self-Examination SemanticType:[diap] PreferredName:Self awareness SemanticType:[menp] POS:VBG POS:JJ POS:NN POS:NN POS:CC POS:NN POS:NN POS:CD POS:. 
[sentNum: 40]<Annotation Id="18808" Type="Sentence" StartNode="2509" EndNode="2623">The relative value of each element and appropriate age of initiation, cessation, and frequency of screening remain PreferredName:Relative SemanticType:[qlco] PreferredName:Appropriate SemanticType:[qlco] PreferredName:Elements SemanticType:[elii] PreferredName:Transcription Initiation SemanticType:[genf] PreferredName:Age SemanticType:[orga] PreferredName:Frequencies (time pattern) SemanticType:[tmco] PreferredName:Cessation SemanticType:[acty] PreferredName:Aspects of disease screening SemanticType:[ftcn] POS:DT POS:JJ POS:NN POS:IN POS:DT POS:NN POS:CC POS:JJ POS:NN POS:IN POS:NN POS:, POS:NN POS:, POS:CC POS:NN POS:IN POS:NN POS:VBP 
[sentNum: 41]<Annotation Id="18809" Type="Sentence" StartNode="2628" EndNode="2671">Committee on Practice Bulletins&#x2014;Gynecology. PreferredName:Committee SemanticType:[grup] PreferredName:Gynecologist SemanticType:[prog] PreferredName:Practice Experience SemanticType:[menp] POS:NNP POS:IN POS:NNP POS:NNP POS:NNP POS:. 
[sentNum: 42]<Annotation Id="18810" Type="Sentence" StartNode="2672" EndNode="2846">This Practice Bulletin was developed by the Committee on Practice Bulletins&#x2014;Gynecology with the assistance of Jennifer Griffin, MD, Mary Gemignani, MD, and Mark Pearlman, MD. PreferredName:Committee SemanticType:[grup] PreferredName:Practice Experience SemanticType:[menp] PreferredName:Gynecologist SemanticType:[prog] PreferredName:Practice Experience SemanticType:[menp] PreferredName:Massive SemanticType:[qlco] PreferredName:Helping Behavior SemanticType:[socb] POS:DT POS:NN POS:NNP POS:VBD POS:VBN POS:IN POS:DT POS:NNP POS:IN POS:NNP POS:NNP POS:NNP POS:IN POS:DT POS:NN POS:IN POS:NNP POS:NNP POS:, POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:, POS:CC POS:NNP POS:NNP POS:, POS:NNP POS:. 
[sentNum: 43]<Annotation Id="18811" Type="Sentence" StartNode="2847" EndNode="2965">The information is designed to aid practitioners in making decisions about appropriate obstetric and gynecologic care. PreferredName:Design SemanticType:[acty] PreferredName:Information SemanticType:[idcn] PreferredName:Manufactured aid SemanticType:[mnob] PreferredName:To SemanticType:[qlco] PreferredName:Decision Making SemanticType:[menp] PreferredName:Practitioner SemanticType:[prog] PreferredName:Obstetrical SemanticType:[ftcn] PreferredName:Appropriate SemanticType:[qlco] PreferredName:care activity SemanticType:[acty] PreferredName:Gynecologic SemanticType:[spco] POS:DT POS:NN POS:VBZ POS:VBN POS:TO POS:VB POS:NNS POS:IN POS:VBG POS:NNS POS:IN POS:JJ POS:JJ POS:CC POS:JJ POS:NN POS:. 
[sentNum: 44]<Annotation Id="18812" Type="Sentence" StartNode="2966" EndNode="3066">These guidelines should not be construed as dictating an exclusive course of treatment or procedure. PreferredName:Negation SemanticType:[ftcn] PreferredName:Guidelines SemanticType:[inpr] PreferredName:Course SemanticType:[tmco] PreferredName:Exclusive SemanticType:[idcn] PreferredName:Interventional procedure SemanticType:[diap, topp] PreferredName:Therapeutic procedure SemanticType:[topp] POS:DT POS:NNS POS:MD POS:RB POS:VB POS:VBN POS:IN POS:VBG POS:DT POS:JJ POS:NN POS:IN POS:NN POS:CC POS:NN POS:. 
[sentNum: 45]<Annotation Id="18813" Type="Sentence" StartNode="3067" EndNode="3226">Variations in practice may be warranted based on the needs of the individual patient, resources, and limitations unique to the institution or type of practice. PreferredName:Within SemanticType:[spco] PreferredName:Variant SemanticType:[qlco] PreferredName:Base - General Qualifier SemanticType:[idcn] PreferredName:Practice Experience SemanticType:[menp] PreferredName:Patient need for (contextual qualifier) SemanticType:[ftcn] PreferredName:Persons SemanticType:[popg] PreferredName:Limitation SemanticType:[ftcn] PreferredName:Resources SemanticType:[idcn] PreferredName:Health care facility SemanticType:[hcro, mnob] PreferredName:Unique SemanticType:[qlco] PreferredName:Practice Experience SemanticType:[menp] PreferredName:Type - attribute SemanticType:[qlco] POS:NNS POS:IN POS:NN POS:MD POS:VB POS:VBN POS:VBN POS:IN POS:DT POS:NNS POS:IN POS:DT POS:JJ POS:NN POS:, POS:NNS POS:, POS:CC POS:NNS POS:JJ POS:TO POS:DT POS:NN POS:CC POS:NN POS:IN POS:NN POS:. 
[sentNum: 46]<Annotation Id="18814" Type="Sentence" StartNode="3229" EndNode="3243">controversial. PreferredName:controversy SemanticType:[socb] POS:JJ POS:. 
[sentNum: 47]<Annotation Id="18815" Type="Sentence" StartNode="3244" EndNode="3333">Table 2 outlines the current screening guidelines of several major medical organizations. PreferredName:Table - furniture SemanticType:[mnob] PreferredName:Current (present time) SemanticType:[tmco] PreferredName:Outlines (document) SemanticType:[inpr] PreferredName:Guidelines SemanticType:[inpr] PreferredName:Screening procedure SemanticType:[hlca] PreferredName:Organization administrative structures SemanticType:[orgt] PreferredName:Major medical SemanticType:[idcn] POS:NNP POS:CD POS:VBZ POS:DT POS:JJ POS:NN POS:NNS POS:IN POS:JJ POS:JJ POS:JJ POS:NNS POS:. 
[sentNum: 48]<Annotation Id="18816" Type="Sentence" StartNode="3334" EndNode="3486">The American College of Obstetricians and Gynecologists (the College) continues to endorse inclusion of all three strategies in breast cancer screening. PreferredName:College SemanticType:[mnob] PreferredName:American College of Obstetricians and Gynecologists SemanticType:[pros] PreferredName:Inclusion SemanticType:[qlco] PreferredName:Continuous SemanticType:[idcn] PreferredName:strategy SemanticType:[menp] PreferredName:Three SemanticType:[qnco] PreferredName:Screening procedure SemanticType:[hlca] PreferredName:Malignant neoplasm of breast SemanticType:[neop] POS:DT POS:NNP POS:NNP POS:IN POS:NNPS POS:CC POS:NNPS POS:VBP POS:DT POS:NNP POS:NN POS:VBZ POS:TO POS:VB POS:NN POS:IN POS:DT POS:CD POS:NNS POS:IN POS:NN POS:NN POS:NN POS:. 
[sentNum: 49]<Annotation Id="18817" Type="Sentence" StartNode="3493" EndNode="3514">Screening Mammography PreferredName:Screening mammography SemanticType:[topp] POS:VBG POS:NN 
[sentNum: 50]<Annotation Id="18818" Type="Sentence" StartNode="3517" EndNode="3553">Rationale for Mammographic Screening PreferredName:Mammography SemanticType:[diap] PreferredName:Indication of (contextual qualifier) SemanticType:[idcn] POS:NN POS:IN POS:NNP POS:NNP 
[sentNum: 51]<Annotation Id="18819" Type="Sentence" StartNode="3556" EndNode="3729">Tumors detected at an early stage that are small and confined to the breast are more likely to be successfully treated, with a 98% 5-year survival for localized disease (3). PreferredName:Neoplasm SemanticType:[neop] PreferredName:Early SemanticType:[tmco] PreferredName:Detection SemanticType:[topp] PreferredName:Small SemanticType:[qnco] PreferredName:Phase SemanticType:[tmco] PreferredName:More SemanticType:[ftcn] PreferredName:Entire breast SemanticType:[bpoc] PreferredName:Treated with SemanticType:[topp] PreferredName:Probably SemanticType:[idcn] PreferredName:per year SemanticType:[tmco] PreferredName:In addition to SemanticType:[qlco] PreferredName:Localized SemanticType:[spco] PreferredName:Continuance of life SemanticType:[acty] PreferredName:&lt;3 (qualifier value) SemanticType:[qnco] PreferredName:N-(1-oxyl-2,2,5,5-tetramethyl-3-pyrrolidinyl)maleimide SemanticType:[orch] POS:NNS POS:VBD POS:IN POS:DT POS:JJ POS:NN POS:WDT POS:VBP POS:JJ POS:CC POS:VBN POS:TO POS:DT POS:NN POS:VBP POS:RBR POS:JJ POS:TO POS:VB POS:RB POS:VBN POS:, POS:IN POS:DT POS:CD POS:NN POS:CD POS:: POS:NN POS:NN POS:IN POS:JJ POS:NN POS:NN POS:CD POS:NN POS:. 
[sentNum: 52]<Annotation Id="18820" Type="Sentence" StartNode="3730" EndNode="3896">After 18 years of follow-up, one initial study found that 89% of tumors measuring1 cm or less were cured by primary surgery (mastectomy and axillary dissec­tion) (6). PreferredName:year SemanticType:[tmco] PreferredName:Post SemanticType:[tmco] PreferredName:One SemanticType:[qnco] PreferredName:Follow-Up Studies SemanticType:[resa] PreferredName:Present SemanticType:[qnco] PreferredName:Initially SemanticType:[tmco] PreferredName:Less Than SemanticType:[inpr] PreferredName:Neoplasm SemanticType:[neop] PreferredName:Primary operation SemanticType:[topp] PreferredName:Cure (remedy) SemanticType:[cnce] PreferredName:Axilla SemanticType:[blor] PreferredName:Mastectomy SemanticType:[topp] POS:IN POS:CD POS:NNS POS:IN POS:NN POS:, POS:CD POS:JJ POS:NN POS:VBD POS:IN POS:CD POS:NN POS:IN POS:NNS POS:VBG POS:CD POS:NN POS:CC POS:JJR POS:VBD POS:VBN POS:IN POS:JJ POS:NN POS:CD POS:NN POS:CC POS:JJ POS:NN POS:CD POS:CD POS:CD POS:NN POS:. 
[sentNum: 53]<Annotation Id="18821" Type="Sentence" StartNode="3897" EndNode="4203">Other studies have confirmed these results, with 90% of patients experiencing 10-year (or longer) disease-free survival periods after tumors measuring 1cm or less were detected by mammography, indicating the likelihood that the tumors had not yet metastasized before they were diagnosed and treated (7&#x2013;11). PreferredName:Confirmation SemanticType:[idcn] PreferredName:Scientific Study SemanticType:[lbpr] PreferredName:In addition to SemanticType:[qlco] PreferredName:Result SemanticType:[ftcn] PreferredName:Patients SemanticType:[podg] PreferredName:&lt;90 SemanticType:[qnco] PreferredName:per year SemanticType:[tmco] PreferredName:Experience SemanticType:[menp] PreferredName:Disease-Free Survival SemanticType:[qnco] PreferredName:Long SemanticType:[qlco] PreferredName:Neoplasm SemanticType:[neop] PreferredName:Period (temporal qualifier) SemanticType:[tmco] PreferredName:Less Than SemanticType:[inpr] PreferredName:Measured SemanticType:[qlco] PreferredName:Mammography SemanticType:[diap] PreferredName:Detection SemanticType:[topp] PreferredName:Neoplasm SemanticType:[neop] PreferredName:Probability SemanticType:[qnco] PreferredName:Neoplasm Metastasis SemanticType:[neop] PreferredName:Negation SemanticType:[ftcn] PreferredName:Treated with SemanticType:[topp] PreferredName:Diagnosis SemanticType:[fndg] POS:JJ POS:NNS POS:VBP POS:VBN POS:DT POS:NNS POS:, POS:IN POS:CD POS:NN POS:IN POS:NNS POS:VBG POS:CD POS:: POS:NN POS:CD POS:CC POS:JJR POS:CD POS:JJ POS:NN POS:NNS POS:IN POS:NNS POS:VBG POS:CD POS:NN POS:CC POS:JJR POS:VBD POS:VBN POS:IN POS:NN POS:, POS:VBG POS:DT POS:NN POS:IN POS:DT POS:NNS POS:VBD POS:RB POS:RB POS:VBN POS:IN POS:PRP POS:VBD POS:VBN POS:CC POS:VBN POS:NN POS:CD POS:NN POS:CD POS:NN POS:. 
[sentNum: 54]<Annotation Id="18822" Type="Sentence" StartNode="4206" EndNode="4421">By mathematical estimation, a typical ductal adeno­carcinoma with a constant mean doubling time of 100 days would have been present for more than 11 years before it grew to a generally palpable size of 2 cm (12&#x2013;14). PreferredName:estimation &lt;subjective> SemanticType:[menp] PreferredName:Mathematics SemanticType:[ocdi] PreferredName:Ductal Breast Carcinoma SemanticType:[neop] PreferredName:Usual SemanticType:[qlco] PreferredName:Population Mean SemanticType:[qnco] PreferredName:Constant (qualifier) SemanticType:[qlco] PreferredName:Temporal periods of day SemanticType:[tmco] PreferredName:Doubling SemanticType:[acty] PreferredName:year SemanticType:[tmco] PreferredName:Presentation SemanticType:[idcn] PreferredName:size SemanticType:[spco] PreferredName:Palpable SemanticType:[qlco] POS:IN POS:JJ POS:NN POS:, POS:DT POS:JJ POS:JJ POS:NN POS:IN POS:DT POS:JJ POS:NN POS:VBG POS:NN POS:IN POS:CD POS:NNS POS:MD POS:VB POS:VBN POS:JJ POS:IN POS:JJR POS:IN POS:CD POS:NNS POS:IN POS:PRP POS:VBD POS:TO POS:DT POS:RB POS:JJ POS:NN POS:IN POS:CD POS:NN POS:NN POS:CD POS:CD POS:CD POS:NN POS:. 
[sentNum: 55]<Annotation Id="18823" Type="Sentence" StartNode="4422" EndNode="4595">Mammography screening could potentially identify a nonpalpable mass measuring approximately 1mm to1cm during its preclinical phase,3years before it becomes palpable (12&#x2013;15). PreferredName:Mass of body structure SemanticType:[fndg] PreferredName:Screening mammography SemanticType:[topp] PreferredName:Approximate SemanticType:[qlco] PreferredName:Measured SemanticType:[qlco] PreferredName:Phase SemanticType:[tmco] PreferredName:Preclinical SemanticType:[qlco] PreferredName:Palpable SemanticType:[qlco] POS:NN POS:NN POS:MD POS:RB POS:VB POS:DT POS:JJ POS:NN POS:VBG POS:RB POS:CD POS:NN POS:TO POS:CD POS:NN POS:IN POS:PRP$ POS:JJ POS:NN POS:, POS:CD POS:NNS POS:IN POS:PRP POS:VBZ POS:JJ POS:NN POS:CD POS:CD POS:CD POS:NN POS:. 
[sentNum: 56]<Annotation Id="18824" Type="Sentence" StartNode="4596" EndNode="4748">This concept is commonly referred to as sojourn time, which is the time interval when cancer may be detected by screening before it becomes symptomatic. PreferredName:concept SemanticType:[idcn] PreferredName:To SemanticType:[qlco] PreferredName:Referral placed SemanticType:[ftcn] PreferredName:Time SemanticType:[tmco] PreferredName:Sojourn SemanticType:[orch, phsu] PreferredName:Primary malignant neoplasm SemanticType:[neop] PreferredName:Time Interval SemanticType:[tmco] PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:Detection SemanticType:[topp] PreferredName:Symptomatic SemanticType:[ftcn] POS:DT POS:NN POS:VBZ POS:RB POS:VBN POS:TO POS:IN POS:NN POS:NN POS:, POS:WDT POS:VBZ POS:DT POS:NN POS:NN POS:WRB POS:NN POS:MD POS:VB POS:VBN POS:IN POS:VBG POS:IN POS:PRP POS:VBZ POS:JJ POS:. 
[sentNum: 57]<Annotation Id="18825" Type="Sentence" StartNode="4749" EndNode="4886">The sojourn time of an individual type of cancer varies, with more biologically aggressive tumors typically having shorter sojourn times. PreferredName:Sojourn SemanticType:[orch, phsu] PreferredName:Individual SemanticType:[humn] PreferredName:Time SemanticType:[tmco] PreferredName:Primary malignant neoplasm SemanticType:[neop] PreferredName:Type - attribute SemanticType:[qlco] PreferredName:More SemanticType:[ftcn] PreferredName:Varies SemanticType:[inpr] PreferredName:Aggressive course SemanticType:[tmco] PreferredName:biological SemanticType:[qlco] PreferredName:Short Value SemanticType:[qnco] PreferredName:Neoplasm SemanticType:[neop] PreferredName:Time SemanticType:[tmco] PreferredName:Sojourn SemanticType:[orch, phsu] POS:DT POS:NN POS:NN POS:IN POS:DT POS:JJ POS:NN POS:IN POS:NN POS:VBZ POS:, POS:IN POS:JJR POS:RB POS:JJ POS:NNS POS:RB POS:VBG POS:JJR POS:NN POS:NNS POS:. 
[sentNum: 58]<Annotation Id="18826" Type="Sentence" StartNode="4887" EndNode="4962">The great­est predictor of sojourn time in breast cancer appears to be age. PreferredName:Predictor SemanticType:[idcn] PreferredName:Greater SemanticType:[qnco] PreferredName:Time SemanticType:[tmco] PreferredName:Sojourn SemanticType:[orch, phsu] PreferredName:Appearance SemanticType:[qlco] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Age SemanticType:[orga] PreferredName:To SemanticType:[qlco] POS:DT POS:JJS POS:NN POS:IN POS:NN POS:NN POS:IN POS:NN POS:NN POS:VBZ POS:TO POS:VB POS:NN POS:. 
[sentNum: 59]<Annotation Id="18827" Type="Sentence" StartNode="4963" EndNode="5182">Estimates of mean sojourn time for breast cancer in women increase with age: for ages40&#x2013;49 years, mean sojourn timeis2&#x2013;2.4 years;50&#x2013;59 years, 2.5&#x2013;3.7 years; 60&#x2013;69 years, 3.5&#x2013;4.2 years; and 70&#x2013;74 years, 4&#x2013;4.1 years (16). PreferredName:Population Mean SemanticType:[qnco] PreferredName:Estimated SemanticType:[qnco] PreferredName:Time SemanticType:[tmco] PreferredName:Sojourn SemanticType:[orch, phsu] PreferredName:Female Breast Carcinoma SemanticType:[neop] PreferredName:Preposition For SemanticType:[qlco] PreferredName:Age SemanticType:[orga] PreferredName:Increase SemanticType:[ftcn] PreferredName:Population Mean SemanticType:[qnco] PreferredName:year SemanticType:[tmco] PreferredName:year SemanticType:[tmco] PreferredName:Sojourn SemanticType:[orch, phsu] PreferredName:2/5 SemanticType:[qnco] PreferredName:year SemanticType:[tmco] PreferredName:Arabic numeral 69 SemanticType:[inpr] PreferredName:year SemanticType:[tmco] PreferredName:3/5 SemanticType:[qnco] PreferredName:year SemanticType:[tmco] PreferredName:year SemanticType:[tmco] PreferredName:year SemanticType:[tmco] PreferredName:year SemanticType:[tmco] POS:NNS POS:IN POS:NN POS:NN POS:NN POS:IN POS:NN POS:NN POS:IN POS:NNS POS:VBP POS:IN POS:NN POS:: POS:IN POS:NNS POS:CD POS:CD POS:CD POS:NNS POS:, POS:VB POS:NN POS:NN POS:CD POS:NN POS:CD POS:. POS:CD POS:NNS POS:: POS:CD POS:CD POS:CD POS:NNS POS:, POS:CD POS:. POS:CD POS:CD POS:CD POS:. POS:CD POS:NNS POS:: POS:CD POS:CD POS:CD POS:NNS POS:, POS:CD POS:. POS:CD POS:CD POS:CD POS:. POS:CD POS:NNS POS:: POS:CC POS:CD POS:CD POS:CD POS:NNS POS:, POS:CD POS:CD POS:CD POS:. POS:CD POS:NNS POS:RB POS:CD POS:NN POS:. 
[sentNum: 60]<Annotation Id="18828" Type="Sentence" StartNode="5185" EndNode="5320">The mean sojourn time has implications for breast cancer screening because it is desirable to detect tumors during this sojourn period. PreferredName:Population Mean SemanticType:[qnco] PreferredName:Time SemanticType:[tmco] PreferredName:Sojourn SemanticType:[orch, phsu] PreferredName:Detected (finding) SemanticType:[fndg] PreferredName:Screening for malignant neoplasm of breast SemanticType:[topp] PreferredName:Sojourn SemanticType:[orch, phsu] PreferredName:Neoplasm SemanticType:[neop] PreferredName:Period (temporal qualifier) SemanticType:[tmco] POS:DT POS:NN POS:NN POS:NN POS:VBZ POS:NNS POS:IN POS:NN POS:NN POS:NN POS:IN POS:PRP POS:VBZ POS:JJ POS:TO POS:VB POS:NNS POS:IN POS:DT POS:NN POS:NN POS:. 
[sentNum: 61]<Annotation Id="18829" Type="Sentence" StartNode="5321" EndNode="5543">Individuals who are likely to have types of cancer with shorter sojourn times are more likely to benefit from more frequent screening when compared with those with slow-growing tumors that have a larger preclinical window. PreferredName:Individual SemanticType:[humn] PreferredName:Type - attribute SemanticType:[qlco] PreferredName:Probably SemanticType:[idcn] PreferredName:Short Value SemanticType:[qnco] PreferredName:Primary malignant neoplasm SemanticType:[neop] PreferredName:Time SemanticType:[tmco] PreferredName:Sojourn SemanticType:[orch, phsu] PreferredName:Probably SemanticType:[idcn] PreferredName:More SemanticType:[ftcn] PreferredName:Frequent SemanticType:[tmco] PreferredName:Benefits SemanticType:[qnco] PreferredName:Comparison SemanticType:[acty] PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:Neoplasm SemanticType:[neop] PreferredName:Slow SemanticType:[qlco] PreferredName:Preclinical SemanticType:[qlco] PreferredName:Largest SemanticType:[qnco] PreferredName:Interval SemanticType:[tmco] POS:NNS POS:WP POS:VBP POS:JJ POS:TO POS:VB POS:NNS POS:IN POS:NN POS:IN POS:JJR POS:NN POS:NNS POS:VBP POS:RBR POS:JJ POS:TO POS:VB POS:IN POS:JJR POS:JJ POS:NN POS:WRB POS:VBN POS:IN POS:DT POS:IN POS:JJ POS:NNS POS:WDT POS:VBP POS:DT POS:JJR POS:JJ POS:NN POS:. 
[sentNum: 62]<Annotation Id="18830" Type="Sentence" StartNode="5544" EndNode="5734">Screening strat­egies should be designed to maximize the likelihood of detecting the cancer during the preclinical window, when treatment options may be greater and outcomes may be improved. PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:Design SemanticType:[acty] PreferredName:Egypt SemanticType:[geoa] PreferredName:Probability SemanticType:[qnco] PreferredName:To SemanticType:[qlco] PreferredName:Primary malignant neoplasm SemanticType:[neop] PreferredName:Detected (finding) SemanticType:[fndg] PreferredName:Interval SemanticType:[tmco] PreferredName:Preclinical SemanticType:[qlco] PreferredName:Largest SemanticType:[qnco] PreferredName:treatment options SemanticType:[topp] PreferredName:Better SemanticType:[qlco] PreferredName:Result SemanticType:[ftcn] POS:VBG POS:NNS POS:MD POS:VB POS:VBN POS:TO POS:VB POS:DT POS:NN POS:IN POS:VBG POS:DT POS:NN POS:IN POS:DT POS:JJ POS:NN POS:, POS:WRB POS:NN POS:NNS POS:MD POS:VB POS:JJR POS:CC POS:NNS POS:MD POS:VB POS:VBN POS:. 
[sentNum: 63]<Annotation Id="18831" Type="Sentence" StartNode="5741" EndNode="5766">Evaluation of Mammography PreferredName:Mammography SemanticType:[diap] PreferredName:Evaluation SemanticType:[ftcn] POS:NN POS:IN POS:NN 
[sentNum: 64]<Annotation Id="18832" Type="Sentence" StartNode="5769" EndNode="5964">A recent meta-analysis conducted for the United States Preventive Services Task Force reviewed eight random­ized controlled trials of mammographic screening con­ducted between 1986 and 2006 (17). PreferredName:Meta-Analysis (publications) SemanticType:[inpr] PreferredName:Recent SemanticType:[tmco] PreferredName:United States SemanticType:[geoa] PreferredName:Behavior SemanticType:[inbe] PreferredName:Advisory Committees SemanticType:[gora] PreferredName:Preventive service healthcare SemanticType:[hlca] PreferredName:Eight SemanticType:[qnco] PreferredName:Review [Publication Type] SemanticType:[inpr] PreferredName:Within SemanticType:[spco] PreferredName:Randomized Controlled Trials as Topic SemanticType:[inpr, resa] PreferredName:Screening mammography SemanticType:[topp] POS:DT POS:JJ POS:NN POS:VBN POS:IN POS:DT POS:NNP POS:NNPS POS:NNP POS:NNPS POS:NNP POS:NNP POS:VBN POS:CD POS:VBN POS:JJ POS:NNS POS:IN POS:JJ POS:NN POS:NN POS:IN POS:CD POS:CC POS:CD POS:CD POS:CD POS:NN POS:. 
[sentNum: 65]<Annotation Id="18833" Type="Sentence" StartNode="5965" EndNode="6201">Despite some study limitations (all studies were rated of &#x201c;fair&#x201d; quality by the United States Preventive Services Task Force), this review reaffirmed a reduction in breast cancer-related mortalityfor womenaged39&#x2013;69 yearswho were invited PreferredName:Study SemanticType:[resa] PreferredName:Scientific Study SemanticType:[lbpr] PreferredName:Limitation SemanticType:[ftcn] PreferredName:Fair (qualifier) SemanticType:[qlco] PreferredName:Rating (action) SemanticType:[acty] PreferredName:United States SemanticType:[geoa] PreferredName:Quality SemanticType:[qlco] PreferredName:Advisory Committees SemanticType:[gora] PreferredName:Preventive service healthcare SemanticType:[hlca] PreferredName:Reduction - action SemanticType:[topp] PreferredName:Act Class - review SemanticType:[idcn] PreferredName:Relationships SemanticType:[qlco] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Arabic numeral 69 SemanticType:[inpr] POS:IN POS:DT POS:NN POS:NNS POS:VBP POS:DT POS:NNS POS:VBD POS:VBN POS:IN POS:CD POS:JJ POS:JJ POS:NN POS:IN POS:DT POS:NNP POS:NNPS POS:NNP POS:NNPS POS:NNP POS:NNP POS:NN POS:, POS:DT POS:NN POS:VBD POS:DT POS:NN POS:IN POS:NN POS:JJ POS:NN POS:VBD POS:CD POS:CD POS:CD POS:NN POS:VBD POS:VBN 
[sentNum: 66]<Annotation Id="18834" Type="Sentence" StartNode="6204" EndNode="6212">Table 2. PreferredName:Table - furniture SemanticType:[mnob] POS:NNP POS:CD POS:. 
[sentNum: 67]<Annotation Id="18835" Type="Sentence" StartNode="6213" EndNode="6252">Breast Cancer Screening Recommendations PreferredName:Recommendation SemanticType:[idcn] PreferredName:Screening for malignant neoplasm of breast SemanticType:[topp] POS:NN POS:NN POS:VBG POS:NNS 
[sentNum: 68]<Annotation Id="18836" Type="Sentence" StartNode="6257" EndNode="6358">Mammography  Clinical Breast Examination  Breast Self-Examination Instruction  Breast Self- Awareness PreferredName:Clinical SemanticType:[qlco] PreferredName:Mammography SemanticType:[diap] PreferredName:Awareness SemanticType:[menp] PreferredName:Breast self-examination technique education SemanticType:[hlca] POS:NN POS:JJ POS:NN POS:NN POS:NN POS:NN POS:NN POS:NN POS:NN POS:NN POS:NN 
[sentNum: 69]<Annotation Id="18837" Type="Sentence" StartNode="6362" EndNode="6562">American College of Obstetricians and Gynecologists	  Age 40 years and older annually	  Age 20&#x2013;39 years every 1&#x2013;3 years	 Age 40 years and older annually  Consider for high-risk	 patients	  Recommended	PreferredName:Age-Years SemanticType:[tmco] PreferredName:American College of Obstetricians and Gynecologists SemanticType:[pros] PreferredName:Old age SemanticType:[popg] PreferredName:/40 SemanticType:[tmco] PreferredName:year SemanticType:[tmco] PreferredName:Annual SemanticType:[tmco] PreferredName:year SemanticType:[tmco] PreferredName:1+ Score, WHO SemanticType:[clas] PreferredName:/40 SemanticType:[tmco] PreferredName:Age SemanticType:[orga] PreferredName:Annual SemanticType:[tmco] PreferredName:Old SemanticType:[tmco] PreferredName:High risk of SemanticType:[qlco] PreferredName:consider SemanticType:[idcn] PreferredName:Recommendation SemanticType:[idcn] PreferredName:Patients SemanticType:[podg] POS:NNP POS:NNP POS:IN POS:NNPS POS:CC POS:NNPS POS:NNP POS:CD POS:NNS POS:CC POS:JJR POS:RB POS:NNP POS:CD POS:CD POS:CD POS:NNS POS:DT POS:CD POS:NN POS:CD POS:NNS POS:NNP POS:CD POS:NNS POS:CC POS:JJR POS:RB POS:VB POS:IN POS:JJ POS:NNS POS:VBN 
[sentNum: 70]<Annotation Id="18838" Type="Sentence" StartNode="6567" EndNode="6711">American Cancer Society	  Age 40 years and older annually	  Age 20&#x2013;39 years	 every 1&#x2013;3 years  Optional for age 20 years	 and older	  Recommended	PreferredName:Age-Years SemanticType:[tmco] PreferredName:American Cancer Society SemanticType:[pros] PreferredName:Old age SemanticType:[popg] PreferredName:/40 SemanticType:[tmco] PreferredName:year SemanticType:[tmco] PreferredName:Annual SemanticType:[tmco] PreferredName:year SemanticType:[tmco] PreferredName:1+ Score, WHO SemanticType:[clas] PreferredName:Age-Years SemanticType:[tmco] PreferredName:Optional SemanticType:[qlco] PreferredName:Recommendation SemanticType:[idcn] PreferredName:Old age SemanticType:[popg] POS:NNP POS:NNP POS:NNP POS:NNP POS:CD POS:NNS POS:CC POS:JJR POS:RB POS:NNP POS:CD POS:CD POS:CD POS:NNS POS:DT POS:CD POS:NN POS:CD POS:NNS POS:JJ POS:IN POS:NN POS:CD POS:NNS POS:CC POS:JJR POS:VBN 
[sentNum: 71]<Annotation Id="18839" Type="Sentence" StartNode="6716" EndNode="6748">Age 40 years and	 older annually	PreferredName:year SemanticType:[tmco] PreferredName:/40 SemanticType:[tmco] PreferredName:Annual SemanticType:[tmco] PreferredName:Old age SemanticType:[popg] POS:NNP POS:CD POS:NNS POS:CC POS:JJR POS:RB 
[sentNum: 72]<Annotation Id="18840" Type="Sentence" StartNode="6753" EndNode="6887">National Comprehensive Cancer Network	  Age 40 years and	 older annually	  Age 20&#x2013;39 years	 every 1&#x2013;3 years  Recommended	  Recommended	PreferredName:/40 SemanticType:[tmco] PreferredName:National Comprehensive Cancer Network SemanticType:[hcro] PreferredName:Old age SemanticType:[popg] PreferredName:year SemanticType:[tmco] PreferredName:year SemanticType:[tmco] PreferredName:Annual SemanticType:[tmco] PreferredName:year SemanticType:[tmco] PreferredName:1+ Score, WHO SemanticType:[clas] PreferredName:Recommendation SemanticType:[idcn] PreferredName:Recommendation SemanticType:[idcn] POS:NNP POS:NNP POS:NNP POS:NNP POS:NNP POS:CD POS:NNS POS:CC POS:JJR POS:RB POS:NNP POS:CD POS:CD POS:CD POS:NNS POS:DT POS:CD POS:NN POS:CD POS:NNS POS:VBN POS:VBN 
[sentNum: 73]<Annotation Id="18841" Type="Sentence" StartNode="6892" EndNode="6924">Age 40 years and	 older annually	PreferredName:/40 SemanticType:[tmco] PreferredName:Age-Years SemanticType:[tmco] PreferredName:Annual SemanticType:[tmco] PreferredName:Old age SemanticType:[popg] POS:NNP POS:CD POS:NNS POS:CC POS:JJR POS:RB 
[sentNum: 74]<Annotation Id="18842" Type="Sentence" StartNode="6929" EndNode="7032">National Cancer Institute	  Age 40 years and	 older every 1&#x2013;2 years	  Recommended	  Not recommended	  &#x2014;	PreferredName:/40 SemanticType:[tmco] PreferredName:National Cancer Institute SemanticType:[hcro] PreferredName:Old SemanticType:[tmco] PreferredName:year SemanticType:[tmco] PreferredName:year SemanticType:[tmco] PreferredName:Phase I/II Trial SemanticType:[resa] PreferredName:Negation SemanticType:[ftcn] PreferredName:Recommendation SemanticType:[idcn] PreferredName:Recommendation SemanticType:[idcn] POS:NNP POS:NNP POS:NNP POS:NNP POS:CD POS:NNS POS:CC POS:JJR POS:DT POS:CD POS:NN POS:CD POS:NNS POS:VBN POS:RB POS:VBN POS:NN 
[sentNum: 75]<Annotation Id="18843" Type="Sentence" StartNode="7037" EndNode="7147">U.S. Preventive Services Task Force	  Age 50&#x2013;74 years biennially	  Insufficient evidence	  Not recommended	  &#x2014; PreferredName:United States SemanticType:[geoa] PreferredName:Advisory Committees SemanticType:[gora] PreferredName:Preventive service healthcare SemanticType:[hlca] PreferredName:Insufficient (qualifier) SemanticType:[qlco] PreferredName:Age-Years SemanticType:[tmco] PreferredName:Negation SemanticType:[ftcn] PreferredName:Evidence of SemanticType:[ftcn] PreferredName:Recommendation SemanticType:[idcn] POS:NNP POS:. POS:NN POS:. POS:NNP POS:NNPS POS:NNP POS:NNP POS:NNP POS:CD POS:CD POS:CD POS:NNS POS:RB POS:JJ POS:NN POS:RB POS:VBD POS:CD 
[sentNum: 76]<Annotation Id="18844" Type="Sentence" StartNode="7153" EndNode="7167">for screening. PreferredName:Aspects of disease screening SemanticType:[ftcn] POS:IN POS:NN POS:. 
[sentNum: 77]<Annotation Id="18845" Type="Sentence" StartNode="7168" EndNode="7265">This is consistent with the mortality reduc­tions demonstrated in previous meta-analyses (18&#x2013;22). PreferredName:Mortality Vital Statistics SemanticType:[qnco] PreferredName:Consistent with SemanticType:[idcn] PreferredName:Meta Analysis (statistical procedure) SemanticType:[resa] PreferredName:Previous SemanticType:[tmco] PreferredName:18/22 SemanticType:[qnco] POS:DT POS:VBZ POS:JJ POS:IN POS:DT POS:NN POS:NNS POS:VBD POS:IN POS:JJ POS:NNS POS:VBP POS:CD POS:CD POS:CD POS:NN POS:. 
[sentNum: 78]<Annotation Id="18846" Type="Sentence" StartNode="7268" EndNode="7446">Relative risk of breast cancer mortality in women invited for screening was 0.85 for women aged 39&#x2013;49 years; 0.86 for women aged 50&#x2013;59 years; and 0.68 for women aged 60&#x2013;69 years. PreferredName:Relative Risk SemanticType:[qnco] PreferredName:Mortality Vital Statistics SemanticType:[qnco] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:Woman SemanticType:[popg] PreferredName:Age SemanticType:[orga] PreferredName:Woman SemanticType:[popg] PreferredName:Woman SemanticType:[popg] PreferredName:year SemanticType:[tmco] PreferredName:year SemanticType:[tmco] PreferredName:Age SemanticType:[orga] PreferredName:Woman SemanticType:[popg] PreferredName:Arabic numeral 68 SemanticType:[inpr] PreferredName:Arabic numeral 69 SemanticType:[inpr] PreferredName:Age SemanticType:[orga] PreferredName:year SemanticType:[tmco] POS:JJ POS:NN POS:IN POS:NN POS:NN POS:NN POS:IN POS:NNS POS:VBN POS:IN POS:NN POS:VBD POS:CD POS:. POS:CD POS:IN POS:NNS POS:JJ POS:CD POS:CD POS:CD POS:NNS POS:: POS:CD POS:. POS:CD POS:IN POS:NNS POS:JJ POS:CD POS:CD POS:CD POS:NNS POS:: POS:CC POS:CD POS:. POS:CD POS:IN POS:NNS POS:JJ POS:CD POS:CD POS:CD POS:NNS POS:. 
[sentNum: 79]<Annotation Id="18847" Type="Sentence" StartNode="7447" EndNode="7554">Evidence was insufficient to demonstrate a mortality reduction for women aged 70 years and older (Table 3). PreferredName:Evidence of SemanticType:[ftcn] PreferredName:Mortality Vital Statistics SemanticType:[qnco] PreferredName:Insufficient (qualifier) SemanticType:[qlco] PreferredName:Woman SemanticType:[popg] PreferredName:Reduction - action SemanticType:[topp] PreferredName:year SemanticType:[tmco] PreferredName:Age SemanticType:[orga] PreferredName:Table - furniture SemanticType:[mnob] PreferredName:Old SemanticType:[tmco] POS:NN POS:VBD POS:JJ POS:TO POS:VB POS:DT POS:NN POS:NN POS:IN POS:NNS POS:JJ POS:CD POS:NNS POS:CC POS:JJR POS:CD POS:NNP POS:CD POS:NN POS:. 
[sentNum: 80]<Annotation Id="18848" Type="Sentence" StartNode="7555" EndNode="7783">However, because of the increasing incidence of breast cancer as women age, more young women (aged 39&#x2013;49 years) had to be invited for screening to prevent one breast cancer-related death when compared with older women (Table 3). PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:increasing incidence SemanticType:[ftcn] PreferredName:Age SemanticType:[orga] PreferredName:Woman SemanticType:[popg] PreferredName:Young SemanticType:[tmco] PreferredName:More SemanticType:[ftcn] PreferredName:Age-Years SemanticType:[tmco] PreferredName:Woman SemanticType:[popg] PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:To SemanticType:[qlco] PreferredName:One SemanticType:[qnco] PreferredName:PREVENT (product) SemanticType:[phsu] PreferredName:Relationships SemanticType:[qlco] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Comparison SemanticType:[acty] PreferredName:Cessation of life SemanticType:[orgf] PreferredName:Woman SemanticType:[popg] PreferredName:Old SemanticType:[tmco] PreferredName:Table - furniture SemanticType:[mnob] POS:RB POS:, POS:IN POS:IN POS:DT POS:VBG POS:NN POS:IN POS:NN POS:NN POS:IN POS:NNS POS:NN POS:, POS:JJR POS:JJ POS:NNS POS:VBP POS:JJ POS:CD POS:CD POS:CD POS:NNS POS:CD POS:VBD POS:TO POS:VB POS:VBN POS:IN POS:VBG POS:TO POS:VB POS:CD POS:NN POS:JJ POS:NN POS:WRB POS:VBN POS:IN POS:JJR POS:NNS POS:VBP POS:NNP POS:CD POS:NN POS:. 
[sentNum: 81]<Annotation Id="18849" Type="Sentence" StartNode="7784" EndNode="8012">The number needed to invite for screening (over several rounds of screening and at least 11 years of follow-up) to prevent one breast cancer deathin women aged39&#x2013;49 years was 1,904, compared with 1,339 in women aged 50&#x2013;59 years. PreferredName:Numbers SemanticType:[qnco] PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:Needs SemanticType:[qlco] PreferredName:Round shape SemanticType:[spco] PreferredName:Over (spatial) SemanticType:[spco] PreferredName:And SemanticType:[idcn] PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:Follow-up status SemanticType:[fndg] PreferredName:year SemanticType:[tmco] PreferredName:PREVENT (product) SemanticType:[phsu] PreferredName:To SemanticType:[qlco] PreferredName:Malignant neoplasm of female breast SemanticType:[neop] PreferredName:One SemanticType:[qnco] PreferredName:1+ Score SemanticType:[qnco] PreferredName:year SemanticType:[tmco] PreferredName:Woman SemanticType:[popg] PreferredName:Comparison SemanticType:[acty] PreferredName:year SemanticType:[tmco] PreferredName:Age SemanticType:[orga] POS:DT POS:NN POS:VBN POS:TO POS:VB POS:IN POS:JJ POS:NN POS:IN POS:JJ POS:NNS POS:IN POS:NN POS:CC POS:IN POS:JJS POS:CD POS:NNS POS:IN POS:NN POS:CD POS:TO POS:VB POS:CD POS:NN POS:NN POS:NN POS:NNS POS:JJ POS:CD POS:CD POS:CD POS:NNS POS:VBD POS:CD POS:, POS:CD POS:, POS:VBN POS:IN POS:CD POS:, POS:CD POS:IN POS:NNS POS:JJ POS:CD POS:CD POS:CD POS:NNS POS:. 
[sentNum: 82]<Annotation Id="18850" Type="Sentence" StartNode="8013" EndNode="8269">This difference in number needed to invite for screening to prevent one death was a key reason the United States Preventive Services Task Force elected not to recommend routine screening for women aged40&#x2013;49 years, despite similar mortality reductions (23). PreferredName:Delta (difference) SemanticType:[qnco] PreferredName:This SemanticType:[euka] PreferredName:Needs SemanticType:[qlco] PreferredName:Numbers SemanticType:[qnco] PreferredName:PREVENT (product) SemanticType:[phsu] PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:Cessation of life SemanticType:[orgf] PreferredName:One SemanticType:[qnco] PreferredName:United States SemanticType:[geoa] PreferredName:Indication of (contextual qualifier) SemanticType:[idcn] PreferredName:Advisory Committees SemanticType:[gora] PreferredName:Preventive service healthcare SemanticType:[hlca] PreferredName:Recommendation SemanticType:[idcn] PreferredName:Negation SemanticType:[ftcn] PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:Routine SemanticType:[qlco] PreferredName:year SemanticType:[tmco] PreferredName:Woman SemanticType:[popg] PreferredName:Mortality Vital Statistics SemanticType:[qnco] PreferredName:Similarity SemanticType:[qlco] PreferredName:Arabic numeral 23 SemanticType:[qnco] PreferredName:Reduction - action SemanticType:[topp] POS:DT POS:NN POS:IN POS:NN POS:VBN POS:TO POS:VB POS:IN POS:VBG POS:TO POS:VB POS:CD POS:NN POS:VBD POS:DT POS:JJ POS:NN POS:DT POS:NNP POS:NNPS POS:NNP POS:NNPS POS:NNP POS:NNP POS:VBD POS:RB POS:TO POS:VB POS:JJ POS:NN POS:IN POS:NNS POS:JJ POS:CD POS:CD POS:CD POS:NNS POS:, POS:IN POS:JJ POS:NN POS:NNS POS:VBP POS:CD POS:CD POS:. 
[sentNum: 83]<Annotation Id="18851" Type="Sentence" StartNode="8272" EndNode="8563">Because of differences in study design, with most randomized clinical trials evaluating biennial mammo­graphic screening, these randomized controlled trials do not provide meaningful comparisons between different screening strategies in terms of age at initiation, cessa­tion, and frequency. PreferredName:Research Design SemanticType:[resa] PreferredName:Delta (difference) SemanticType:[qnco] PreferredName:Evaluation SemanticType:[ftcn] PreferredName:Clinical Trials, Randomized SemanticType:[inpr, resa] PreferredName:Randomized Controlled Trials as Topic SemanticType:[inpr, resa] PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:Providing (action) SemanticType:[acty] PreferredName:Negation SemanticType:[ftcn] PreferredName:Comparison SemanticType:[acty] PreferredName:Meaning SemanticType:[idcn] PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:Different SemanticType:[qlco] PreferredName:Term (temporal) SemanticType:[tmco] PreferredName:strategy SemanticType:[menp] PreferredName:Cognitive function: initiation SemanticType:[menp] PreferredName:Age SemanticType:[orga] PreferredName:Frequencies (time pattern) SemanticType:[tmco] POS:IN POS:IN POS:NNS POS:IN POS:NN POS:NN POS:, POS:IN POS:JJS POS:VBN POS:JJ POS:NNS POS:VBG POS:JJ POS:JJ POS:NN POS:, POS:DT POS:VBN POS:JJ POS:NNS POS:VBP POS:RB POS:VB POS:JJ POS:NNS POS:IN POS:JJ POS:NN POS:NNS POS:IN POS:NNS POS:IN POS:NN POS:IN POS:NN POS:, POS:NN POS:, POS:CC POS:NN POS:. 
[sentNum: 84]<Annotation Id="18852" Type="Sentence" StartNode="8564" EndNode="8794">The lack of clear evidence on this issue led the United States Preventive Services Task Force to commission the creation of screening models that could compare different strategies to help guide national screening recommendations. PreferredName:Lacking SemanticType:[qlco] PreferredName:Evidence of SemanticType:[ftcn] PreferredName:Clear SemanticType:[qlco] PreferredName:Light Emitting Diode Device Component SemanticType:[mnob] PreferredName:Problem SemanticType:[fndg] PreferredName:Preventive service healthcare SemanticType:[hlca] PreferredName:United States SemanticType:[geoa] PreferredName:Surgical construction SemanticType:[topp] PreferredName:Advisory Committees SemanticType:[gora] PreferredName:Model SemanticType:[inpr] PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:Different SemanticType:[qlco] PreferredName:Comparison SemanticType:[acty] PreferredName:Helping Behavior SemanticType:[socb] PreferredName:strategy SemanticType:[menp] PreferredName:National citizen SemanticType:[inpr] PreferredName:Professional guide SemanticType:[prog] PreferredName:Recommendation SemanticType:[idcn] PreferredName:Aspects of disease screening SemanticType:[ftcn] POS:DT POS:NN POS:IN POS:JJ POS:NN POS:IN POS:DT POS:NN POS:VBD POS:DT POS:NNP POS:NNPS POS:NNP POS:NNPS POS:NNP POS:NNP POS:TO POS:VB POS:DT POS:NN POS:IN POS:NN POS:NNS POS:WDT POS:MD POS:VB POS:JJ POS:NNS POS:TO POS:VB POS:NN POS:JJ POS:JJ POS:NNS POS:. 
[sentNum: 85]<Annotation Id="18853" Type="Sentence" StartNode="8795" EndNode="8966">These six models were created by independent investigative groups that are a part of the National Cancer Institute&#x2019;s Cancer Intervention and Surveillance Modeling Network. PreferredName:Model SemanticType:[inpr] PreferredName:Six SemanticType:[qnco] PreferredName:Independence SemanticType:[idcn] PreferredName:Created By SemanticType:[qlco] PreferredName:Part of SemanticType:[spco] PreferredName:Groups SemanticType:[idcn] PreferredName:Intervention regimes SemanticType:[hlca] PreferredName:National Cancer Institute SemanticType:[hcro] PreferredName:Consortium or Network SemanticType:[prog] PreferredName:Surveillance Modeling SemanticType:[resa] POS:DT POS:CD POS:NNS POS:VBD POS:VBN POS:IN POS:JJ POS:JJ POS:NNS POS:WDT POS:VBP POS:DT POS:NN POS:IN POS:DT POS:NNP POS:NNP POS:NNP POS:NN POS:VBZ POS:NN POS:NN POS:CC POS:NNP POS:NNP POS:NNP POS:. 
[sentNum: 86]<Annotation Id="18854" Type="Sentence" StartNode="8967" EndNode="9214">These models were created using a common set of age-specific variables, with the goal of identifying efficient screen­ing strategies (ie, those that produce a gain in mortality reduction or a gain in life years per additional screening mammogram). PreferredName:Creation SemanticType:[acty] PreferredName:Model SemanticType:[inpr] PreferredName:shared attribute SemanticType:[ftcn] PreferredName:Use of SemanticType:[ftcn] PreferredName:Age SemanticType:[orga] PreferredName:Set scale SemanticType:[ftcn] PreferredName:Variable (uniformity) SemanticType:[qlco] PreferredName:Specific qualifier value SemanticType:[qlco] PreferredName:objective (goal) SemanticType:[inpr] PreferredName:In addition to SemanticType:[qlco] PreferredName:Screening - procedure intent SemanticType:[ftcn] PreferredName:Efficient SemanticType:[qlco] PreferredName:Gain SemanticType:[qnco] PreferredName:strategy SemanticType:[menp] PreferredName:Reduction - action SemanticType:[topp] PreferredName:Mortality Vital Statistics SemanticType:[qnco] PreferredName:Life SemanticType:[idcn] PreferredName:Gain SemanticType:[qnco] PreferredName:Additional SemanticType:[ftcn] PreferredName:year SemanticType:[tmco] PreferredName:Screening mammography SemanticType:[topp] POS:DT POS:NNS POS:VBD POS:VBN POS:VBG POS:DT POS:JJ POS:NN POS:IN POS:JJ POS:NNS POS:, POS:IN POS:DT POS:NN POS:IN POS:VBG POS:JJ POS:VBG POS:NNS POS:CD POS:FW POS:, POS:DT POS:WDT POS:VBP POS:DT POS:NN POS:IN POS:NN POS:NN POS:CC POS:DT POS:NN POS:IN POS:NN POS:NNS POS:IN POS:JJ POS:NN POS:NN POS:NN POS:. 
[sentNum: 87]<Annotation Id="18855" Type="Sentence" StartNode="9217" EndNode="9400">Biennial screening was used in seven of eight screening strategies found to be efficient in reducing mortality, and in six of these eight strategies, screen­ing began at age 50 years. PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:Seven SemanticType:[qnco] PreferredName:Use of SemanticType:[ftcn] PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:Eight SemanticType:[qnco] PreferredName:Present SemanticType:[qnco] PreferredName:strategy SemanticType:[menp] PreferredName:Efficient SemanticType:[qlco] PreferredName:To SemanticType:[qlco] PreferredName:Mortality Vital Statistics SemanticType:[qnco] PreferredName:Reduced SemanticType:[qlco] PreferredName:Six SemanticType:[qnco] PreferredName:And SemanticType:[idcn] PreferredName:strategy SemanticType:[menp] PreferredName:Eight SemanticType:[qnco] PreferredName:Beginning SemanticType:[tmco] PreferredName:Screening - procedure intent SemanticType:[ftcn] PreferredName:Age-Years SemanticType:[tmco] POS:JJ POS:NN POS:VBD POS:VBN POS:IN POS:CD POS:IN POS:CD POS:NN POS:NNS POS:VBN POS:TO POS:VB POS:JJ POS:IN POS:VBG POS:NN POS:, POS:CC POS:IN POS:CD POS:IN POS:DT POS:CD POS:NNS POS:, POS:VBG POS:VBD POS:IN POS:NN POS:CD POS:NNS POS:. 
[sentNum: 88]<Annotation Id="18856" Type="Sentence" StartNode="9401" EndNode="9585">A review of the strategies concluded that more lives could be saved by extending screening to women older than 69 years, rather than extending screening to women aged 40&#x2013;49 years (24). PreferredName:Act Class - review SemanticType:[idcn] PreferredName:Conclude Resin SemanticType:[bodm, orch] PreferredName:strategy SemanticType:[menp] PreferredName:% live SemanticType:[qlco] PreferredName:More SemanticType:[ftcn] PreferredName:Extent SemanticType:[spco] PreferredName:Commit Operation SemanticType:[mcha] PreferredName:Woman SemanticType:[popg] PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:Arabic numeral 69 SemanticType:[inpr] PreferredName:Old SemanticType:[tmco] PreferredName:Extent SemanticType:[spco] PreferredName:year SemanticType:[tmco] PreferredName:Woman SemanticType:[popg] PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:/40 SemanticType:[tmco] PreferredName:Age SemanticType:[orga] PreferredName:year SemanticType:[tmco] POS:DT POS:NN POS:IN POS:DT POS:NNS POS:VBD POS:IN POS:JJR POS:NNS POS:MD POS:VB POS:VBN POS:IN POS:VBG POS:NN POS:TO POS:NNS POS:JJR POS:IN POS:CD POS:NNS POS:, POS:RB POS:IN POS:VBG POS:NN POS:TO POS:NNS POS:VBN POS:CD POS:CD POS:CD POS:NNS POS:VBP POS:CD POS:CD POS:. 
[sentNum: 89]<Annotation Id="18857" Type="Sentence" StartNode="9586" EndNode="9733">However, when defining benefit as number of life years gained through screening, screening was started at age 40 years in four of eight strategies. PreferredName:Benefits SemanticType:[qnco] PreferredName:Life SemanticType:[idcn] PreferredName:Numbers SemanticType:[qnco] PreferredName:Gain SemanticType:[qnco] PreferredName:year SemanticType:[tmco] PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:/40 SemanticType:[tmco] PreferredName:Age Started SemanticType:[tmco] PreferredName:Within SemanticType:[spco] PreferredName:year SemanticType:[tmco] PreferredName:Eight SemanticType:[qnco] PreferredName:Four SemanticType:[qnco] PreferredName:strategy SemanticType:[menp] POS:RB POS:, POS:WRB POS:VBG POS:NN POS:IN POS:NN POS:IN POS:NN POS:NNS POS:VBN POS:IN POS:NN POS:, POS:NN POS:VBD POS:VBN POS:IN POS:NN POS:CD POS:NNS POS:IN POS:CD POS:IN POS:CD POS:NNS POS:. 
[sentNum: 90]<Annotation Id="18858" Type="Sentence" StartNode="9734" EndNode="9920">Although annual screening was an efficient strategy for reducing breast cancer mortality and increasing life years gained, it was noted by the authors to be more resource intensive (24). PreferredName:annual screening SemanticType:[diap] PreferredName:strategy SemanticType:[menp] PreferredName:Efficient SemanticType:[qlco] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Reduced SemanticType:[qlco] PreferredName:Increasing SemanticType:[ftcn] PreferredName:Mortality Vital Statistics SemanticType:[qnco] PreferredName:year SemanticType:[tmco] PreferredName:Life SemanticType:[idcn] PreferredName:Evaluation and management note:Finding:Point in time:{Setting}:Document:{Provider} SemanticType:[clna] PreferredName:Gain SemanticType:[qnco] PreferredName:More SemanticType:[ftcn] PreferredName:Journalist SemanticType:[prog] PreferredName:Resources SemanticType:[idcn] POS:IN POS:JJ POS:NN POS:VBD POS:DT POS:JJ POS:NN POS:IN POS:VBG POS:NN POS:NN POS:NN POS:CC POS:VBG POS:NN POS:NNS POS:VBN POS:, POS:PRP POS:VBD POS:VBN POS:IN POS:DT POS:NNS POS:TO POS:VB POS:RBR POS:NN POS:JJ POS:NN POS:CD POS:NN POS:. 
[sentNum: 91]<Annotation Id="18859" Type="Sentence" StartNode="9929" EndNode="9953">Other Imaging Techniques PreferredName:Imaging Techniques SemanticType:[diap] POS:JJ POS:NNP POS:NNS 
[sentNum: 92]<Annotation Id="18860" Type="Sentence" StartNode="9956" EndNode="10040">Ultrasonography is an established adjunct to mammog­raphy in the imaging evaluation. PreferredName:Accepted SemanticType:[qlco] PreferredName:Ultrasonography SemanticType:[diap] PreferredName:Evaluation procedure SemanticType:[hlca] PreferredName:Imaging Techniques SemanticType:[diap] POS:NNP POS:VBZ POS:DT POS:JJ POS:NN POS:TO POS:NN POS:IN POS:DT POS:NN POS:NN POS:. 
[sentNum: 93]<Annotation Id="18861" Type="Sentence" StartNode="10041" EndNode="10293">It is useful in eval-	 uating inconclusive mammographic findings, in evaluat­ing young patients and other women with dense breast tissue, in guiding tissue core-needle biopsy and other biopsy techniques, and in differentiating a cyst from a solid mass. PreferredName:CDISC SDTM Evaluator Terminology SemanticType:[inpr] PreferredName:utilization qualifier SemanticType:[ftcn] PreferredName:Mammography finding SemanticType:[fndg] PreferredName:Inconclusive (qualifier value) SemanticType:[qlco] PreferredName:Patients SemanticType:[podg] PreferredName:Young SemanticType:[tmco] PreferredName:Woman SemanticType:[popg] PreferredName:Other SemanticType:[qlco] PreferredName:Breast tissue sample SemanticType:[bpoc] PreferredName:Dense SemanticType:[qlco] PreferredName:Tissue Specimen Code SemanticType:[inpr] PreferredName:Guide device SemanticType:[medd] PreferredName:Method of biopsy SemanticType:[hlca] PreferredName:Core needle biopsy SemanticType:[diap] PreferredName:Well Differentiated SemanticType:[qlco] PreferredName:And SemanticType:[idcn] PreferredName:Cyst SemanticType:[dsyn] PreferredName:Mass of body structure SemanticType:[fndg] PreferredName:Solid SemanticType:[qlco] POS:PRP POS:VBZ POS:JJ POS:IN POS:JJ POS:JJ POS:JJ POS:JJ POS:NNS POS:, POS:IN POS:VBG POS:JJ POS:NNS POS:CC POS:JJ POS:NNS POS:IN POS:JJ POS:NN POS:NN POS:, POS:IN POS:VBG POS:NN POS:JJ POS:NN POS:CC POS:JJ POS:NN POS:NNS POS:, POS:CC POS:IN POS:VBG POS:DT POS:NN POS:IN POS:DT POS:JJ POS:NN POS:. 
[sentNum: 94]<Annotation Id="18862" Type="Sentence" StartNode="10294" EndNode="10394">It is not recommended as a screening modality for women at average risk of developing breast cancer. PreferredName:Negation SemanticType:[ftcn] PreferredName:Disease Screening SemanticType:[diap] PreferredName:Recommendation SemanticType:[idcn] PreferredName:Preposition For SemanticType:[qlco] PreferredName:Diagnostic Radiology Modality SemanticType:[diap] PreferredName:Average SemanticType:[qnco] PreferredName:Woman SemanticType:[popg] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Risk SemanticType:[qlco] POS:PRP POS:VBZ POS:RB POS:VBN POS:IN POS:DT POS:NN POS:NN POS:IN POS:NNS POS:IN POS:JJ POS:NN POS:IN POS:VBG POS:NN POS:NN POS:. 
[sentNum: 95]<Annotation Id="18863" Type="Sentence" StartNode="10395" EndNode="10549">Ultrasonography may be an option for additional screening in women at high risk who are candidates for magnetic resonance imaging (MRI) screening but can-PreferredName:Options SemanticType:[ftcn] PreferredName:Ultrasonography SemanticType:[diap] PreferredName:Disease Screening SemanticType:[diap] PreferredName:Additional SemanticType:[ftcn] PreferredName:Woman SemanticType:[popg] PreferredName:Present SemanticType:[qnco] PreferredName:Magnetic Resonance Imaging SemanticType:[diap] PreferredName:High risk of SemanticType:[qlco] PreferredName:Disease Screening SemanticType:[diap] POS:NN POS:MD POS:VB POS:DT POS:NN POS:IN POS:JJ POS:NN POS:IN POS:NNS POS:IN POS:JJ POS:NN POS:WP POS:VBP POS:NNS POS:IN POS:JJ POS:NN POS:NN POS:CD POS:NNP POS:CD POS:NN POS:CC POS:NN 
[sentNum: 96]<Annotation Id="18864" Type="Sentence" StartNode="10553" EndNode="10561">Table 3. PreferredName:Table - furniture SemanticType:[mnob] POS:NNP POS:CD POS:. 
[sentNum: 97]<Annotation Id="18865" Type="Sentence" StartNode="10562" EndNode="10658">Pooled Relative Risks for Breast Cancer Mortality From Mammography Screening Trials for All Ages PreferredName:Relative Risk SemanticType:[qnco] PreferredName:Pooled Sample SemanticType:[sbst] PreferredName:Mortality Vital Statistics SemanticType:[qnco] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Screening mammography SemanticType:[topp] PreferredName:From SemanticType:[qlco] PreferredName:Age SemanticType:[orga] PreferredName:Clinical Trials SemanticType:[resa] POS:VBN POS:JJ POS:NNS POS:IN POS:NN POS:NN POS:NN POS:IN POS:NN POS:NN POS:NNS POS:IN POS:DT POS:NNPS 
[sentNum: 98]<Annotation Id="18866" Type="Sentence" StartNode="10661" EndNode="10677">NNI to Prevent 1 PreferredName:1+ Score, WHO SemanticType:[clas] PreferredName:PREVENT (product) SemanticType:[phsu] POS:NN POS:TO POS:VB POS:CD 
[sentNum: 99]<Annotation Id="18867" Type="Sentence" StartNode="10681" EndNode="10722">RR for Breast Cancer  Breast Cancer Death PreferredName:death age SemanticType:[fndg] PreferredName:Malignant neoplasm of breast SemanticType:[neop] POS:NN POS:IN POS:NN POS:NN POS:NN POS:NN POS:NN 
[sentNum: 100]<Annotation Id="18868" Type="Sentence" StartNode="10726" EndNode="10781">Age  Trials Included, n  Mortality (95% CrI)  (95% CrI) PreferredName:Including (qualifier) SemanticType:[ftcn] PreferredName:Clinical Trials SemanticType:[resa] PreferredName:Mortality Vital Statistics SemanticType:[qnco] PreferredName:N not otherwise specified Antibody SemanticType:[aapp, imft] PreferredName:Costa Rica SemanticType:[geoa] PreferredName:Costa Rica SemanticType:[geoa] POS:NNP POS:NNP POS:VBD POS:, POS:NN POS:NN POS:CD POS:CD POS:NN POS:NN POS:CD POS:CD POS:CD POS:NN POS:NN POS:CD 
[sentNum: 101]<Annotation Id="18869" Type="Sentence" StartNode="10785" EndNode="10834">39&#x2013;49 y	  8*	  0.85 (0.75&#x2013;0.96)	  1904 (929&#x2013;6378) POS:CD POS:CD POS:CD POS:NN POS:CD POS:SYM POS:CD POS:. POS:CD POS:CD POS:CD POS:. POS:CD POS:CD POS:CD POS:. POS:CD POS:CD POS:CD POS:NN POS:CD POS:CD POS:CD POS:NN 
[sentNum: 102]<Annotation Id="18870" Type="Sentence" StartNode="10838" EndNode="10886">50&#x2013;59 y	  6&#x2020;  0.86 (0.75&#x2013;0.99)	  1339 (322&#x2013;7455) POS:CD POS:CD POS:CD POS:NN POS:CD POS:NN POS:CD POS:. POS:CD POS:CD POS:CD POS:. POS:CD POS:CD POS:CD POS:. POS:CD POS:CD POS:CD POS:NN POS:CD POS:CD POS:CD POS:NN 
[sentNum: 103]<Annotation Id="18871" Type="Sentence" StartNode="10890" EndNode="10937">60&#x2013;69 y	  2&#x2021;  0.68 (0.54&#x2013;0.87)	  377 (230&#x2013;1050) PreferredName:Arabic numeral 68 SemanticType:[inpr] PreferredName:Arabic numeral 69 SemanticType:[inpr] POS:CD POS:CD POS:CD POS:NN POS:CD POS:CD POS:CD POS:. POS:CD POS:CD POS:CD POS:. POS:CD POS:CD POS:CD POS:. POS:CD POS:NN POS:CD POS:NN POS:CD POS:CD POS:CD POS:NN 
[sentNum: 104]<Annotation Id="18872" Type="Sentence" StartNode="10941" EndNode="10987">70&#x2013;74 y	  1§  1.12 (0.73&#x2013;1.72)	  Not available PreferredName:Not available SemanticType:[idcn] PreferredName:1+ Score, WHO SemanticType:[clas] POS:CD POS:CD POS:CD POS:NN POS:CD POS:NN POS:CD POS:. POS:CD POS:CD POS:CD POS:. POS:CD POS:NN POS:CD POS:. POS:CD POS:CD POS:RB POS:JJ 
[sentNum: 105]<Annotation Id="18873" Type="Sentence" StartNode="10993" EndNode="11103">Abbreviations: CrI, credible interval; NNI, number needed to invite to screening; RR, relative risk; y, years. PreferredName:Costa Rica SemanticType:[geoa] PreferredName:Abbreviations SemanticType:[inpr] PreferredName:Data Type Interval SemanticType:[inpr] PreferredName:credibility SemanticType:[qlco] PreferredName:Needs SemanticType:[qlco] PreferredName:Numbers SemanticType:[qnco] PreferredName:Relative Risk SemanticType:[qnco] PreferredName:Trial Screening SemanticType:[resa] PreferredName:year SemanticType:[tmco] POS:NNS POS:: POS:NN POS:, POS:JJ POS:NN POS:: POS:NNP POS:, POS:NN POS:VBN POS:TO POS:VB POS:TO POS:NN POS:: POS:NNP POS:, POS:JJ POS:NN POS:: POS:NN POS:, POS:NNS POS:. 
[sentNum: 106]<Annotation Id="18874" Type="Sentence" StartNode="11106" EndNode="11281">*Health Insurance Plan of Greater New York, Canadian National Breast Screening Study-1, Stockholm, Malm&#x650;, Swedish Two-County trial (2 trials), Gothenburg trial, and Age trial. PreferredName:health insurance plan SemanticType:[inpr] PreferredName:New York (geographic location) SemanticType:[geoa] PreferredName:Largest SemanticType:[qnco] PreferredName:National citizen SemanticType:[inpr] PreferredName:CANADIAN SemanticType:[fndg] PreferredName:Screening Study SemanticType:[resa] PreferredName:Entire breast SemanticType:[bpoc] PreferredName:Two SemanticType:[qnco] PreferredName:Swedish SemanticType:[popg] PreferredName:Clinical Trials SemanticType:[resa] PreferredName:County SemanticType:[geoa] PreferredName:Clinical Trials SemanticType:[resa] PreferredName:2+ Score SemanticType:[qnco] PreferredName:Age SemanticType:[orga] PreferredName:Clinical Trials SemanticType:[resa] PreferredName:Clinical Trials SemanticType:[resa] POS:SYM POS:NNP POS:NNP POS:NNP POS:IN POS:NNP POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:NN POS:NN POS:NN POS:CD POS:, POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:NNP POS:NN POS:NN POS:CD POS:NNS POS:RB POS:, POS:NNP POS:NN POS:, POS:CC POS:NNP POS:NN POS:. 
[sentNum: 107]<Annotation Id="18875" Type="Sentence" StartNode="11284" EndNode="11387">&#x2020;Canadian National Breast Screening Study-1, Stockholm, Malm&#x650;, Swedish Two-County trial (2 trials), and PreferredName:CANADIAN SemanticType:[fndg] PreferredName:Entire breast SemanticType:[bpoc] PreferredName:National citizen SemanticType:[inpr] PreferredName:Swedish SemanticType:[popg] PreferredName:Screening Study SemanticType:[resa] PreferredName:County SemanticType:[geoa] PreferredName:Two SemanticType:[qnco] PreferredName:2+ Score SemanticType:[qnco] PreferredName:Clinical Trials SemanticType:[resa] PreferredName:Clinical Trials SemanticType:[resa] POS:CD POS:JJ POS:NNP POS:NN POS:NN POS:NN POS:CD POS:, POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:NNP POS:NN POS:NN POS:CD POS:NNS POS:RB POS:, POS:CC 
[sentNum: 108]<Annotation Id="18876" Type="Sentence" StartNode="11389" EndNode="11406">Gothenburg trial. PreferredName:Clinical Trials SemanticType:[resa] POS:NNP POS:NN POS:. 
[sentNum: 109]<Annotation Id="18877" Type="Sentence" StartNode="11410" EndNode="11461">&#x2021;Malm&#x650; and Swedish Two-County trial (&#x636;sterg&#x650;tland). PreferredName:Two SemanticType:[qnco] PreferredName:Swedish SemanticType:[popg] PreferredName:Clinical Trials SemanticType:[resa] PreferredName:County SemanticType:[geoa] POS:NN POS:NN POS:NN POS:CC POS:JJ POS:NNP POS:NNP POS:NN POS:CD POS:NN POS:NN POS:CD POS:NN POS:NN POS:. 
[sentNum: 110]<Annotation Id="18878" Type="Sentence" StartNode="11463" EndNode="11504">§Swedish Two-County trial (&#x636;sterg&#x650;tland). PreferredName:Two SemanticType:[qnco] PreferredName:Swedish SemanticType:[popg] PreferredName:Clinical Trials SemanticType:[resa] PreferredName:County SemanticType:[geoa] POS:NN POS:JJ POS:NNP POS:NNP POS:NN POS:CD POS:NN POS:NN POS:CD POS:NN POS:NN POS:. 
[sentNum: 111]<Annotation Id="18879" Type="Sentence" StartNode="11506" EndNode="11611">Reprinted with permission from Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L. Screening for PreferredName:Authorization documentation SemanticType:[inpr] PreferredName:Reprint SemanticType:[inpr] PreferredName:KNG1 gene SemanticType:[gngm] PreferredName:K Prime SemanticType:[qnco] PreferredName:Trial Screening SemanticType:[resa] POS:VBN POS:IN POS:NN POS:IN POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:. POS:NN POS:IN 
[sentNum: 112]<Annotation Id="18880" Type="Sentence" StartNode="11615" EndNode="11684">breast cancer: An update for the U.S. Preventive Services Task Force. PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:United States SemanticType:[geoa] PreferredName:Update SemanticType:[tmco] PreferredName:Advisory Committees SemanticType:[gora] PreferredName:Preventive service healthcare SemanticType:[hlca] POS:NN POS:NN POS:: POS:DT POS:VBP POS:IN POS:DT POS:NNP POS:. POS:NN POS:. POS:NNP POS:NNPS POS:NNP POS:NNP POS:. 
[sentNum: 113]<Annotation Id="18881" Type="Sentence" StartNode="11685" EndNode="11716">Ann Intern Med 2009;151:727&#x2013;37. PreferredName:Intern SemanticType:[prog] POS:NNP POS:NNP POS:NNP POS:CD POS:: POS:CD POS:: POS:CD POS:CD POS:CD POS:. 
[sentNum: 114]<Annotation Id="18882" Type="Sentence" StartNode="11720" EndNode="11810">not receive MRI because of gadolinium contrast allergy, claustrophobia, or other barriers. PreferredName:Negation SemanticType:[ftcn] PreferredName:Magnetic Resonance Imaging SemanticType:[diap] PreferredName:Receive SemanticType:[qlco] PreferredName:Contrast SemanticType:[qlco] PreferredName:Gadolinium SemanticType:[elii, irda] PreferredName:Claustrophobia SemanticType:[mobd] PreferredName:History of allergies SemanticType:[fndg] PreferredName:BARRIER SemanticType:[medd] POS:RB POS:VB POS:NNP POS:IN POS:IN POS:NN POS:NN POS:NN POS:, POS:NN POS:, POS:CC POS:JJ POS:NNS POS:. 
[sentNum: 115]<Annotation Id="18883" Type="Sentence" StartNode="11813" EndNode="12023">Magnetic resonanceimagingcanbe a useful adjunct to diagnostic mammography, but cost, duration of the examination, and injection of contrast material prohibit itsuseasaroutine,population-basedscreeningtechnique. PreferredName:Magnetism SemanticType:[npop] PreferredName:Mammography SemanticType:[diap] PreferredName:diagnostic use SemanticType:[diap] PreferredName:Duration (temporal concept) SemanticType:[tmco] PreferredName:Financial cost SemanticType:[qnco] PreferredName:Contrast Media SemanticType:[irda] PreferredName:Injection of therapeutic agent SemanticType:[topp] PreferredName:geographic population SemanticType:[qnco] PreferredName:Prohibit SemanticType:[carb, imft, phsu] POS:JJ POS:NN POS:DT POS:JJ POS:NN POS:TO POS:JJ POS:NN POS:, POS:CC POS:NN POS:, POS:NN POS:IN POS:DT POS:NN POS:, POS:CC POS:NN POS:IN POS:NN POS:NN POS:VBP POS:NN POS:, POS:NN POS:. 
[sentNum: 116]<Annotation Id="18884" Type="Sentence" StartNode="12024" EndNode="12319">The American Cancer Society has issued guidelines regarding the use of MRI for screening in high-risk women.Basedonexpertpanelreviewoftheevidence,the AmericanCancerSocietyrecommendsMRIscreeningfor women with a20% orgreaterlifetime risk ofdeveloping breastcancer,including women withthefollowing: PreferredName:Problem SemanticType:[fndg] PreferredName:American Cancer Society SemanticType:[pros] PreferredName:Use of SemanticType:[ftcn] PreferredName:Guideline [Publication Type] SemanticType:[inpr] PreferredName:Preposition For SemanticType:[qlco] PreferredName:Magnetic Resonance Imaging SemanticType:[diap] PreferredName:High risk of SemanticType:[qlco] PreferredName:Disease Screening SemanticType:[diap] PreferredName:Female Breast Carcinoma SemanticType:[neop] PreferredName:Woman SemanticType:[popg] PreferredName:Including (qualifier) SemanticType:[ftcn] PreferredName:Risk SemanticType:[qlco] PreferredName:Woman SemanticType:[popg] POS:DT POS:NNP POS:NNP POS:NNP POS:VBZ POS:VBN POS:NNS POS:VBG POS:DT POS:NN POS:IN POS:NNP POS:IN POS:VBG POS:IN POS:JJ POS:NNS POS:. POS:NN POS:, POS:DT POS:NNP POS:NNS POS:IN POS:DT POS:CD POS:NN POS:NN POS:NN POS:VBG POS:NN POS:, POS:VBG POS:NNS POS:VBG POS:: 
[sentNum: 117]<Annotation Id="18885" Type="Sentence" StartNode="12322" EndNode="12323">&#x2022;	POS:NN 
[sentNum: 118]<Annotation Id="18886" Type="Sentence" StartNode="12327" EndNode="12368">Have a known BRCA1 or BRCA2 gene mutation PreferredName:Known SemanticType:[qlco] PreferredName:BRCA2 Gene Mutation SemanticType:[comd] POS:VBP POS:DT POS:JJ POS:NN POS:CD POS:CC POS:NN POS:CD POS:NN POS:NN 
[sentNum: 119]<Annotation Id="18887" Type="Sentence" StartNode="12373" EndNode="12374">&#x2022;	POS:NN 
[sentNum: 120]<Annotation Id="18888" Type="Sentence" StartNode="12378" EndNode="12479">Haveafirst-degreerelativewith a BRCA1 or BRCA2 gene mutation and have not had any testing them­selves PreferredName:BRCA2 Gene Mutation SemanticType:[comd] PreferredName:Testing SemanticType:[ftcn] PreferredName:Negation SemanticType:[ftcn] PreferredName:Self SemanticType:[idcn] POS:NN POS:DT POS:NN POS:CD POS:CC POS:NN POS:CD POS:NN POS:NN POS:CC POS:VBP POS:RB POS:VBN POS:DT POS:NN POS:VBZ 
[sentNum: 121]<Annotation Id="18889" Type="Sentence" StartNode="12484" EndNode="12485">&#x2022;	POS:NN 
[sentNum: 122]<Annotation Id="18890" Type="Sentence" StartNode="12489" EndNode="12615">A lifetime risk of breast cancer of 20% or greater, according to risk assessment tools that are based mainly on family history PreferredName:Lifetime Risk SemanticType:[qnco] PreferredName:Largest SemanticType:[qnco] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Scientific Equipment SemanticType:[mnob] PreferredName:Risk Assessment SemanticType:[hlca] PreferredName:Family History Domain SemanticType:[idcn] PreferredName:Base - General Qualifier SemanticType:[idcn] POS:DT POS:NN POS:NN POS:IN POS:NN POS:NN POS:IN POS:CD POS:NN POS:CC POS:JJR POS:, POS:VBG POS:TO POS:VB POS:NN POS:NNS POS:WDT POS:VBP POS:VBN POS:RB POS:IN POS:NN POS:NN 
[sentNum: 123]<Annotation Id="18891" Type="Sentence" StartNode="12620" EndNode="12621">&#x2022;	POS:NN 
[sentNum: 124]<Annotation Id="18892" Type="Sentence" StartNode="12625" EndNode="12710">A history of radiation therapy to the chest between the ages of 10 years and 30 years PreferredName:To SemanticType:[qlco] PreferredName:History of radiation therapy SemanticType:[fndg] PreferredName:Age-Years SemanticType:[tmco] PreferredName:Anterior thoracic region SemanticType:[blor] PreferredName:year SemanticType:[tmco] POS:DT POS:NN POS:IN POS:NN POS:NN POS:TO POS:DT POS:NN POS:IN POS:DT POS:NNS POS:IN POS:CD POS:NNS POS:CC POS:CD POS:NNS 
[sentNum: 125]<Annotation Id="18893" Type="Sentence" StartNode="12715" EndNode="12716">&#x2022;	POS:NN 
[sentNum: 126]<Annotation Id="18894" Type="Sentence" StartNode="12720" EndNode="12884">Other genetic syndromes, including Li&#x2013;Fraumeni syndrome, Cowden syndrome, or Bannayan&#x2013;Riley&#x2013; Ruvalcaba syndrome or one of these syndromes in a first-degree relative PreferredName:Genetic syndrome SemanticType:[dsyn] PreferredName:Lithium Cation SemanticType:[elii] PreferredName:Including (qualifier) SemanticType:[ftcn] PreferredName:Hamartoma Syndrome, Multiple SemanticType:[neop] PreferredName:Syndrome SemanticType:[dsyn] PreferredName:One SemanticType:[qnco] PreferredName:Ruvalcaba Syndrome SemanticType:[cgab] PreferredName:First Degree Relative SemanticType:[famg] PreferredName:Adverse Event Associated with Syndromes SemanticType:[fndg] POS:JJ POS:JJ POS:NNS POS:, POS:VBG POS:NNP POS:NNP POS:NN POS:, POS:NN POS:NN POS:, POS:CC POS:NNP POS:NNP POS:NNP POS:NN POS:CC POS:CD POS:IN POS:DT POS:NNS POS:IN POS:DT POS:JJ POS:JJ 
[sentNum: 127]<Annotation Id="18895" Type="Sentence" StartNode="12891" EndNode="13131">The panel concluded that there was insufficient evidence to recommend for or against MRI screening for women with a personal history of breast cancer, carcinoma in situ, atypical hyperplasia, and extremely dense breasts on mammography (25). PreferredName:Conclude Resin SemanticType:[bodm, orch] PreferredName:Laboratory Order Panels SemanticType:[inpr] PreferredName:Evidence of SemanticType:[ftcn] PreferredName:Insufficient (qualifier) SemanticType:[qlco] PreferredName:Magnetic Resonance Imaging SemanticType:[diap] PreferredName:Recommendation SemanticType:[idcn] PreferredName:Preposition For SemanticType:[qlco] PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:Personal Attribute SemanticType:[orga] PreferredName:Woman SemanticType:[popg] PreferredName:Carcinoma in Situ SemanticType:[neop] PreferredName:History of malignant neoplasm of breast SemanticType:[fndg] PreferredName:Mammographic breast density SemanticType:[fndg] PreferredName:Atypical hyperplasia SemanticType:[patf] POS:DT POS:NN POS:VBD POS:IN POS:EX POS:VBD POS:JJ POS:NN POS:TO POS:VB POS:IN POS:CC POS:IN POS:NNP POS:VBG POS:IN POS:NNS POS:IN POS:DT POS:JJ POS:NN POS:IN POS:NN POS:NN POS:, POS:NN POS:FW POS:FW POS:, POS:JJ POS:NN POS:, POS:CC POS:RB POS:JJ POS:NNS POS:IN POS:NN POS:NN POS:CD POS:NN POS:. 
[sentNum: 128]<Annotation Id="18896" Type="Sentence" StartNode="13132" EndNode="13226">Breast MRI is not recommended for screening women at average risk of developing breast cancer. PreferredName:Negation SemanticType:[ftcn] PreferredName:Multisection:Finding:Point in time:Breast:Narrative:MRI SemanticType:[clna] PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:Recommendation SemanticType:[idcn] PreferredName:At risk SemanticType:[qlco] PreferredName:Woman SemanticType:[popg] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Average SemanticType:[qnco] POS:NN POS:NNP POS:VBZ POS:RB POS:VBN POS:IN POS:VBG POS:NNS POS:IN POS:JJ POS:NN POS:IN POS:VBG POS:NN POS:NN POS:. 
[sentNum: 129]<Annotation Id="18897" Type="Sentence" StartNode="13229" EndNode="13478">Color Doppler ultrasonography, computer-aided detection, positron emission tomography, scintimam­mography, and digital breast tomosynthesis have shown promise in selected clinical situations or as adjuncts to mammography for breast cancer diagnosis. PreferredName:Computers SemanticType:[mnob] PreferredName:Ultrasonography, Doppler, Color SemanticType:[diap] PreferredName:Detection SemanticType:[topp] PreferredName:Helping Behavior SemanticType:[socb] PreferredName:Digital breast tomosynthesis SemanticType:[diap] PreferredName:Positron-Emission Tomography SemanticType:[diap] PreferredName:promise SemanticType:[idcn] PreferredName:Show SemanticType:[inpr] PreferredName:Clinical SemanticType:[qlco] PreferredName:Choose (action) SemanticType:[acty] PreferredName:Mammography SemanticType:[diap] PreferredName:To SemanticType:[qlco] PreferredName:Breast Carcinoma SemanticType:[neop] POS:NNP POS:NNP POS:NN POS:, POS:JJ POS:NN POS:, POS:JJ POS:NN POS:NN POS:, POS:NN POS:, POS:CC POS:JJ POS:NN POS:NN POS:VBP POS:VBN POS:NN POS:IN POS:VBN POS:JJ POS:NNS POS:CC POS:IN POS:NNS POS:TO POS:NN POS:IN POS:NN POS:NN POS:NN POS:. 
[sentNum: 130]<Annotation Id="18898" Type="Sentence" StartNode="13479" EndNode="13561">However, thesetechnologies are not considered alternativesto rou­tine mammography. PreferredName:Negation SemanticType:[ftcn] PreferredName:Romania SemanticType:[geoa] PreferredName:consider SemanticType:[idcn] PreferredName:Mammography SemanticType:[diap] PreferredName:Tines SemanticType:[medd] POS:RB POS:, POS:NNS POS:VBP POS:RB POS:VBN POS:NN POS:NN POS:NN POS:. 
[sentNum: 131]<Annotation Id="18899" Type="Sentence" StartNode="13568" EndNode="13587">Digital Mammography PreferredName:Digital Mammography SemanticType:[diap] POS:NNP POS:NN 
[sentNum: 132]<Annotation Id="18900" Type="Sentence" StartNode="13590" EndNode="13682">In 2005, the results of the Digital Mammographic Imaging Screening Trial were reported (26). PreferredName:Digital SemanticType:[qlco] PreferredName:Diagnostic Imaging SemanticType:[diap] PreferredName:Mammography finding SemanticType:[fndg] PreferredName:Reporting SemanticType:[hlca] PreferredName:Screening Study SemanticType:[resa] POS:IN POS:CD POS:, POS:DT POS:NNS POS:IN POS:DT POS:NNP POS:NNP POS:NNP POS:NNP POS:NNP POS:VBD POS:VBN POS:CD POS:CD POS:NN POS:. 
[sentNum: 133]<Annotation Id="18901" Type="Sentence" StartNode="13683" EndNode="13802">During the 2-year study period, 49,528 women were recruited to the study from 33 sites in the United States and Canada. PreferredName:per year SemanticType:[tmco] PreferredName:2+ Score SemanticType:[qnco] PreferredName:Period (temporal qualifier) SemanticType:[tmco] PreferredName:Study SemanticType:[resa] PreferredName:Study SemanticType:[resa] PreferredName:Woman SemanticType:[popg] PreferredName:Site SemanticType:[spco] PreferredName:From SemanticType:[qlco] PreferredName:Canada SemanticType:[geoa] PreferredName:United States SemanticType:[geoa] POS:IN POS:DT POS:CD POS:: POS:NN POS:NN POS:NN POS:, POS:CD POS:, POS:CD POS:NNS POS:VBD POS:VBN POS:TO POS:DT POS:NN POS:IN POS:CD POS:NNS POS:IN POS:DT POS:NNP POS:NNPS POS:CC POS:NNP POS:. 
[sentNum: 134]<Annotation Id="18902" Type="Sentence" StartNode="13803" EndNode="13892">All participants underwent both digital mammography and film mammography in random order. PreferredName:Digital Mammography SemanticType:[diap] PreferredName:Participant SemanticType:[popg] PreferredName:Randomization SemanticType:[resa] PreferredName:Film Mammography SemanticType:[diap] PreferredName:Order (arrangement) SemanticType:[qlco] POS:DT POS:NNS POS:VBD POS:CC POS:JJ POS:NN POS:CC POS:NN POS:NN POS:IN POS:JJ POS:NN POS:. 
[sentNum: 135]<Annotation Id="18903" Type="Sentence" StartNode="13893" EndNode="14003">The diagnostic accuracy of digital mammography and film mammog­raphy was similar across the entire population. PreferredName:Diagnostic Accuracy SemanticType:[qlco] PreferredName:film (photographic) SemanticType:[mnob] PreferredName:Digital Mammography SemanticType:[diap] PreferredName:Entire SemanticType:[qnco] PreferredName:Similarity SemanticType:[qlco] PreferredName:geographic population SemanticType:[qnco] POS:DT POS:JJ POS:NN POS:IN POS:JJ POS:NN POS:CC POS:NN POS:NN POS:VBD POS:JJ POS:IN POS:DT POS:JJ POS:NN POS:. 
[sentNum: 136]<Annotation Id="18904" Type="Sentence" StartNode="14004" EndNode="14195">Digital mammography was superior to film mammography in women younger than 50 years, women with heteroge­neously dense or extremely dense breasts, and premeno­pausal and perimenopausal women. PreferredName:Digital Mammography SemanticType:[diap] PreferredName:film (photographic) SemanticType:[mnob] PreferredName:Upper SemanticType:[spco] PreferredName:Woman SemanticType:[popg] PreferredName:Mammography SemanticType:[diap] PreferredName:year SemanticType:[tmco] PreferredName:Young SemanticType:[tmco] PreferredName:Dense SemanticType:[qlco] PreferredName:Woman SemanticType:[popg] PreferredName:Pauses:Number = Count/Time:Duration of the study:Heart:Quantitative:EKG SemanticType:[clna] PreferredName:Dense breasts NOS SemanticType:[fndg] PreferredName:Woman SemanticType:[popg] PreferredName:Perimenopausal SemanticType:[tmco] POS:NNP POS:NN POS:VBD POS:JJ POS:TO POS:NN POS:NN POS:IN POS:NNS POS:JJR POS:IN POS:CD POS:NNS POS:, POS:NNS POS:IN POS:RB POS:JJ POS:CC POS:RB POS:JJ POS:NNS POS:, POS:CC POS:JJ POS:CC POS:JJ POS:NNS POS:. 
[sentNum: 137]<Annotation Id="18905" Type="Sentence" StartNode="14198" EndNode="14267">In2007,thefollow-upandfinal results oftheOsloII	 study were reported. PreferredName:Reporting SemanticType:[hlca] PreferredName:research outcome SemanticType:[fndg] POS:IN POS:CD POS:, POS:JJ POS:NNS POS:NN POS:NN POS:VBD POS:VBN POS:. 
[sentNum: 138]<Annotation Id="18906" Type="Sentence" StartNode="14268" EndNode="14530">This was a randomized trial of screen-film versus full-field digital mammography in a population-based screening program of women aged 45&#x2013;69years.Inthistrial, women aged45&#x2013;69years were assignedto undergofilm mammography(n=16,985) or digital mammography(n=6,944).ThegroupPreferredName:Screening - procedure intent SemanticType:[ftcn] PreferredName:Clinical Trials, Randomized SemanticType:[inpr, resa] PreferredName:Full field SemanticType:[spco] PreferredName:film (photographic) SemanticType:[mnob] PreferredName:Population Programs SemanticType:[hlca] PreferredName:Digital Mammography SemanticType:[diap] PreferredName:Disease Screening SemanticType:[diap] PreferredName:Base - General Qualifier SemanticType:[idcn] PreferredName:Age SemanticType:[orga] PreferredName:Woman SemanticType:[popg] PreferredName:Mammography SemanticType:[diap] PreferredName:Woman SemanticType:[popg] PreferredName:Digital Mammography SemanticType:[diap] PreferredName:N not otherwise specified Antibody SemanticType:[aapp, imft] PreferredName:N not otherwise specified Antibody SemanticType:[aapp, imft] POS:DT POS:VBD POS:DT POS:JJ POS:NN POS:IN POS:NN POS:CC POS:JJ POS:JJ POS:NN POS:IN POS:DT POS:JJ POS:NN POS:NN POS:IN POS:NNS POS:JJ POS:CD POS:CD POS:CD POS:NNS POS:. POS:NNP POS:, POS:NNS POS:JJ POS:CD POS:CD POS:CD POS:NNS POS:VBD POS:JJ POS:NN POS:NN POS:NN POS:NN POS:JJ POS:CD POS:, POS:NNS POS:CD POS:CC POS:JJ POS:NN POS:NN POS:NN POS:JJ POS:CD POS:, POS:CD POS:NN POS:. 
[sentNum: 139]<Annotation Id="18907" Type="Sentence" StartNode="14530" EndNode="14792">Thegroup of women aged45&#x2013;49years was monitoredfor1.5years and the group of women aged50&#x2013;69years was monitoredfor 2years.There was a significantdifferencein the cancer detection ratebetweenthedigitalmammography(0.59%) andfilm mammography(0.38%)(P=0.02)groups(27). PreferredName:Woman SemanticType:[popg] PreferredName:Cancer Detection SemanticType:[hlca] PreferredName:Women's Groups SemanticType:[popg] PreferredName:P Blood group antibodies SemanticType:[aapp, imft] PreferredName:Mammography SemanticType:[diap] PreferredName:Population Group SemanticType:[popg] POS:NN POS:IN POS:NNS POS:JJ POS:CD POS:CD POS:CD POS:NNS POS:VBD POS:NN POS:CD POS:. POS:CD POS:NNS POS:CC POS:DT POS:NN POS:IN POS:NNS POS:JJ POS:CD POS:CD POS:CD POS:NNS POS:VBD POS:NN POS:CD POS:NNS POS:. POS:EX POS:VBD POS:DT POS:NN POS:DT POS:NN POS:NN POS:NN POS:CD POS:CD POS:. POS:CD POS:NN POS:CD POS:NN POS:NN POS:NN POS:CD POS:. POS:CD POS:NN POS:CD POS:CD POS:NN POS:JJ POS:CD POS:. POS:CD POS:NN POS:NNS POS:VBP POS:CD POS:CD POS:. 
[sentNum: 140]<Annotation Id="18908" Type="Sentence" StartNode="14795" EndNode="15026">A recent meta-analysis of data from eight large randomized studies found that, overall, digital mam­mography demonstrated a slightly higher detection rate than film mammography, particularly for women aged 60 years or younger (28). PreferredName:Recent SemanticType:[tmco] PreferredName:Data SemanticType:[idcn] PreferredName:Meta-Analysis (publications) SemanticType:[inpr] PreferredName:Large SemanticType:[qnco] PreferredName:Eight SemanticType:[qnco] PreferredName:Scientific Study SemanticType:[lbpr] PreferredName:Randomization SemanticType:[resa] PreferredName:Overall Publication Type SemanticType:[inpr] PreferredName:Present SemanticType:[qnco] PreferredName:Mammography SemanticType:[diap] PreferredName:Digital SemanticType:[qlco] PreferredName:Value Above Reference Range SemanticType:[inpr] PreferredName:Slightly SemanticType:[idcn] PreferredName:Rating (action) SemanticType:[acty] PreferredName:Detection SemanticType:[topp] PreferredName:Woman SemanticType:[popg] PreferredName:Film Mammography SemanticType:[diap] PreferredName:year SemanticType:[tmco] PreferredName:Age SemanticType:[orga] PreferredName:Young SemanticType:[tmco] POS:DT POS:JJ POS:NN POS:IN POS:NNS POS:IN POS:CD POS:JJ POS:JJ POS:NNS POS:VBD POS:IN POS:, POS:RB POS:, POS:JJ POS:NN POS:VBD POS:DT POS:RB POS:JJR POS:NN POS:NN POS:IN POS:NN POS:NN POS:, POS:RB POS:IN POS:NNS POS:JJ POS:CD POS:NNS POS:CC POS:JJR POS:CD POS:CD POS:NN POS:. 
[sentNum: 141]<Annotation Id="18909" Type="Sentence" StartNode="15033" EndNode="15076">Clinical Considerations and Recommendations PreferredName:Clinical SemanticType:[qlco] PreferredName:Recommendation SemanticType:[idcn] PreferredName:consideration SemanticType:[fndg] POS:JJ POS:NNS POS:CC POS:NNS 
[sentNum: 142]<Annotation Id="18910" Type="Sentence" StartNode="15083" EndNode="15207">What is the difference between breast self-examination and breast self-awareness, and are these screening methods effective? PreferredName:Breast Self-Examination SemanticType:[diap] PreferredName:Menopause SemanticType:[phsf] PreferredName:Self awareness SemanticType:[menp] PreferredName:Entire breast SemanticType:[bpoc] PreferredName:Effectiveness SemanticType:[qlco] PreferredName:Screening procedure SemanticType:[hlca] POS:WP POS:VBZ POS:DT POS:NN POS:IN POS:NN POS:NN POS:CC POS:NN POS:NN POS:, POS:CC POS:VBP POS:DT POS:NN POS:NNS POS:JJ POS:. 
[sentNum: 143]<Annotation Id="18911" Type="Sentence" StartNode="15210" EndNode="15375">Breast self-examination is the performance of an exami­nation of the breasts in a consistent, systematic way by the individual on a regular basis, typically monthly. PreferredName:Performance SemanticType:[inbe] PreferredName:Breast Self-Examination SemanticType:[diap] PreferredName:Breast SemanticType:[bpoc] PreferredName:Nation SemanticType:[orgt] PreferredName:Consistent with SemanticType:[idcn] PreferredName:Present SemanticType:[qnco] PreferredName:Persons SemanticType:[popg] PreferredName:systematic SemanticType:[ftcn] PreferredName:Basis - conceptual entity SemanticType:[ftcn] PreferredName:Regular SemanticType:[qlco] PreferredName:Monthly (qualifier value) SemanticType:[tmco] POS:NN POS:NN POS:VBZ POS:DT POS:NN POS:IN POS:DT POS:NN POS:IN POS:DT POS:NNS POS:IN POS:DT POS:JJ POS:, POS:JJ POS:NN POS:IN POS:DT POS:NN POS:IN POS:DT POS:JJ POS:NN POS:, POS:RB POS:JJ POS:. 
[sentNum: 144]<Annotation Id="18912" Type="Sentence" StartNode="15376" EndNode="15553">Historically, physicians have been encouraged to edu­cate their patients on how to perform these examina­tions, and public awareness campaigns have focused on this intervention. PreferredName:Physicians SemanticType:[prog] PreferredName:CTSE gene SemanticType:[gngm] PreferredName:ethylene diurea SemanticType:[orch, phsu] PreferredName:Performed SemanticType:[ftcn] PreferredName:Patients SemanticType:[podg] PreferredName:Focal SemanticType:[spco] PreferredName:prevention through information dissemination SemanticType:[topp] PreferredName:Intervention regimes SemanticType:[hlca] POS:NNP POS:, POS:NNS POS:VBP POS:VBN POS:VBN POS:TO POS:VB POS:PRP$ POS:NNS POS:IN POS:WRB POS:TO POS:VB POS:DT POS:NNS POS:, POS:CC POS:JJ POS:NN POS:NNS POS:VBP POS:VBN POS:IN POS:DT POS:NN POS:. 
[sentNum: 145]<Annotation Id="18913" Type="Sentence" StartNode="15554" EndNode="15671">It still may be appropriate for certain high-risk populations and for other women who choose to follow this approach. PreferredName:Appropriate SemanticType:[qlco] PreferredName:High Risk Populations SemanticType:[popg] PreferredName:Certain (qualifier value) SemanticType:[qlco] PreferredName:Woman SemanticType:[popg] PreferredName:And SemanticType:[idcn] PreferredName:To SemanticType:[qlco] PreferredName:Choose (action) SemanticType:[acty] PreferredName:Approach SemanticType:[spco] PreferredName:Followed by SemanticType:[tmco] POS:PRP POS:RB POS:MD POS:VB POS:JJ POS:IN POS:JJ POS:JJ POS:NNS POS:CC POS:IN POS:JJ POS:NNS POS:WP POS:VBP POS:TO POS:VB POS:DT POS:NN POS:. 
[sentNum: 146]<Annotation Id="18914" Type="Sentence" StartNode="15674" EndNode="15791">Currently, there is an evolution away from teaching breastself-examination towardthe concept ofbreast self-awareness. PreferredName:Biological Evolution SemanticType:[genf] PreferredName:Current (present time) SemanticType:[tmco] PreferredName:concept SemanticType:[idcn] PreferredName:Educational process of instructing SemanticType:[edac] PreferredName:Awareness SemanticType:[menp] PreferredName:Self-Examination SemanticType:[diap] POS:RB POS:, POS:EX POS:VBZ POS:DT POS:NN POS:RB POS:IN POS:NN POS:NN POS:NN POS:NN POS:NN POS:NN POS:. 
[sentNum: 147]<Annotation Id="18915" Type="Sentence" StartNode="15792" EndNode="15989">The College, the American Cancer Society, andtheNationalComprehensiveCancerNetworkendorse breast self-awareness,whichisdefinedaswomen&#x2019;saware­ness of the normal appearance and feel of their breasts. PreferredName:American Cancer Society SemanticType:[pros] PreferredName:College SemanticType:[mnob] PreferredName:Self awareness SemanticType:[menp] PreferredName:Entire breast SemanticType:[bpoc] PreferredName:Normal appearance (finding) SemanticType:[fndg] PreferredName:Nes (fish) SemanticType:[fish] PreferredName:Breast SemanticType:[bpoc] PreferredName:Emotions SemanticType:[menp] POS:DT POS:NNP POS:, POS:DT POS:NNP POS:NNP POS:NNP POS:, POS:JJ POS:NN POS:NN POS:, POS:JJ POS:NN POS:NN POS:IN POS:DT POS:JJ POS:NN POS:CC POS:NN POS:IN POS:PRP$ POS:NNS POS:. 
[sentNum: 148]<Annotation Id="18916" Type="Sentence" StartNode="15990" EndNode="16239">This concept has arisen because approximately one half	 of all cases ofbreast cancerin women50years and older and morethan70% of cases of cancerin womenyounger than 50 years are detected by women themselves, fre­quentlyas anincidentalfinding(29,30).InPreferredName:Approximate SemanticType:[qlco] PreferredName:concept SemanticType:[idcn] PreferredName:Half SemanticType:[qnco] PreferredName:One SemanticType:[qnco] PreferredName:Old SemanticType:[tmco] PreferredName:Case unit dose SemanticType:[qnco] PreferredName:Case unit dose SemanticType:[qnco] PreferredName:Within SemanticType:[spco] PreferredName:Detection SemanticType:[topp] PreferredName:year SemanticType:[tmco] PreferredName:FRZB gene SemanticType:[gngm] PreferredName:Woman SemanticType:[popg] POS:DT POS:NN POS:VBZ POS:VBN POS:IN POS:RB POS:CD POS:NN POS:IN POS:DT POS:NNS POS:NN POS:NN POS:NNS POS:CD POS:NNS POS:CC POS:JJR POS:CC POS:JJR POS:CD POS:NN POS:IN POS:NNS POS:IN POS:NN POS:NN POS:IN POS:CD POS:NNS POS:VBP POS:VBN POS:IN POS:NNS POS:PRP POS:, POS:NNS POS:VBG POS:CD POS:CD POS:, POS:CD POS:NN POS:. 
[sentNum: 149]<Annotation Id="18917" Type="Sentence" StartNode="16239" EndNode="16365">In addition, the effectiveness of self-examination was at odds with what was anticipatedbased onthe aforementioned statistics. PreferredName:Self Efficacy SemanticType:[menp] PreferredName:Add - instruction imperative SemanticType:[ftcn] PreferredName:Science of Statistics SemanticType:[ocdi] PreferredName:Wiskott-Aldrich Syndrome SemanticType:[dsyn] POS:IN POS:NN POS:, POS:DT POS:NN POS:IN POS:NN POS:VBD POS:IN POS:NNS POS:IN POS:WP POS:VBD POS:JJ POS:NN POS:JJ POS:NNS POS:. 
[sentNum: 150]<Annotation Id="18918" Type="Sentence" StartNode="16368" EndNode="16451">Breast self-awareness should be encouraged and can include breast self-examination. PreferredName:Self awareness SemanticType:[menp] PreferredName:Entire breast SemanticType:[bpoc] PreferredName:Breast Self-Examination SemanticType:[diap] PreferredName:Include (action) SemanticType:[acty] POS:NN POS:NN POS:MD POS:VB POS:VBN POS:CC POS:MD POS:VB POS:NN POS:NN POS:. 
[sentNum: 151]<Annotation Id="18919" Type="Sentence" StartNode="16452" EndNode="16645">Women who desire to perform self-examination as a part of this breast self-awareness strategy may be instructed in the appropriate technique, although emphasis is not on examination techniques. PreferredName:desires SemanticType:[menp] PreferredName:Woman SemanticType:[popg] PreferredName:Performed SemanticType:[ftcn] PreferredName:To SemanticType:[qlco] PreferredName:Examination of breast SemanticType:[diap] PreferredName:Self awareness SemanticType:[menp] PreferredName:strategy SemanticType:[menp] PreferredName:Part SemanticType:[spco] PreferredName:Techniques SemanticType:[ftcn] PreferredName:Appropriate SemanticType:[qlco] PreferredName:Examination by method SemanticType:[diap] PreferredName:Negation SemanticType:[ftcn] POS:NNS POS:WP POS:VBP POS:TO POS:VB POS:NN POS:IN POS:DT POS:NN POS:IN POS:DT POS:NN POS:NN POS:NN POS:MD POS:VB POS:VBN POS:IN POS:DT POS:JJ POS:NN POS:, POS:IN POS:NN POS:VBZ POS:RB POS:IN POS:NN POS:NNS POS:. 
[sentNum: 152]<Annotation Id="18920" Type="Sentence" StartNode="16646" EndNode="16726">Women should report any changes in their breasts to their health care providers. PreferredName:Reporting SemanticType:[hlca] PreferredName:Woman SemanticType:[popg] PreferredName:Health Personnel SemanticType:[prog] PreferredName:Breast changes SemanticType:[fndg] POS:NNS POS:MD POS:VB POS:DT POS:NNS POS:IN POS:PRP$ POS:NNS POS:TO POS:PRP$ POS:NN POS:NN POS:NNS POS:. 
[sentNum: 153]<Annotation Id="18921" Type="Sentence" StartNode="16727" EndNode="17034">Although this patient education strategy has not been studied to date, breast awareness may be of particular importance as part of a screening strategy because some women may falsely assume that negative mammography or clinical breast examination results definitively exclude the pres­ence of breast cancer. PreferredName:strategy SemanticType:[menp] PreferredName:Respiratory Therapist, Registered - Patient Education SemanticType:[prog] PreferredName:Study Start Date SemanticType:[tmco] PreferredName:Negation SemanticType:[ftcn] PreferredName:Awareness SemanticType:[menp] PreferredName:Entire breast SemanticType:[bpoc] PreferredName:Part of SemanticType:[spco] PreferredName:Exist SemanticType:[cnce] PreferredName:strategy SemanticType:[menp] PreferredName:Screening procedure SemanticType:[hlca] PreferredName:Negative Finding SemanticType:[fndg] PreferredName:Woman SemanticType:[popg] PreferredName:Clinical Breast Examination SemanticType:[topp] PreferredName:Mammography SemanticType:[diap] PreferredName:Exclusion SemanticType:[acty] PreferredName:Experimental Result SemanticType:[fndg] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Pressure- physical agent SemanticType:[phpr] POS:IN POS:DT POS:NN POS:NN POS:NN POS:VBZ POS:RB POS:VBN POS:VBN POS:TO POS:NN POS:, POS:NN POS:NN POS:MD POS:VB POS:IN POS:JJ POS:NN POS:IN POS:NN POS:IN POS:DT POS:NN POS:NN POS:IN POS:DT POS:NNS POS:MD POS:RB POS:VB POS:IN POS:JJ POS:NN POS:CC POS:JJ POS:NN POS:NN POS:VBZ POS:RB POS:VBP POS:DT POS:NN POS:IN POS:NN POS:NN POS:. 
[sentNum: 154]<Annotation Id="18922" Type="Sentence" StartNode="17035" EndNode="17240">New cases of cancer can arise during screening intervals, and breast self-awareness may prompt women not to delay in reporting breast changes based on false reassurance of recent negative screening result. PreferredName:Case unit dose SemanticType:[qnco] PreferredName:New SemanticType:[tmco] PreferredName:Screening procedure SemanticType:[hlca] PreferredName:Primary malignant neoplasm SemanticType:[neop] PreferredName:Entire breast SemanticType:[bpoc] PreferredName:Interval SemanticType:[tmco] PreferredName:Prompt SemanticType:[phsu] PreferredName:Self awareness SemanticType:[menp] PreferredName:Negation SemanticType:[ftcn] PreferredName:Woman SemanticType:[popg] PreferredName:Reporting SemanticType:[hlca] PreferredName:Deferred SemanticType:[tmco] PreferredName:Base - General Qualifier SemanticType:[idcn] PreferredName:Breast changes SemanticType:[fndg] PreferredName:Group reassurance SemanticType:[topp] PreferredName:False Negative Result Medical Device Problem SemanticType:[fndg] PreferredName:Screening procedure SemanticType:[hlca] PreferredName:Recent SemanticType:[tmco] POS:NNP POS:NNS POS:IN POS:NN POS:MD POS:VB POS:IN POS:NN POS:NNS POS:, POS:CC POS:NN POS:NN POS:MD POS:VB POS:NNS POS:RB POS:TO POS:VB POS:IN POS:VBG POS:NN POS:NNS POS:VBN POS:IN POS:JJ POS:NN POS:IN POS:JJ POS:JJ POS:JJ POS:NN POS:. 
[sentNum: 155]<Annotation Id="18923" Type="Sentence" StartNode="17241" EndNode="17414">Breast self-awareness aims to capture the importance of self-detection and prompt evaluation of symptoms because it relates to overall breast cancer morbidity and mortality. PreferredName:Self awareness SemanticType:[menp] PreferredName:Entire breast SemanticType:[bpoc] PreferredName:To SemanticType:[qlco] PreferredName:Aim (idea) SemanticType:[idcn] PreferredName:Detection SemanticType:[topp] PreferredName:subscriber - self SemanticType:[inpr] PreferredName:Symptom Evaluation SemanticType:[hlca] PreferredName:Prompt SemanticType:[phsu] PreferredName:Overall Publication Type SemanticType:[inpr] PreferredName:Relate - vinyl resin SemanticType:[orch] PreferredName:morbidity aspects SemanticType:[inpr] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Mortality Vital Statistics SemanticType:[qnco] POS:NN POS:NN POS:VBZ POS:TO POS:VB POS:DT POS:NN POS:IN POS:NN POS:CC POS:JJ POS:NN POS:IN POS:NNS POS:IN POS:PRP POS:VBZ POS:TO POS:JJ POS:NN POS:NN POS:NN POS:CC POS:NN POS:. 
[sentNum: 156]<Annotation Id="18924" Type="Sentence" StartNode="17415" EndNode="17491">However, the effect of breast self-awareness education has not been studied. PreferredName:Effect SemanticType:[qlco] PreferredName:Self awareness SemanticType:[menp] PreferredName:Entire breast SemanticType:[bpoc] PreferredName:Negation SemanticType:[ftcn] PreferredName:Educational Status SemanticType:[fndg] PreferredName:Study SemanticType:[resa] POS:RB POS:, POS:DT POS:NN POS:IN POS:NN POS:NN POS:NN POS:VBZ POS:RB POS:VBN POS:VBN POS:. 
[sentNum: 157]<Annotation Id="18925" Type="Sentence" StartNode="17496" EndNode="17708">TheUnitedStatesPreventiveServicesTaskForcehas recommended against teaching breast self-examination basedon alack of evidenceto showbenefit andpotential harm resultingfrom evaluation offalse-positivefindings (23).AprospectivePreferredName:Recommendation SemanticType:[idcn] PreferredName:Breast Self-Examination SemanticType:[diap] PreferredName:education evaluation SemanticType:[edac] PreferredName:Arabic numeral 23 SemanticType:[qnco] POS:NNP POS:VBD POS:IN POS:NN POS:NN POS:NN POS:NN POS:NN POS:IN POS:NN POS:NN POS:JJ POS:NN POS:NN POS:NN POS:NNS POS:VBP POS:CD POS:CD POS:. 
[sentNum: 158]<Annotation Id="18926" Type="Sentence" StartNode="17708" EndNode="18259">Aprospective studyof604patients withbreast can­cer revealedthat only7.6% ofthe448 women whoprac­ticed regular breast self-examination had detected their owncancer,andthosewhodidshowednosurvivaladvan­tage(31).TheShanghaibreast self-examinationtrial of 266,000women aged39&#x2013;72years randomizedto receive either breast self-examination instruction plus follow-up or no information on breast cancer screening reported essentially no difference in breast cancer-related deaths betweenthetwogroups(135 versus131, respectively) after10&#x2013;11years offollow-up(32).HoweverPreferredName:CER tumor staging notation SemanticType:[inpr] PreferredName:Regular SemanticType:[qlco] PreferredName:Woman SemanticType:[popg] PreferredName:Detection SemanticType:[topp] PreferredName:Breast Self-Examination SemanticType:[diap] PreferredName:subscriber - self SemanticType:[inpr] PreferredName:Arabic numeral 31 SemanticType:[inpr] PreferredName:Breast self-examination technique education SemanticType:[hlca] PreferredName:Receive SemanticType:[qlco] PreferredName:Follow-Up Report SemanticType:[inpr] PreferredName:In addition to SemanticType:[qlco] PreferredName:Screening for malignant neoplasm of breast SemanticType:[topp] PreferredName:No Information Available SemanticType:[qlco] PreferredName:Delta (difference) SemanticType:[qnco] PreferredName:Reporting SemanticType:[hlca] PreferredName:Relationships SemanticType:[qlco] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Cessation of life SemanticType:[orgf] POS:JJ POS:NN POS:CD POS:NNS POS:JJ POS:NN POS:NN POS:RB POS:CD POS:. POS:CD POS:NN POS:NN POS:CD POS:NNS POS:VBD POS:JJ POS:NN POS:NN POS:VBD POS:VBN POS:PRP$ POS:NN POS:, POS:NN POS:CD POS:CD POS:NN POS:. POS:NN POS:NN POS:IN POS:CD POS:, POS:CD POS:NNS POS:JJ POS:CD POS:CD POS:CD POS:NNS POS:JJ POS:VBP POS:CC POS:NN POS:NN POS:NN POS:CC POS:NN POS:CC POS:DT POS:NN POS:IN POS:NN POS:NN POS:NN POS:VBD POS:RB POS:DT POS:NN POS:IN POS:NN POS:JJ POS:NNS POS:NNS POS:VBP POS:CD POS:CC POS:CD POS:, POS:RB POS:RB POS:IN POS:CD POS:CD POS:CD POS:NNS POS:JJ POS:CD POS:CD POS:NN POS:. 
[sentNum: 159]<Annotation Id="18927" Type="Sentence" StartNode="18259" EndNode="18356">However, womenin theinstructiongroup were morelikely to undergobreast biopsyforbenignlesions(32). POS:RB POS:, POS:NN POS:NN POS:VBD POS:RB POS:TO POS:NN POS:NNS POS:VBP POS:CD POS:CD POS:. 
[sentNum: 160]<Annotation Id="18928" Type="Sentence" StartNode="18359" EndNode="18559">A Cochrane systematic review published in 2003 included the Shanghai breast trial (32) and another large population-based study from Russia that com­pared breast self-examination with no intervention. PreferredName:Review, Systematic SemanticType:[inpr] PreferredName:Including (qualifier) SemanticType:[ftcn] PreferredName:Scientific Publication SemanticType:[inpr] PreferredName:Clinical Trials SemanticType:[resa] PreferredName:Entire breast SemanticType:[bpoc] PreferredName:Population Based Study SemanticType:[resa] PreferredName:Large SemanticType:[qnco] PreferredName:Breast Self-Examination SemanticType:[diap] PreferredName:Russia SemanticType:[geoa] PreferredName:Intervention regimes SemanticType:[hlca] POS:DT POS:NNP POS:JJ POS:NN POS:VBN POS:IN POS:CD POS:VBD POS:DT POS:NNP POS:NN POS:NN POS:CD POS:CD POS:NN POS:CC POS:DT POS:JJ POS:JJ POS:NN POS:IN POS:NNP POS:WDT POS:VBD POS:NN POS:NN POS:IN POS:DT POS:NN POS:. 
[sentNum: 161]<Annotation Id="18929" Type="Sentence" StartNode="18560" EndNode="18702">In both trials, almost twice as many biopsies with benign results were performed in the screening group com­pared with the control group (33). PreferredName:Clinical Trials SemanticType:[resa] PreferredName:Biopsy SemanticType:[diap] PreferredName:Twice (Numerical Qualifier) SemanticType:[qnco] PreferredName:Experimental Result SemanticType:[fndg] PreferredName:Benign SemanticType:[qlco] PreferredName:Screening procedure SemanticType:[hlca] PreferredName:Performed SemanticType:[ftcn] PreferredName:Control Groups SemanticType:[grup] PreferredName:Population Group SemanticType:[popg] POS:IN POS:DT POS:NNS POS:, POS:RB POS:RB POS:IN POS:JJ POS:NNS POS:IN POS:JJ POS:NNS POS:VBD POS:VBN POS:IN POS:DT POS:JJ POS:NN POS:VBN POS:IN POS:DT POS:NN POS:NN POS:CD POS:CD POS:NN POS:. 
[sentNum: 162]<Annotation Id="18930" Type="Sentence" StartNode="18703" EndNode="18916">The Canadian Task Force on Preventive Health Care also recommended against teaching breast self-examination based on fair evidence that breast self-examination had no benefit and good evidence that it was harmful. PreferredName:Advisory Committees SemanticType:[gora] PreferredName:CANADIAN SemanticType:[fndg] PreferredName:Recommendation SemanticType:[idcn] PreferredName:preventive health care SemanticType:[topp] PreferredName:Breast Self-Examination SemanticType:[diap] PreferredName:Educational process of instructing SemanticType:[edac] PreferredName:Fair (qualifier) SemanticType:[qlco] PreferredName:Base - General Qualifier SemanticType:[idcn] PreferredName:Breast Self-Examination SemanticType:[diap] PreferredName:Evidence of SemanticType:[ftcn] PreferredName:Good SemanticType:[qlco] PreferredName:Benefits SemanticType:[qnco] PreferredName:Evidence of SemanticType:[ftcn] POS:DT POS:JJ POS:NNP POS:NNP POS:IN POS:NNP POS:NNP POS:NNP POS:RB POS:VBD POS:IN POS:NN POS:NN POS:NN POS:VBN POS:IN POS:JJ POS:NN POS:IN POS:NN POS:NN POS:VBD POS:DT POS:NN POS:CC POS:JJ POS:NN POS:IN POS:PRP POS:VBD POS:JJ POS:. 
[sentNum: 163]<Annotation Id="18931" Type="Sentence" StartNode="18917" EndNode="19067">Their review cited additional evidence that patients experience increased worry, anxiety, and depression associated with breast self-examination (34). PreferredName:Act Class - review SemanticType:[idcn] PreferredName:Evidence of SemanticType:[ftcn] PreferredName:Additional SemanticType:[ftcn] PreferredName:Practice Experience SemanticType:[menp] PreferredName:Patients SemanticType:[podg] PreferredName:Worried SemanticType:[fndg] PreferredName:Increase SemanticType:[ftcn] PreferredName:Mental Depression SemanticType:[mobd] PreferredName:Anxiety SemanticType:[menp] PreferredName:Breast Self-Examination SemanticType:[diap] PreferredName:Associated with SemanticType:[qlco] POS:PRP$ POS:NN POS:VBD POS:JJ POS:NN POS:IN POS:NNS POS:NN POS:VBD POS:NN POS:, POS:NN POS:, POS:CC POS:NN POS:VBN POS:IN POS:NN POS:NN POS:CD POS:CD POS:NN POS:. 
[sentNum: 164]<Annotation Id="18932" Type="Sentence" StartNode="19070" EndNode="19306">Because other screening methods (mammography and clinical breast examination) can have false-negative	 resultsandcasesofbreast cancer canoccurin unscreened women, there are clearly situations in which women willdetect cancer themselves. PreferredName:Mammography SemanticType:[diap] PreferredName:Screening procedure SemanticType:[hlca] PreferredName:False Negative SemanticType:[lbtr] PreferredName:Clinical Breast Examination SemanticType:[topp] PreferredName:Woman SemanticType:[popg] PreferredName:Primary malignant neoplasm SemanticType:[neop] PreferredName:Primary malignant neoplasm SemanticType:[neop] PreferredName:Woman SemanticType:[popg] POS:IN POS:JJ POS:JJ POS:NNS POS:VBP POS:NN POS:CC POS:JJ POS:NN POS:NN POS:NN POS:MD POS:VB POS:JJ POS:NN POS:NN POS:NN POS:JJ POS:NNS POS:, POS:EX POS:VBP POS:RB POS:NNS POS:IN POS:WDT POS:NNS POS:JJ POS:NN POS:PRP POS:. 
[sentNum: 165]<Annotation Id="18933" Type="Sentence" StartNode="19307" EndNode="19533">As such, the College, the AmericanCancerSociety, and theNationalComprehen­sive Cancer Network endorse educating women aged 20 years and older regarding breast self-awareness, as a meanstoplay a rolein earlierdetection(Table2). PreferredName:Primary malignant neoplasm SemanticType:[neop] PreferredName:College SemanticType:[mnob] PreferredName:Educational process of instructing SemanticType:[edac] PreferredName:Consortium or Network SemanticType:[prog] PreferredName:Elderly (population group) SemanticType:[popg] PreferredName:Woman SemanticType:[popg] PreferredName:Old SemanticType:[tmco] PreferredName:year SemanticType:[tmco] PreferredName:Self awareness SemanticType:[menp] PreferredName:Entire breast SemanticType:[bpoc] POS:IN POS:JJ POS:, POS:DT POS:NNP POS:, POS:DT POS:NNP POS:, POS:CC POS:NNP POS:NNP POS:NNP POS:VB POS:VBG POS:NNS POS:JJ POS:CD POS:NNS POS:CC POS:JJR POS:VBG POS:NN POS:NN POS:, POS:IN POS:DT POS:NN POS:DT POS:NN POS:NN POS:CD POS:NNP POS:CD POS:CD POS:. 
[sentNum: 166]<Annotation Id="18934" Type="Sentence" StartNode="19542" EndNode="19640">Is clinical(ie,healthcareproviderperformed) breastexamination effectiveforbreast cancer screening? PreferredName:Screening for cancer SemanticType:[diap] PreferredName:Clinical SemanticType:[qlco] POS:VBZ POS:JJ POS:NN POS:FW POS:, POS:JJ POS:NN POS:NN POS:NN POS:NN POS:NN POS:. 
[sentNum: 167]<Annotation Id="18935" Type="Sentence" StartNode="19641" EndNode="19686">If so, how frequently should it be performed? PreferredName:Frequent SemanticType:[tmco] PreferredName:Somalia SemanticType:[geoa] PreferredName:Performed SemanticType:[ftcn] POS:IN POS:RB POS:, POS:WRB POS:RB POS:MD POS:PRP POS:VB POS:VBN POS:. 
[sentNum: 168]<Annotation Id="18936" Type="Sentence" StartNode="19689" EndNode="20021">Astudy using data from the National Breast and Cervical Cancer Early Detection Program, where 752,081 clinical breast examinations were performed in the community setting in women aged 40 years and older, concluded that clinical breast examination alone has a sensitiv­ity for cancer detection of 58.8%, with a specificity of 93.4%. PreferredName:Use of SemanticType:[ftcn] PreferredName:National citizen SemanticType:[inpr] PreferredName:Data SemanticType:[idcn] PreferredName:early detection of cervical cancer SemanticType:[topp] PreferredName:Entire breast SemanticType:[bpoc] PreferredName:Clinical Breast Examination SemanticType:[topp] PreferredName:Program SemanticType:[phsu] PreferredName:Community SemanticType:[geoa] PreferredName:Performed SemanticType:[ftcn] PreferredName:Woman SemanticType:[popg] PreferredName:{Setting} SemanticType:[qnco] PreferredName:/40 SemanticType:[tmco] PreferredName:Elderly (population group) SemanticType:[popg] PreferredName:Old SemanticType:[tmco] PreferredName:year SemanticType:[tmco] PreferredName:Clinical Breast Examination SemanticType:[topp] PreferredName:Conclude Resin SemanticType:[bodm, orch] PreferredName:Cancer Detection SemanticType:[hlca] PreferredName:alone - group size SemanticType:[grpa] PreferredName:Specificity SemanticType:[qnco] PreferredName:In addition to SemanticType:[qlco] POS:NNP POS:VBG POS:NNS POS:IN POS:DT POS:NNP POS:NN POS:CC POS:JJ POS:NN POS:JJ POS:NN POS:NN POS:, POS:WRB POS:CD POS:, POS:CD POS:JJ POS:NN POS:NNS POS:VBD POS:VBN POS:IN POS:DT POS:NN POS:NN POS:IN POS:NNS POS:JJ POS:CD POS:NNS POS:CC POS:JJR POS:, POS:VBD POS:IN POS:JJ POS:NN POS:NN POS:RB POS:VBZ POS:DT POS:NN POS:IN POS:NN POS:NN POS:IN POS:CD POS:. POS:CD POS:NN POS:, POS:IN POS:DT POS:NN POS:IN POS:CD POS:. POS:CD POS:NN POS:. 
[sentNum: 169]<Annotation Id="18937" Type="Sentence" StartNode="20022" EndNode="20127">In this population, five cases of cancer were detected per 1,000 clinical breast examinations per­formed. PreferredName:Five SemanticType:[qnco] PreferredName:Population Group SemanticType:[popg] PreferredName:Primary malignant neoplasm SemanticType:[neop] PreferredName:Case unit dose SemanticType:[qnco] PreferredName:Clinical Breast Examination SemanticType:[topp] PreferredName:Detection SemanticType:[topp] PreferredName:Formed SemanticType:[ftcn] POS:IN POS:DT POS:NN POS:, POS:CD POS:NNS POS:IN POS:NN POS:VBD POS:VBN POS:IN POS:CD POS:, POS:CD POS:JJ POS:NN POS:NNS POS:VBN POS:. 
[sentNum: 170]<Annotation Id="18938" Type="Sentence" StartNode="20128" EndNode="20271">When the clinical breast examination finding was abnormal and the mammogram was normal, 7.4 cases of cancer were detected per 1,000 screenings. PreferredName:Physical findings SemanticType:[fndg] PreferredName:Abnormal Reference Range SemanticType:[inpr] PreferredName:Entire breast SemanticType:[bpoc] PreferredName:Normal SemanticType:[qlco] PreferredName:Mammography SemanticType:[diap] PreferredName:Primary malignant neoplasm SemanticType:[neop] PreferredName:Case unit dose SemanticType:[qnco] PreferredName:Screening procedure SemanticType:[hlca] PreferredName:Detection SemanticType:[topp] POS:WRB POS:DT POS:JJ POS:NN POS:NN POS:NN POS:VBD POS:JJ POS:CC POS:DT POS:NN POS:VBD POS:JJ POS:, POS:CD POS:. POS:CD POS:NNS POS:IN POS:NN POS:VBD POS:VBN POS:IN POS:CD POS:, POS:CD POS:NNS POS:. 
[sentNum: 171]<Annotation Id="18939" Type="Sentence" StartNode="20272" EndNode="20384">The authors concluded that the addition of clinical breast examination &#x201c;modestly improved&#x201d; early detection (35). PreferredName:Conclude Resin SemanticType:[bodm, orch] PreferredName:Journalist SemanticType:[prog] PreferredName:Clinical SemanticType:[qlco] PreferredName:Add - instruction imperative SemanticType:[ftcn] PreferredName:Better SemanticType:[qlco] PreferredName:Examination of breast SemanticType:[diap] PreferredName:Early Diagnosis SemanticType:[diap] POS:DT POS:NNS POS:VBD POS:IN POS:DT POS:NN POS:IN POS:JJ POS:NN POS:NN POS:CD POS:RB POS:VBN POS:RB POS:JJ POS:NN POS:CD POS:CD POS:NN POS:. 
[sentNum: 172]<Annotation Id="18940" Type="Sentence" StartNode="20387" EndNode="20518">Multiple reviews have supported the combination of clinical breast examination and mammography for breast cancer screening (36&#x2013;41).ArecentPreferredName:Numerous SemanticType:[qnco] PreferredName:Supportive assistance SemanticType:[cnce] PreferredName:Review [Publication Type] SemanticType:[inpr] PreferredName:Clinical SemanticType:[qlco] PreferredName:Combined SemanticType:[qlco] PreferredName:Mammography SemanticType:[diap] PreferredName:Examination of breast SemanticType:[diap] PreferredName:Screening for malignant neoplasm of breast SemanticType:[topp] POS:JJ POS:NNS POS:VBP POS:VBN POS:DT POS:NN POS:IN POS:JJ POS:NN POS:NN POS:CC POS:NN POS:IN POS:NN POS:NN POS:NN POS:CD POS:CD POS:NN POS:CD POS:NN POS:. 
[sentNum: 173]<Annotation Id="18941" Type="Sentence" StartNode="20518" EndNode="20699">Arecent study demon­strated improved sensitivity for breast cancer detection (94.6% versus 88.6%) when comparing mammography plus clinical breast examination with mammography alone. PreferredName:Study SemanticType:[resa] PreferredName:Statistical sensitivity SemanticType:[qnco] PreferredName:Better SemanticType:[qlco] PreferredName:Comparison SemanticType:[acty] PreferredName:Breast Cancer Detection Research SemanticType:[hlca] PreferredName:In addition to SemanticType:[qlco] PreferredName:Mammography SemanticType:[diap] PreferredName:Mammography SemanticType:[diap] PreferredName:Clinical Breast Examination SemanticType:[topp] PreferredName:alone - group size SemanticType:[grpa] POS:JJ POS:NN POS:VBD POS:VBN POS:NN POS:IN POS:NN POS:NN POS:NN POS:CD POS:CD POS:. POS:CD POS:NN POS:CC POS:CD POS:. POS:CD POS:NN POS:CD POS:WRB POS:VBG POS:NN POS:CC POS:JJ POS:NN POS:NN POS:IN POS:NN POS:RB POS:. 
[sentNum: 174]<Annotation Id="18942" Type="Sentence" StartNode="20700" EndNode="20868">However, the false-positive rate was also higher in the group receiving clinical breast examination com­pared with the mammography-alone group (12.4% versus 7.4%) (41). PreferredName:False Discovery Rate SemanticType:[qnco] PreferredName:Population Group SemanticType:[popg] PreferredName:Value Above Reference Range SemanticType:[inpr] PreferredName:Clinical Breast Examination SemanticType:[topp] PreferredName:Receive SemanticType:[qlco] PreferredName:Single Group Study SemanticType:[resa] PreferredName:Mammography SemanticType:[diap] POS:RB POS:, POS:DT POS:JJ POS:NN POS:VBD POS:RB POS:JJR POS:IN POS:DT POS:NN POS:VBG POS:JJ POS:NN POS:NN POS:VBN POS:IN POS:DT POS:JJ POS:NN POS:CD POS:CD POS:. POS:CD POS:NN POS:CC POS:CD POS:. POS:CD POS:NN POS:CD POS:CD POS:CD POS:NN POS:. 
[sentNum: 175]<Annotation Id="18943" Type="Sentence" StartNode="20869" EndNode="21093">Based on available evidence, the College, the American Cancer Society, and the National Comprehensive Cancer Network recommend that clini­cal breast examination should be performed annually for women aged 40 years and older. PreferredName:Availability of SemanticType:[ftcn] PreferredName:Base - General Qualifier SemanticType:[idcn] PreferredName:College SemanticType:[mnob] PreferredName:Evidence of SemanticType:[ftcn] PreferredName:National Comprehensive Cancer Network SemanticType:[hcro] PreferredName:American Cancer Society SemanticType:[pros] PreferredName:Examination of breast SemanticType:[diap] PreferredName:Recommendation SemanticType:[idcn] PreferredName:Annual SemanticType:[tmco] PreferredName:Performed SemanticType:[ftcn] PreferredName:Elderly (population group) SemanticType:[popg] PreferredName:Woman SemanticType:[popg] PreferredName:year SemanticType:[tmco] PreferredName:/40 SemanticType:[tmco] PreferredName:Old SemanticType:[tmco] POS:VBN POS:IN POS:JJ POS:NN POS:, POS:DT POS:NNP POS:, POS:DT POS:NNP POS:NNP POS:NNP POS:, POS:CC POS:DT POS:NNP POS:NNP POS:NNP POS:NNP POS:VB POS:IN POS:JJ POS:NN POS:NN POS:MD POS:VB POS:VBN POS:RB POS:IN POS:NNS POS:JJ POS:CD POS:NNS POS:CC POS:JJR POS:. 
[sentNum: 176]<Annotation Id="18944" Type="Sentence" StartNode="21094" EndNode="21417">Although the value of screening clinical breast examination for women with a low prevalence of breast cancer (ie, women aged 20&#x2013;39 years) is not clear, the College, the American Cancer Society, and the National Comprehensive Cancer Network continue to recommend clinical breast exami­nation for these women every 1&#x2013;3 years. PreferredName:Numerical value SemanticType:[qnco] PreferredName:Clinical SemanticType:[qlco] PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:Preposition For SemanticType:[qlco] PreferredName:Examination of breast SemanticType:[diap] PreferredName:Low Prevalence SemanticType:[qnco] PreferredName:Woman SemanticType:[popg] PreferredName:Woman SemanticType:[popg] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:year SemanticType:[tmco] PreferredName:Elderly (population group) SemanticType:[popg] PreferredName:Clear SemanticType:[qlco] PreferredName:Negation SemanticType:[ftcn] PreferredName:American Cancer Society SemanticType:[pros] PreferredName:College SemanticType:[mnob] PreferredName:Continuous SemanticType:[idcn] PreferredName:National Comprehensive Cancer Network SemanticType:[hcro] PreferredName:Recommendation SemanticType:[idcn] PreferredName:To SemanticType:[qlco] PreferredName:Female breast SemanticType:[bpoc] PreferredName:Clinical SemanticType:[qlco] PreferredName:1+ Score SemanticType:[qnco] PreferredName:Nation SemanticType:[orgt] PreferredName:year SemanticType:[tmco] POS:IN POS:DT POS:NN POS:IN POS:VBG POS:JJ POS:NN POS:NN POS:IN POS:NNS POS:IN POS:DT POS:JJ POS:NN POS:IN POS:NN POS:NN POS:CD POS:NN POS:, POS:NNS POS:JJ POS:CD POS:CD POS:CD POS:NNS POS:CD POS:VBZ POS:RB POS:JJ POS:, POS:DT POS:NNP POS:, POS:DT POS:NNP POS:NNP POS:NNP POS:, POS:CC POS:DT POS:NNP POS:NNP POS:NNP POS:NNP POS:VBP POS:TO POS:VB POS:JJ POS:NN POS:NN POS:IN POS:DT POS:NNS POS:DT POS:CD POS:NN POS:CD POS:NNS POS:. 
[sentNum: 177]<Annotation Id="18945" Type="Sentence" StartNode="21426" EndNode="21508">When should mammography begin, and how frequently should mammography be performed? PreferredName:Mammography SemanticType:[diap] PreferredName:Frequent SemanticType:[tmco] PreferredName:Beginning SemanticType:[tmco] PreferredName:Performed SemanticType:[ftcn] PreferredName:Mammography SemanticType:[diap] POS:WRB POS:MD POS:NN POS:VB POS:, POS:CC POS:WRB POS:RB POS:MD POS:VB POS:VB POS:VBN POS:. 
[sentNum: 178]<Annotation Id="18946" Type="Sentence" StartNode="21511" EndNode="21755">Based on the incidence of breast cancer, the sojourn time for breast cancer growth, and the potential for reduction in breast cancer mortality, the College recommends that women aged 40 years and older be offered screening mammography annually. PreferredName:incidence of cases SemanticType:[ftcn] PreferredName:Base - General Qualifier SemanticType:[idcn] PreferredName:Sojourn SemanticType:[orch, phsu] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Time SemanticType:[tmco] PreferredName:Potential SemanticType:[qlco] PreferredName:growth aspects SemanticType:[phsf] PreferredName:Cancer Death Rate SemanticType:[qnco] PreferredName:Reduction mammaplasty SemanticType:[topp] PreferredName:Recommendation SemanticType:[idcn] PreferredName:College SemanticType:[mnob] PreferredName:Age SemanticType:[orga] PreferredName:Woman SemanticType:[popg] PreferredName:year SemanticType:[tmco] PreferredName:/40 SemanticType:[tmco] PreferredName:Offered SemanticType:[fndg] PreferredName:Old SemanticType:[tmco] PreferredName:Mammography SemanticType:[diap] PreferredName:Disease Screening SemanticType:[diap] PreferredName:Annual SemanticType:[tmco] POS:VBN POS:IN POS:DT POS:NN POS:IN POS:NN POS:NN POS:, POS:DT POS:NN POS:NN POS:IN POS:NN POS:NN POS:NN POS:, POS:CC POS:DT POS:NN POS:IN POS:NN POS:IN POS:NN POS:NN POS:NN POS:, POS:DT POS:NNP POS:VBZ POS:IN POS:NNS POS:JJ POS:CD POS:NNS POS:CC POS:JJR POS:VB POS:VBN POS:JJ POS:NN POS:RB POS:. 
[sentNum: 179]<Annotation Id="18947" Type="Sentence" StartNode="21756" EndNode="21920">However, as with any screen­ing test, women should be educated on the predictive value ofthetest andthepotentialforfalse-positiveresults and false-negative results. PreferredName:Screening Tests SemanticType:[hlca] PreferredName:Educational process of instructing SemanticType:[edac] PreferredName:Woman SemanticType:[popg] PreferredName:False Negative Result Medical Device Problem SemanticType:[fndg] PreferredName:Predictive Value SemanticType:[qlco] POS:RB POS:, POS:IN POS:IN POS:DT POS:VBG POS:NN POS:, POS:NNS POS:MD POS:VB POS:VBN POS:IN POS:DT POS:JJ POS:NN POS:NN POS:NNS POS:CC POS:JJ POS:NNS POS:. 
[sentNum: 180]<Annotation Id="18948" Type="Sentence" StartNode="21921" EndNode="22049">Women should be informed of the potential for additional imaging or biopsies that may be recommended based on screening results. PreferredName:Informed SemanticType:[qlco] PreferredName:Woman SemanticType:[popg] PreferredName:Additional SemanticType:[ftcn] PreferredName:Potential SemanticType:[qlco] PreferredName:Biopsy SemanticType:[diap] PreferredName:Imaging Techniques SemanticType:[diap] PreferredName:Base - General Qualifier SemanticType:[idcn] PreferredName:Recommendation SemanticType:[idcn] PreferredName:Growth Inhibition Screening Result SemanticType:[cnce] POS:NNS POS:MD POS:VB POS:VBN POS:IN POS:DT POS:NN POS:IN POS:JJ POS:NN POS:CC POS:NNS POS:WDT POS:MD POS:VB POS:VBN POS:VBN POS:IN POS:NN POS:NNS POS:. 
[sentNum: 181]<Annotation Id="18949" Type="Sentence" StartNode="22050" EndNode="22249">The physician should work with the patient todetermine the best screening strategybased onindividual risk and val-ues.In some women,biennial screening maybe a more appropriate or acceptable strategy. PreferredName:Physicians SemanticType:[prog] PreferredName:Patients SemanticType:[podg] PreferredName:Work SemanticType:[ocac] PreferredName:Disease Screening SemanticType:[diap] PreferredName:best (quality) SemanticType:[qlco] PreferredName:Valine SemanticType:[aapp, bacs, phsu] PreferredName:Risk SemanticType:[qlco] PreferredName:Woman SemanticType:[popg] PreferredName:Undifferentiated (Embryonal) Sarcoma SemanticType:[neop] PreferredName:More SemanticType:[ftcn] PreferredName:Disease Screening SemanticType:[diap] PreferredName:Acceptable SemanticType:[qlco] PreferredName:Appropriate SemanticType:[qlco] PreferredName:strategy SemanticType:[menp] POS:DT POS:NN POS:MD POS:VB POS:IN POS:DT POS:NN POS:NN POS:DT POS:JJS POS:NN POS:JJ POS:JJ POS:NN POS:CC POS:NNS POS:. POS:IN POS:DT POS:NNS POS:, POS:JJ POS:NN POS:RB POS:DT POS:RBR POS:JJ POS:CC POS:JJ POS:NN POS:. 
[sentNum: 182]<Annotation Id="18950" Type="Sentence" StartNode="22250" EndNode="22515">Some average-risk women may prefer biennial screening, which maintains most of thebenefits of screening while minimizingboth thefrequencyofscreeningandthepotentialforadditional testing, whereas other women prefer annual screening becauseitmaximizes cancerdetection. PreferredName:Average SemanticType:[qnco] PreferredName:Woman SemanticType:[popg] PreferredName:Risk SemanticType:[qlco] PreferredName:Maintenance SemanticType:[acty] PreferredName:Disease Screening SemanticType:[diap] PreferredName:Disease Screening SemanticType:[diap] PreferredName:Most SemanticType:[qnco] PreferredName:Woman SemanticType:[popg] PreferredName:Testing SemanticType:[ftcn] PreferredName:annual screening SemanticType:[diap] POS:DT POS:JJ POS:NNS POS:MD POS:VB POS:JJ POS:NN POS:, POS:WDT POS:VBZ POS:JJS POS:IN POS:NNS POS:IN POS:NN POS:IN POS:NN POS:JJ POS:NN POS:, POS:IN POS:JJ POS:NNS POS:VBP POS:JJ POS:NN POS:NNS POS:NN POS:. 
[sentNum: 183]<Annotation Id="18951" Type="Sentence" StartNode="22520" EndNode="22632">Various groups have offered recommendations on the timing of initiation and frequency of mammogra­phy screening. PreferredName:Various patch test substance SemanticType:[irda] PreferredName:Offered SemanticType:[fndg] PreferredName:Population Group SemanticType:[popg] PreferredName:Timing SemanticType:[tmco] PreferredName:Recommendation SemanticType:[idcn] PreferredName:Frequencies (time pattern) SemanticType:[tmco] PreferredName:Initiation SemanticType:[ftcn] PreferredName:Aspects of disease screening SemanticType:[ftcn] POS:JJ POS:NNS POS:VBP POS:VBN POS:NNS POS:IN POS:DT POS:NN POS:IN POS:NN POS:CC POS:NN POS:IN POS:NN POS:NN POS:. 
[sentNum: 184]<Annotation Id="18952" Type="Sentence" StartNode="22633" EndNode="23019">Each group places different values on competing considerations, such as published evidence, cost-effectiveness, efficiency, accuracy, adverse conse­quences, specificity, sensitivity, false-positive results, false-negative results, positive predictive value, patient adherence, availability of health care resources, con­flicting health care needs, and opinions of experts and advocates. PreferredName:Population Group SemanticType:[popg] PreferredName:Change values SemanticType:[inpr] PreferredName:Place SemanticType:[spco] PreferredName:Scientific Publication SemanticType:[inpr] PreferredName:consideration SemanticType:[fndg] PreferredName:Cost Effectiveness SemanticType:[qnco] PreferredName:Evidence of SemanticType:[ftcn] PreferredName:Accurate (qualifier) SemanticType:[qlco] PreferredName:Efficiency SemanticType:[qnco] PreferredName:Statistical sensitivity SemanticType:[qnco] PreferredName:Specificity SemanticType:[qnco] PreferredName:False Negative Result Medical Device Problem SemanticType:[fndg] PreferredName:False Positive SemanticType:[lbtr] PreferredName:Compliance behavior SemanticType:[inbe] PreferredName:Positive Predictive Value of Diagnostic Test SemanticType:[qnco] PreferredName:health care resources SemanticType:[qnco] PreferredName:Availability of SemanticType:[ftcn] PreferredName:Needs SemanticType:[qlco] PreferredName:Health Care SemanticType:[hlca] PreferredName:Advocate (person) SemanticType:[ocdi] PreferredName:Expert Opinion SemanticType:[cnce] POS:DT POS:NN POS:VBZ POS:JJ POS:NNS POS:IN POS:VBG POS:NNS POS:, POS:JJ POS:IN POS:VBN POS:NN POS:, POS:NN POS:, POS:NN POS:, POS:NN POS:, POS:JJ POS:NNS POS:, POS:NN POS:, POS:NN POS:, POS:JJ POS:NNS POS:, POS:JJ POS:NNS POS:, POS:JJ POS:JJ POS:NN POS:, POS:NN POS:NN POS:, POS:NN POS:IN POS:NN POS:NN POS:NNS POS:, POS:VBG POS:NN POS:NN POS:NNS POS:, POS:CC POS:NNS POS:IN POS:NNS POS:CC POS:NNS POS:. 
[sentNum: 185]<Annotation Id="18953" Type="Sentence" StartNode="23020" EndNode="23077">A summary of the recommendations can be found in Table 2. PreferredName:Recommendation SemanticType:[idcn] PreferredName:Summary (document) SemanticType:[inpr] PreferredName:Table - furniture SemanticType:[mnob] PreferredName:Present SemanticType:[qnco] POS:DT POS:NN POS:IN POS:DT POS:NNS POS:MD POS:VB POS:VBN POS:IN POS:NNP POS:CD POS:. 
[sentNum: 186]<Annotation Id="18954" Type="Sentence" StartNode="23080" EndNode="23228">The American Cancer Society and the National Comprehensive Cancer Network recommend annual screening mammography beginning at age 40 years (42, 43). PreferredName:National Comprehensive Cancer Network SemanticType:[hcro] PreferredName:American Cancer Society SemanticType:[pros] PreferredName:annual screening SemanticType:[diap] PreferredName:Recommendation SemanticType:[idcn] PreferredName:Beginning SemanticType:[tmco] PreferredName:Mammography SemanticType:[diap] PreferredName:/40 SemanticType:[tmco] PreferredName:Age-Years SemanticType:[tmco] POS:DT POS:NNP POS:NNP POS:NNP POS:CC POS:DT POS:NNP POS:NNP POS:NNP POS:NNP POS:VB POS:JJ POS:NN POS:NN POS:VBG POS:IN POS:NN POS:CD POS:NNS POS:VBP POS:CD POS:, POS:CD POS:NN POS:. 
[sentNum: 187]<Annotation Id="18955" Type="Sentence" StartNode="23229" EndNode="23386">In contrast, the United States Preventive Services Task Force recently changed their guidelines to recom­mend biennial mammography in women aged 50&#x2013;74 years. PreferredName:United States SemanticType:[geoa] PreferredName:Contrast SemanticType:[qlco] PreferredName:Advisory Committees SemanticType:[gora] PreferredName:Preventive service healthcare SemanticType:[hlca] PreferredName:Changing SemanticType:[ftcn] PreferredName:Recent SemanticType:[tmco] PreferredName:MEND ashed powder SemanticType:[orch, phsu] PreferredName:Guideline [Publication Type] SemanticType:[inpr] PreferredName:Woman SemanticType:[popg] PreferredName:Mammography SemanticType:[diap] PreferredName:year SemanticType:[tmco] PreferredName:Elderly (population group) SemanticType:[popg] POS:IN POS:NN POS:, POS:DT POS:NNP POS:NNPS POS:NNP POS:NNPS POS:NNP POS:NNP POS:RB POS:VBD POS:PRP$ POS:NNS POS:TO POS:VB POS:JJ POS:NN POS:IN POS:NNS POS:JJ POS:CD POS:CD POS:CD POS:NNS POS:. 
[sentNum: 188]<Annotation Id="18956" Type="Sentence" StartNode="23387" EndNode="23622">Although routine screeningin women aged40&#x2013;49 years was not recommended, the Task Force advised that screening in women younger than 50 years should be individualized based on &#x201c;patient values regarding specific benefits and harms&#x201d; (23). PreferredName:Woman SemanticType:[popg] PreferredName:Routine SemanticType:[qlco] PreferredName:Negation SemanticType:[ftcn] PreferredName:year SemanticType:[tmco] PreferredName:Advisory Committees SemanticType:[gora] PreferredName:Recommendation SemanticType:[idcn] PreferredName:Woman SemanticType:[popg] PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:year SemanticType:[tmco] PreferredName:Young SemanticType:[tmco] PreferredName:Patient Base SemanticType:[qnco] PreferredName:Individualized SemanticType:[qlco] PreferredName:Specific qualifier value SemanticType:[qlco] PreferredName:Values SemanticType:[qlco] PreferredName:Arabic numeral 23 SemanticType:[qnco] PreferredName:Benefits SemanticType:[qnco] POS:IN POS:JJ POS:NN POS:NNS POS:JJ POS:CD POS:CD POS:CD POS:NNS POS:VBD POS:RB POS:VBN POS:, POS:DT POS:NNP POS:NNP POS:VBD POS:IN POS:NN POS:IN POS:NNS POS:JJR POS:IN POS:CD POS:NNS POS:MD POS:VB POS:VBN POS:VBN POS:IN POS:CD POS:NN POS:NNS POS:VBG POS:JJ POS:NNS POS:CC POS:VBZ POS:CD POS:CD POS:CD POS:NN POS:. 
[sentNum: 189]<Annotation Id="18957" Type="Sentence" StartNode="23625" EndNode="23962">The American Cancer Society, the National Comprehensive Cancer Network, and the United States Preventive Services Task Force agree that screening mammography reduces breast cancer-related mortal­ity in women aged 40 years and older based on meta-analyses of available randomized controlled trials on mammographic screening (see Table 3). PreferredName:National Comprehensive Cancer Network SemanticType:[hcro] PreferredName:American Cancer Society SemanticType:[pros] PreferredName:Preventive service healthcare SemanticType:[hlca] PreferredName:United States SemanticType:[geoa] PreferredName:Agree SemanticType:[inpr] PreferredName:Advisory Committees SemanticType:[gora] PreferredName:Relationships SemanticType:[qlco] PreferredName:Screening mammography SemanticType:[topp] PreferredName:Elderly (population group) SemanticType:[popg] PreferredName:Female Breast Carcinoma SemanticType:[neop] PreferredName:year SemanticType:[tmco] PreferredName:/40 SemanticType:[tmco] PreferredName:Base - General Qualifier SemanticType:[idcn] PreferredName:Old SemanticType:[tmco] PreferredName:Availability of SemanticType:[ftcn] PreferredName:Meta Analysis (statistical procedure) SemanticType:[resa] PreferredName:Screening mammography SemanticType:[topp] PreferredName:Randomized Controlled Trials as Topic SemanticType:[inpr, resa] PreferredName:Table - furniture SemanticType:[mnob] PreferredName:Vision SemanticType:[orgf] POS:DT POS:NNP POS:NNP POS:NNP POS:, POS:DT POS:NNP POS:NNP POS:NNP POS:NNP POS:, POS:CC POS:DT POS:NNP POS:NNPS POS:NNP POS:NNPS POS:NNP POS:NNP POS:VBP POS:IN POS:VBG POS:NN POS:VBZ POS:NN POS:JJ POS:NN POS:IN POS:NNS POS:JJ POS:CD POS:NNS POS:CC POS:JJR POS:VBN POS:IN POS:NNS POS:IN POS:JJ POS:VBN POS:JJ POS:NNS POS:IN POS:JJ POS:NN POS:NN POS:VBP POS:NNP POS:CD POS:NN POS:. 
[sentNum: 190]<Annotation Id="18958" Type="Sentence" StartNode="23963" EndNode="24333">However, the United States Preventive Services Task Force arrived at a different conclusion regarding routine screening for women aged40&#x2013;49 yearsby placing greater weight on the lower prevalence of disease in this population, which reduces the positive predictive value of mammography and increases the number needed to screen to prevent one breast cancer-related death. PreferredName:Preventive service healthcare SemanticType:[hlca] PreferredName:United States SemanticType:[geoa] PreferredName:Arrival - action SemanticType:[acty] PreferredName:Advisory Committees SemanticType:[gora] PreferredName:Conclusion SemanticType:[idcn] PreferredName:Different SemanticType:[qlco] PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:Routine SemanticType:[qlco] PreferredName:Place SemanticType:[spco] PreferredName:Woman SemanticType:[popg] PreferredName:Weight SemanticType:[qnco] PreferredName:Greater SemanticType:[qnco] PreferredName:Lower - spatial qualifier SemanticType:[spco] PreferredName:Upon - dosing instruction fragment SemanticType:[ftcn] PreferredName:Population Group SemanticType:[popg] PreferredName:disorder prevalence SemanticType:[qnco] PreferredName:Mammography SemanticType:[diap] PreferredName:Positive Predictive Value of Diagnostic Test SemanticType:[qnco] PreferredName:Numbers SemanticType:[qnco] PreferredName:Increase SemanticType:[ftcn] PreferredName:To SemanticType:[qlco] PreferredName:Needs SemanticType:[qlco] PreferredName:To SemanticType:[qlco] PreferredName:Screening - procedure intent SemanticType:[ftcn] PreferredName:One SemanticType:[qnco] PreferredName:PREVENT (product) SemanticType:[phsu] PreferredName:Relationships SemanticType:[qlco] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Cessation of life SemanticType:[orgf] POS:RB POS:, POS:DT POS:NNP POS:NNPS POS:NNP POS:NNPS POS:NNP POS:NNP POS:VBD POS:IN POS:DT POS:JJ POS:NN POS:VBG POS:JJ POS:NN POS:IN POS:NNS POS:JJ POS:CD POS:CD POS:CD POS:JJ POS:VBG POS:JJR POS:NN POS:IN POS:DT POS:JJR POS:NN POS:IN POS:NN POS:IN POS:DT POS:NN POS:, POS:WDT POS:VBZ POS:DT POS:JJ POS:JJ POS:NN POS:IN POS:NN POS:CC POS:VBZ POS:DT POS:NN POS:VBN POS:TO POS:VB POS:TO POS:VB POS:CD POS:NN POS:JJ POS:NN POS:. 
[sentNum: 191]<Annotation Id="18959" Type="Sentence" StartNode="24334" EndNode="24645">In addition, the United States Preventive Services Task Force argues that all women who participate in breast cancer screening may potentially experience a false-positive mammogram (as high as 49% of women after 10 years of screening), with resultant additional imaging, biopsies, and psychologic distress (44). PreferredName:Add - instruction imperative SemanticType:[ftcn] PreferredName:Preventive service healthcare SemanticType:[hlca] PreferredName:United States SemanticType:[geoa] PreferredName:Woman SemanticType:[popg] PreferredName:Advisory Committees SemanticType:[gora] PreferredName:Screening for malignant neoplasm of breast SemanticType:[topp] PreferredName:Within SemanticType:[spco] PreferredName:False Positive SemanticType:[lbtr] PreferredName:Practice Experience SemanticType:[menp] PreferredName:High SemanticType:[qlco] PreferredName:Mammography SemanticType:[diap] PreferredName:Status post SemanticType:[tmco] PreferredName:Woman SemanticType:[popg] PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:year SemanticType:[tmco] PreferredName:Diagnostic Imaging SemanticType:[diap] PreferredName:Additional SemanticType:[ftcn] PreferredName:psychological distress SemanticType:[mobd] PreferredName:Biopsy SemanticType:[diap] POS:IN POS:NN POS:, POS:DT POS:NNP POS:NNPS POS:NNP POS:NNPS POS:NNP POS:NNP POS:VBZ POS:IN POS:DT POS:NNS POS:WP POS:VBP POS:IN POS:NN POS:NN POS:NN POS:MD POS:RB POS:VB POS:DT POS:JJ POS:NN POS:RB POS:RB POS:JJ POS:IN POS:CD POS:NN POS:IN POS:NNS POS:IN POS:CD POS:NNS POS:IN POS:VBG POS:NN POS:, POS:IN POS:JJ POS:JJ POS:NN POS:, POS:NNS POS:, POS:CC POS:JJ POS:NN POS:CD POS:CD POS:NN POS:. 
[sentNum: 192]<Annotation Id="18960" Type="Sentence" StartNode="24646" EndNode="24853">The burden of these additional tests may be perceived as greater on women aged 40&#x2013;49 years because they are less likely to experience breast cancer and, therefore, less likely to benefit from screening (23). PreferredName:Additional SemanticType:[ftcn] PreferredName:Burden SemanticType:[idcn] PreferredName:Perception SemanticType:[menp] PreferredName:Laboratory Procedures SemanticType:[lbpr] PreferredName:Woman SemanticType:[popg] PreferredName:Greater SemanticType:[qnco] PreferredName:/40 SemanticType:[tmco] PreferredName:Elderly (population group) SemanticType:[popg] PreferredName:Less Than SemanticType:[inpr] PreferredName:year SemanticType:[tmco] PreferredName:Practice Experience SemanticType:[menp] PreferredName:Probably SemanticType:[idcn] PreferredName:Less Than SemanticType:[inpr] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Benefits SemanticType:[qnco] PreferredName:Probably SemanticType:[idcn] PreferredName:Arabic numeral 23 SemanticType:[qnco] PreferredName:Aspects of disease screening SemanticType:[ftcn] POS:DT POS:NN POS:IN POS:DT POS:JJ POS:NNS POS:MD POS:VB POS:VBN POS:IN POS:JJR POS:IN POS:NNS POS:JJ POS:CD POS:CD POS:CD POS:NNS POS:IN POS:PRP POS:VBP POS:RBR POS:JJ POS:TO POS:VB POS:NN POS:NN POS:CC POS:, POS:RB POS:, POS:RBR POS:JJ POS:TO POS:VB POS:IN POS:VBG POS:CD POS:CD POS:NN POS:. 
[sentNum: 193]<Annotation Id="18961" Type="Sentence" StartNode="24856" EndNode="25202">In response to this argument, experts who sup­port routine screening for women in their 40s note that although the incidence of cancer is less in the 40&#x2013;49 year age group than in all women older than 50 years, the incidence of cancer in women in their 50s (1 in 38, or 2.60%) is not much higher than in women in their 40s (1 in 69, or 1.44%) (2). PreferredName:Disease Response SemanticType:[fndg] PreferredName:Within SemanticType:[spco] PreferredName:HERPUD1 gene SemanticType:[gngm] PreferredName:Programming Parameter SemanticType:[cnce] PreferredName:Routine SemanticType:[qlco] PreferredName:Data Port SemanticType:[cnce] PreferredName:Woman SemanticType:[popg] PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:Note:Finding:Point in time:{Setting}:Document:Nursing SemanticType:[clna] PreferredName:/40 SemanticType:[tmco] PreferredName:Primary malignant neoplasm SemanticType:[neop] PreferredName:incidence of cases SemanticType:[ftcn] PreferredName:/40 SemanticType:[tmco] PreferredName:Less Than SemanticType:[inpr] PreferredName:Human Age Group SemanticType:[aggp] PreferredName:per year SemanticType:[tmco] PreferredName:Old SemanticType:[tmco] PreferredName:Woman SemanticType:[popg] PreferredName:incidence of cases SemanticType:[ftcn] PreferredName:year SemanticType:[tmco] PreferredName:Within SemanticType:[spco] PreferredName:Primary malignant neoplasm SemanticType:[neop] PreferredName:1+ Score SemanticType:[qnco] PreferredName:Woman SemanticType:[popg] PreferredName:Negation SemanticType:[ftcn] PreferredName:Integer +2 SemanticType:[qnco] PreferredName:Within SemanticType:[spco] PreferredName:High SemanticType:[qlco] PreferredName:/40 SemanticType:[tmco] PreferredName:Woman SemanticType:[popg] PreferredName:Arabic numeral 69 SemanticType:[inpr] PreferredName:1+ Score SemanticType:[qnco] PreferredName:Integer +2 SemanticType:[qnco] PreferredName:1+ Score SemanticType:[qnco] POS:IN POS:NN POS:TO POS:DT POS:NN POS:, POS:NNS POS:WP POS:VBP POS:JJ POS:NN POS:IN POS:NNS POS:IN POS:PRP$ POS:CD POS:NNS POS:VBP POS:IN POS:IN POS:DT POS:NN POS:IN POS:NN POS:VBZ POS:RBR POS:IN POS:DT POS:CD POS:NN POS:CD POS:NN POS:NN POS:NN POS:IN POS:IN POS:DT POS:NNS POS:JJR POS:IN POS:CD POS:NNS POS:, POS:DT POS:NN POS:IN POS:NN POS:IN POS:NNS POS:IN POS:PRP$ POS:CD POS:NNS POS:VBP POS:CD POS:IN POS:CD POS:, POS:CC POS:CD POS:. POS:CD POS:NN POS:CD POS:VBZ POS:RB POS:RB POS:JJR POS:IN POS:IN POS:NNS POS:IN POS:PRP$ POS:CD POS:NNS POS:VBP POS:CD POS:IN POS:CD POS:, POS:CC POS:CD POS:. POS:CD POS:NN POS:CD POS:NN POS:CD POS:NN POS:. 
[sentNum: 194]<Annotation Id="18962" Type="Sentence" StartNode="25203" EndNode="25445">In addition, women who undergo routine screening mammography in their 40s have com­parable mortality reduction compared with women who undergo routine mammography screening in their 50s (16% reduction versus 15% reduction, respectively) (17). PreferredName:Woman SemanticType:[popg] PreferredName:Add - instruction imperative SemanticType:[ftcn] PreferredName:Screening mammography SemanticType:[topp] PreferredName:Routine SemanticType:[qlco] PreferredName:parable SemanticType:[inpr] PreferredName:/40 SemanticType:[tmco] PreferredName:Reduction - action SemanticType:[topp] PreferredName:Mortality Vital Statistics SemanticType:[qnco] PreferredName:Woman SemanticType:[popg] PreferredName:Comparison SemanticType:[acty] PreferredName:Screening mammography SemanticType:[topp] PreferredName:Routine SemanticType:[qlco] PreferredName:Reduction - action SemanticType:[topp] PreferredName:Reduction - action SemanticType:[topp] POS:IN POS:NN POS:, POS:NNS POS:WP POS:VBP POS:JJ POS:NN POS:NN POS:IN POS:PRP$ POS:CD POS:NNS POS:VBP POS:JJ POS:NN POS:NN POS:VBN POS:IN POS:NNS POS:WP POS:VBP POS:JJ POS:NN POS:NN POS:IN POS:PRP$ POS:CD POS:NNS POS:VBP POS:CD POS:NN POS:NN POS:CC POS:CD POS:NN POS:NN POS:, POS:RB POS:CD POS:CD POS:CD POS:NN POS:. 
[sentNum: 195]<Annotation Id="18963" Type="Sentence" StartNode="25446" EndNode="25598">This is of particular importance because each year in the United States breast cancer is diagnosed in approxi­mately 50,000 women younger than 50 years. PreferredName:per year SemanticType:[tmco] PreferredName:Each (qualifier value) SemanticType:[qnco] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:United States SemanticType:[geoa] PreferredName:Woman SemanticType:[popg] PreferredName:Diagnosis SemanticType:[fndg] PreferredName:year SemanticType:[tmco] PreferredName:Young SemanticType:[tmco] POS:DT POS:VBZ POS:IN POS:JJ POS:NN POS:IN POS:DT POS:NN POS:IN POS:DT POS:NNP POS:NNPS POS:NN POS:NN POS:VBZ POS:VBN POS:IN POS:RB POS:CD POS:, POS:CD POS:NNS POS:JJR POS:IN POS:CD POS:NNS POS:. 
[sentNum: 196]<Annotation Id="18964" Type="Sentence" StartNode="25601" EndNode="26102">Regarding the frequency of screening mammogra­phy, the United States Preventive Services Task Force alsodivergedfrom whathasbecome commonpracticein theUnitedStates by recommending biennial rather than annualscreeningforwomenaged50yearsandolder.This decision was based on the National Cancer Institute&#x2019;s CancerIntervention andSurveillanceModelingNetwork screening models, which predicted that81% of theben­efits of screening(ie, mortality reduction) couldbe main­tainedby screening every otheryear(24).ThisPreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:Frequencies (time pattern) SemanticType:[tmco] PreferredName:Preventive service healthcare SemanticType:[hlca] PreferredName:United States SemanticType:[geoa] PreferredName:Recommendation SemanticType:[idcn] PreferredName:Advisory Committees SemanticType:[gora] PreferredName:Base - General Qualifier SemanticType:[idcn] PreferredName:Decision SemanticType:[menp] PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:National Cancer Institute SemanticType:[hcro] PreferredName:Prediction SemanticType:[idcn] PreferredName:Model SemanticType:[inpr] PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:Within SemanticType:[spco] PreferredName:Reduction - action SemanticType:[topp] PreferredName:Mortality Vital Statistics SemanticType:[qnco] PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:Main SemanticType:[qlco] POS:VBG POS:DT POS:NN POS:IN POS:VBG POS:NN POS:, POS:DT POS:NNP POS:NNPS POS:NNP POS:NNPS POS:NNP POS:NNP POS:NN POS:NN POS:NN POS:NNS POS:IN POS:VBG POS:JJ POS:RB POS:IN POS:JJ POS:CD POS:NN POS:. POS:DT POS:NN POS:VBD POS:VBN POS:IN POS:DT POS:NNP POS:NNP POS:NNP POS:NN POS:VBZ POS:NNP POS:NN POS:NN POS:NNS POS:, POS:WDT POS:VBD POS:IN POS:CD POS:NN POS:IN POS:NNS POS:IN POS:VBG POS:CD POS:FW POS:, POS:NN POS:NN POS:CD POS:NN POS:JJ POS:NN POS:DT POS:JJ POS:NN POS:CD POS:NN POS:. 
[sentNum: 197]<Annotation Id="18965" Type="Sentence" StartNode="26102" EndNode="26199">This strategy isless resourceintensive andispredictedto reducefalse­positive results by 50% (23). PreferredName:strategy SemanticType:[menp] PreferredName:This SemanticType:[euka] PreferredName:Experimental Result SemanticType:[fndg] PreferredName:Positive Finding SemanticType:[fndg] PreferredName:Arabic numeral 23 SemanticType:[qnco] POS:DT POS:NN POS:JJ POS:JJ POS:NN POS:JJ POS:NNS POS:IN POS:CD POS:NN POS:CD POS:CD POS:NN POS:. 
[sentNum: 198]<Annotation Id="18966" Type="Sentence" StartNode="26200" EndNode="26415">However, these models demonstrateagreaterreductioninmortalityandincreased number oflifeyearsgainedby screening annually;there­fore, acceptingabiennial strategy reduces some(19%) of thepotentialbenefits of screening. PreferredName:Model Number SemanticType:[inpr] PreferredName:Annual SemanticType:[tmco] PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:strategy SemanticType:[menp] PreferredName:Anterior SemanticType:[ftcn] PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:Within SemanticType:[spco] POS:RB POS:, POS:DT POS:NNS POS:VBD POS:NN POS:JJ POS:NN POS:RB POS:: POS:RB POS:, POS:JJ POS:NN POS:VBZ POS:DT POS:CD POS:CD POS:NN POS:CD POS:IN POS:NNS POS:IN POS:NN POS:. 
[sentNum: 199]<Annotation Id="18967" Type="Sentence" StartNode="26424" EndNode="26493">What are the potential adverse consequences of screening mammography? PreferredName:Consequence of SemanticType:[ftcn] PreferredName:Potential SemanticType:[qlco] PreferredName:Screening mammography SemanticType:[topp] POS:WP POS:VBP POS:DT POS:JJ POS:JJ POS:NNS POS:IN POS:VBG POS:NN POS:. 
[sentNum: 200]<Annotation Id="18968" Type="Sentence" StartNode="26496" EndNode="26644">Potential adverse outcomes of breast cancer screen­ing mammography include false-positive mammo­grams, false-negative mammograms, and overdiagnosis. PreferredName:Potential SemanticType:[qlco] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Result SemanticType:[ftcn] PreferredName:Mammography SemanticType:[diap] PreferredName:Screening - procedure intent SemanticType:[ftcn] PreferredName:False Positive SemanticType:[lbtr] PreferredName:include - SetOperator SemanticType:[idcn] PreferredName:False Negative SemanticType:[lbtr] PreferredName:gram SemanticType:[qnco] PreferredName:overdiagnosis SemanticType:[fndg] PreferredName:Mammography SemanticType:[diap] POS:JJ POS:JJ POS:NNS POS:IN POS:NN POS:NN POS:VBG POS:NN POS:VBP POS:JJ POS:NNS POS:, POS:JJ POS:NNS POS:, POS:CC POS:NN POS:. 
[sentNum: 201]<Annotation Id="18969" Type="Sentence" StartNode="26645" EndNode="26861">Concerns about the risk of radiation exposure (eg, induc­tion of breast cancer from radiation exposure) have largely been decreased by improvements in mammogra­phy technique, technology, and clinical experience (45). PreferredName:Risk SemanticType:[qlco] PreferredName:Concern SemanticType:[idcn] PreferredName:Egypt SemanticType:[geoa] PreferredName:Exposure to radiation SemanticType:[phpr] PreferredName:Exposure to radiation SemanticType:[phpr] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Improvement SemanticType:[cnce] PreferredName:Decreased SemanticType:[qnco] PreferredName:Technology SemanticType:[ocdi] PreferredName:Techniques SemanticType:[ftcn] PreferredName:Experience SemanticType:[menp] PreferredName:Clinical SemanticType:[qlco] POS:NNS POS:IN POS:DT POS:NN POS:IN POS:NN POS:NN POS:CD POS:FW POS:, POS:NN POS:IN POS:NN POS:NN POS:IN POS:NN POS:NN POS:CD POS:VBP POS:RB POS:VBN POS:VBN POS:IN POS:NNS POS:IN POS:NN POS:NN POS:, POS:NN POS:, POS:CC POS:JJ POS:NN POS:CD POS:CD POS:NN POS:. 
[sentNum: 202]<Annotation Id="18970" Type="Sentence" StartNode="26864" EndNode="27035">False-positive mammograms (ie, those with per­ceived abnormalities requiring further evaluation to verify that the lesion is not cancer) are a continuing concern (44, 46). PreferredName:Mammography SemanticType:[diap] PreferredName:False Positive SemanticType:[lbtr] PreferredName:Further SemanticType:[spco] PreferredName:Congenital Abnormality SemanticType:[cgab] PreferredName:Verification SemanticType:[ftcn] PreferredName:Evaluation SemanticType:[ftcn] PreferredName:Negation SemanticType:[ftcn] PreferredName:Lesion SemanticType:[fndg] PreferredName:Continuous SemanticType:[idcn] PreferredName:Primary malignant neoplasm SemanticType:[neop] PreferredName:Concern SemanticType:[idcn] POS:JJ POS:NNS POS:VBP POS:FW POS:, POS:DT POS:IN POS:JJ POS:NNS POS:VBG POS:JJ POS:NN POS:TO POS:VB POS:IN POS:DT POS:NN POS:VBZ POS:RB POS:NN POS:NN POS:VBP POS:DT POS:VBG POS:NN POS:CD POS:CD POS:, POS:CD POS:NN POS:. 
[sentNum: 203]<Annotation Id="18971" Type="Sentence" StartNode="27036" EndNode="27235">False-positive screening mammograms require diagnostic mammography with supplementary views, ultrasonography, and even biopsy in 20&#x2013;30% of cases in an attempt to reach an accurate diagnosis (44, 46). PreferredName:False Positive SemanticType:[lbtr] PreferredName:Diagnostic Mammography SemanticType:[diap] PreferredName:Screening mammography SemanticType:[topp] PreferredName:Ultrasonography SemanticType:[diap] PreferredName:View SemanticType:[spco] PreferredName:Case unit dose SemanticType:[qnco] PreferredName:biopsy characteristics SemanticType:[ftcn] PreferredName:Reaching SemanticType:[orgf] PreferredName:Attempt SemanticType:[evnt] PreferredName:Diagnostic Accuracy SemanticType:[qlco] POS:JJ POS:NN POS:NNS POS:VBP POS:JJ POS:NN POS:IN POS:JJ POS:NNS POS:, POS:NN POS:, POS:CC POS:RB POS:NN POS:IN POS:CD POS:CD POS:CD POS:NN POS:IN POS:NNS POS:IN POS:DT POS:NN POS:TO POS:VB POS:DT POS:JJ POS:NN POS:NN POS:CD POS:, POS:CD POS:NN POS:. 
[sentNum: 204]<Annotation Id="18972" Type="Sentence" StartNode="27236" EndNode="27404">Psychosocial consequences of screening mammog­raphy, such as anxiety and distress, have been identified, reviewed, and are generally short-lived and not severe (47&#x2013;50). PreferredName:Treatment/Psychosocial Effects SemanticType:[fndg] PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:Consequence of SemanticType:[ftcn] PreferredName:Distress SemanticType:[menp] PreferredName:Anxiety SemanticType:[menp] PreferredName:Reviewed SemanticType:[qlco] PreferredName:Identified SemanticType:[qlco] PreferredName:% live SemanticType:[qlco] PreferredName:Short SemanticType:[qnco] PreferredName:Severe (severity modifier) SemanticType:[qlco] PreferredName:Negation SemanticType:[ftcn] POS:JJ POS:NNS POS:IN POS:VBG POS:NN POS:, POS:JJ POS:IN POS:NN POS:CC POS:NN POS:, POS:VBP POS:VBN POS:VBN POS:, POS:VBN POS:, POS:CC POS:VBP POS:RB POS:JJ POS:CC POS:RB POS:JJ POS:NN POS:CD POS:CD POS:CD POS:NN POS:. 
[sentNum: 205]<Annotation Id="18973" Type="Sentence" StartNode="27405" EndNode="27701">Studies evaluating the effect of false-positive results suggest that women in the United States are highly tolerant of false-positive mammograms, and that women who experience a false-positive mammogram are more likely than women with a normal result to adhere to routine screening in the future. PreferredName:Evaluation SemanticType:[ftcn] PreferredName:Scientific Study SemanticType:[lbpr] PreferredName:False Positive SemanticType:[lbtr] PreferredName:Effect SemanticType:[qlco] PreferredName:Woman SemanticType:[popg] PreferredName:suggestion SemanticType:[idcn] PreferredName:High SemanticType:[qlco] PreferredName:United States SemanticType:[geoa] PreferredName:False Positive SemanticType:[lbtr] PreferredName:Tolerant SemanticType:[ftcn] PreferredName:Woman SemanticType:[popg] PreferredName:Mammography SemanticType:[diap] PreferredName:False Positive SemanticType:[lbtr] PreferredName:Experience SemanticType:[menp] PreferredName:More SemanticType:[ftcn] PreferredName:Mammography SemanticType:[diap] PreferredName:Woman SemanticType:[popg] PreferredName:Probably SemanticType:[idcn] PreferredName:Immobile SemanticType:[fndg] PreferredName:Normal result SemanticType:[fndg] PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:Routine SemanticType:[qlco] PreferredName:Future SemanticType:[tmco] POS:NNS POS:VBG POS:DT POS:NN POS:IN POS:JJ POS:NNS POS:VBP POS:IN POS:NNS POS:IN POS:DT POS:NNP POS:NNPS POS:VBP POS:RB POS:JJ POS:IN POS:JJ POS:NNS POS:, POS:CC POS:IN POS:NNS POS:WP POS:VBP POS:DT POS:JJ POS:NN POS:VBP POS:RBR POS:JJ POS:IN POS:NNS POS:IN POS:DT POS:JJ POS:NN POS:TO POS:VB POS:TO POS:JJ POS:NN POS:IN POS:DT POS:NN POS:. 
[sentNum: 206]<Annotation Id="18974" Type="Sentence" StartNode="27702" EndNode="27849">Women with false-positive results were more likely to have anxiety about developing breast cancer,butnotata demonstrably pathologic level (50, 51). PreferredName:Woman SemanticType:[popg] PreferredName:More SemanticType:[ftcn] PreferredName:False Positive SemanticType:[lbtr] PreferredName:Anxiety SemanticType:[menp] PreferredName:Probably SemanticType:[idcn] PreferredName:Pathologic SemanticType:[ftcn] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Disease classification level SemanticType:[clas] POS:NNS POS:IN POS:JJ POS:NNS POS:VBD POS:RBR POS:JJ POS:TO POS:VB POS:NN POS:IN POS:VBG POS:NN POS:NN POS:, POS:NN POS:RB POS:JJ POS:NN POS:NN POS:CD POS:, POS:CD POS:NN POS:. 
[sentNum: 207]<Annotation Id="18975" Type="Sentence" StartNode="27858" EndNode="27934">What are the factors that increase a woman&#x2019;s relative risk of breast cancer? PreferredName:Factor SemanticType:[ftcn] PreferredName:Woman SemanticType:[popg] PreferredName:Increase SemanticType:[ftcn] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Relative Risk SemanticType:[qnco] POS:WP POS:VBP POS:DT POS:NNS POS:WDT POS:VBP POS:DT POS:NN POS:CD POS:NNS POS:JJ POS:NN POS:IN POS:NN POS:NN POS:. 
[sentNum: 208]<Annotation Id="18976" Type="Sentence" StartNode="27937" EndNode="28187">Most women in whom invasive breast cancer is diag­nosed do not have unique identifiable risk factors; however, women with certain characteristics do have an increased lifetime prevalence of breast cancer compared with the general population (52, 53). PreferredName:Female Breast Carcinoma SemanticType:[neop] PreferredName:Most SemanticType:[qnco] PreferredName:Nose SemanticType:[bpoc] PreferredName:Invasive SemanticType:[qlco] PreferredName:Unique SemanticType:[qlco] PreferredName:Negation SemanticType:[ftcn] PreferredName:Act Code - risk factors SemanticType:[idcn] PreferredName:Identified SemanticType:[qlco] PreferredName:Certain (qualifier value) SemanticType:[qlco] PreferredName:Woman SemanticType:[popg] PreferredName:Increase SemanticType:[ftcn] PreferredName:Characteristics SemanticType:[qlco] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Prevalence aspects SemanticType:[qnco] PreferredName:General Population SemanticType:[popg] PreferredName:Comparison SemanticType:[acty] POS:JJS POS:NNS POS:IN POS:WP POS:JJ POS:NN POS:NN POS:VBZ POS:VBN POS:VBP POS:RB POS:VB POS:JJ POS:JJ POS:NN POS:NNS POS:: POS:RB POS:, POS:NNS POS:IN POS:JJ POS:NNS POS:VBP POS:VB POS:DT POS:VBN POS:NN POS:NN POS:IN POS:NN POS:NN POS:VBN POS:IN POS:DT POS:JJ POS:NN POS:CD POS:CD POS:, POS:CD POS:NN POS:. 
[sentNum: 209]<Annotation Id="18977" Type="Sentence" StartNode="28188" EndNode="28252">The incidence of breast cancer increases with advancing age (2). PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Incidence SemanticType:[qnco] PreferredName:Advance SemanticType:[medd] PreferredName:Increase SemanticType:[ftcn] PreferredName:Integer +2 SemanticType:[qnco] PreferredName:Age SemanticType:[orga] POS:DT POS:NN POS:IN POS:NN POS:NN POS:VBZ POS:IN POS:VBG POS:NN POS:NN POS:CD POS:NN POS:. 
[sentNum: 210]<Annotation Id="18978" Type="Sentence" StartNode="28253" EndNode="28438">Because women at high risk need to be appropriately counseled regarding increased surveillance or breast cancer risk reduction, physicians should periodically assess breast cancer risk. PreferredName:High risk of SemanticType:[qlco] PreferredName:Woman SemanticType:[popg] PreferredName:To SemanticType:[qlco] PreferredName:Patient need for (contextual qualifier) SemanticType:[ftcn] PreferredName:Increase SemanticType:[ftcn] PreferredName:Counsel - legal SemanticType:[prog] PreferredName:Reduction mammaplasty SemanticType:[topp] PreferredName:Medical Surveillance SemanticType:[hlca] PreferredName:Physicians SemanticType:[prog] PreferredName:Cancer Risk SemanticType:[qnco] PreferredName:Assessed SemanticType:[acty] PreferredName:Periodic SemanticType:[tmco] PreferredName:Risk SemanticType:[qlco] PreferredName:Malignant neoplasm of breast SemanticType:[neop] POS:IN POS:NNS POS:IN POS:JJ POS:NN POS:VBP POS:TO POS:VB POS:RB POS:VBN POS:VBG POS:VBN POS:NN POS:CC POS:NN POS:NN POS:NN POS:NN POS:, POS:NNS POS:MD POS:RB POS:VB POS:NN POS:NN POS:NN POS:. 
[sentNum: 211]<Annotation Id="18979" Type="Sentence" StartNode="28439" EndNode="28565">The goal of this risk assessment is to catego­rize the woman&#x2019;s risk level as average for her age versus elevated or high risk. PreferredName:Risk Assessment SemanticType:[hlca] PreferredName:Act Mood - Goal SemanticType:[idcn] PreferredName:Risk SemanticType:[qlco] PreferredName:Woman SemanticType:[popg] PreferredName:Average SemanticType:[qnco] PreferredName:Levels (qualifier value) SemanticType:[qlco] PreferredName:High SemanticType:[qlco] PreferredName:Age SemanticType:[orga] PreferredName:High risk of SemanticType:[qlco] POS:DT POS:NN POS:IN POS:DT POS:NN POS:NN POS:VBZ POS:TO POS:VB POS:DT POS:NN POS:CD POS:NNS POS:NN POS:NN POS:IN POS:NN POS:IN POS:PRP$ POS:NN POS:CC POS:JJ POS:CC POS:JJ POS:NN POS:. 
[sentNum: 212]<Annotation Id="18980" Type="Sentence" StartNode="28566" EndNode="28851">Risk assessment should not be used to consider a woman ineligible for screening appropriate for her age, but rather to identify those who may qualify for enhanced screening, such as addition of MRI screen­ing or more frequent clinical breast examinations and risk reduction strategies. PreferredName:Risk Assessment SemanticType:[hlca] PreferredName:Used by SemanticType:[fndg] PreferredName:Negation SemanticType:[ftcn] PreferredName:consider SemanticType:[idcn] PreferredName:To SemanticType:[qlco] PreferredName:Disease Screening SemanticType:[diap] PreferredName:Woman SemanticType:[popg] PreferredName:Age SemanticType:[orga] PreferredName:Appropriate SemanticType:[qlco] PreferredName:Disease Screening SemanticType:[diap] PreferredName:Enhance (action) SemanticType:[acty] PreferredName:Magnetic Resonance Imaging SemanticType:[diap] PreferredName:Add - instruction imperative SemanticType:[ftcn] PreferredName:More SemanticType:[ftcn] PreferredName:Screening procedure SemanticType:[hlca] PreferredName:Clinical Breast Examination SemanticType:[topp] PreferredName:Frequent SemanticType:[tmco] PreferredName:strategy SemanticType:[menp] PreferredName:Risk Reduction SemanticType:[inbe] POS:NN POS:NN POS:MD POS:RB POS:VB POS:VBN POS:TO POS:VB POS:DT POS:NN POS:JJ POS:IN POS:VBG POS:JJ POS:IN POS:PRP$ POS:NN POS:, POS:CC POS:RB POS:TO POS:VB POS:DT POS:WP POS:MD POS:VB POS:IN POS:VBN POS:NN POS:, POS:JJ POS:IN POS:NN POS:IN POS:NNP POS:VBG POS:CC POS:JJR POS:JJ POS:JJ POS:NN POS:NNS POS:CC POS:VB POS:NN POS:NNS POS:. 
[sentNum: 213]<Annotation Id="18981" Type="Sentence" StartNode="28856" EndNode="28881">Reproductive Risk Factors PreferredName:Risk SemanticType:[qlco] PreferredName:Reproductive History SemanticType:[fndg] POS:NNP POS:NNP POS:NNS 
[sentNum: 214]<Annotation Id="18982" Type="Sentence" StartNode="28884" EndNode="29050">Certain reproductive factors also influence breast can­cer risk, including age at menarche, age at first birth, breastfeeding, parity, and age at menopause (Table 4). PreferredName:Entire breast SemanticType:[bpoc] PreferredName:Certain (qualifier value) SemanticType:[qlco] PreferredName:Risk SemanticType:[qlco] PreferredName:CER tumor staging notation SemanticType:[inpr] PreferredName:Age at menarche SemanticType:[fndg] PreferredName:Including (qualifier) SemanticType:[ftcn] PreferredName:First Birth SemanticType:[tmco] PreferredName:Age SemanticType:[orga] PreferredName:Parity:Number:Point in time:^Patient:Quantitative:Reported SemanticType:[clna] PreferredName:Breast Feeding SemanticType:[orgf] PreferredName:Table - furniture SemanticType:[mnob] PreferredName:Age at menopause:Time:Point in time:^Patient:Quantitative SemanticType:[clna] POS:JJ POS:JJ POS:NNS POS:RB POS:VBP POS:NN POS:NN POS:NN POS:, POS:VBG POS:NN POS:IN POS:NN POS:, POS:NN POS:IN POS:JJ POS:NN POS:, POS:NN POS:, POS:NN POS:, POS:CC POS:NN POS:IN POS:NN POS:CD POS:NNP POS:CD POS:CD POS:. 
[sentNum: 215]<Annotation Id="18983" Type="Sentence" StartNode="29051" EndNode="29186">Agreater number of reproductive years, later age at first birth, and lower parity or nulliparity generally increase breast cancer risk. PreferredName:REPRODUCTIVE SemanticType:[clas] PreferredName:Numbers SemanticType:[qnco] PreferredName:Age SemanticType:[orga] PreferredName:year SemanticType:[tmco] PreferredName:Lower - spatial qualifier SemanticType:[spco] PreferredName:First Birth SemanticType:[tmco] PreferredName:Nulliparity SemanticType:[orgf] PreferredName:Parity:Number:Point in time:^Patient:Quantitative:Reported SemanticType:[clna] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Increase SemanticType:[ftcn] PreferredName:Risk SemanticType:[qlco] POS:NNP POS:NN POS:IN POS:JJ POS:NNS POS:, POS:RB POS:NN POS:IN POS:JJ POS:NN POS:, POS:CC POS:JJR POS:NN POS:CC POS:NN POS:RB POS:VBP POS:NN POS:NN POS:NN POS:. 
[sentNum: 216]<Annotation Id="18984" Type="Sentence" StartNode="29193" EndNode="29214">Familial Risk Factors PreferredName:Familial risk factor SemanticType:[qlco] POS:JJ POS:NN POS:NNS 
[sentNum: 217]<Annotation Id="18985" Type="Sentence" StartNode="29217" EndNode="29553">Another important consideration in breast cancer risk assessment is family history to identify cases of breast cancer, ovarian cancer, prostate cancer, and other types of cancerinfirst-degree relatives(parents, sibling, child), second-degreerelatives,andthird-degreerelatives,includ­ingthe age of onsetfor thefamily members with cancer. PreferredName:Entire breast SemanticType:[bpoc] PreferredName:consideration SemanticType:[fndg] PreferredName:Family history SemanticType:[fndg] PreferredName:Assessment for risk of cancer SemanticType:[hlca] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Case unit dose SemanticType:[qnco] PreferredName:Malignant neoplasm of prostate SemanticType:[neop] PreferredName:Malignant neoplasm of ovary SemanticType:[neop] PreferredName:Type - attribute SemanticType:[qlco] PreferredName:Other relative SemanticType:[clna] PreferredName:parent SemanticType:[famg] PreferredName:Degree or extent SemanticType:[qnco] PreferredName:Child SemanticType:[aggp] PreferredName:Sibling - RoleCode SemanticType:[inpr] PreferredName:Age SemanticType:[orga] PreferredName:Second Suffix SemanticType:[qlco] PreferredName:Malignant Neoplasms SemanticType:[neop] PreferredName:member SemanticType:[popg] POS:DT POS:JJ POS:NN POS:IN POS:NN POS:NN POS:NN POS:NN POS:VBZ POS:NN POS:NN POS:TO POS:VB POS:NNS POS:IN POS:NN POS:NN POS:, POS:JJ POS:NN POS:, POS:NN POS:NN POS:, POS:CC POS:JJ POS:NNS POS:IN POS:JJ POS:NNS POS:VBP POS:NNS POS:, POS:NN POS:, POS:NN POS:CD POS:, POS:NNS POS:, POS:NNS POS:, POS:JJ POS:NN POS:IN POS:JJ POS:RB POS:NNS POS:IN POS:NN POS:. 
[sentNum: 218]<Annotation Id="18986" Type="Sentence" StartNode="29554" EndNode="29714">Based on thisfamilyhistory, women maybe eligiblefor testingforBRCA genemutationsorforreferraltoagenetic counselorforfurther evaluation and consideration oftest-PreferredName:Woman SemanticType:[popg] PreferredName:Base - General Qualifier SemanticType:[idcn] PreferredName:consideration SemanticType:[fndg] PreferredName:Evaluation SemanticType:[ftcn] POS:VBN POS:IN POS:NN POS:, POS:NNS POS:RB POS:VBP POS:NN POS:JJ POS:NN POS:NN POS:CC POS:NN POS:NN 
[sentNum: 219]<Annotation Id="18987" Type="Sentence" StartNode="29716" EndNode="29724">Table 4. PreferredName:Table - furniture SemanticType:[mnob] POS:NNP POS:CD POS:. 
[sentNum: 220]<Annotation Id="18988" Type="Sentence" StartNode="29725" EndNode="29790">Factors That Increase the Relative Risk of Breast Cancer in Women PreferredName:Factor SemanticType:[ftcn] PreferredName:Relative Risk SemanticType:[qnco] PreferredName:Increase SemanticType:[ftcn] PreferredName:Woman SemanticType:[popg] PreferredName:Malignant neoplasm of breast SemanticType:[neop] POS:NNS POS:WDT POS:VBP POS:DT POS:JJ POS:NN POS:IN POS:NN POS:NN POS:IN POS:NNS 
[sentNum: 221]<Annotation Id="18989" Type="Sentence" StartNode="29795" EndNode="29816">Relative Risk 	Factor PreferredName:Factor SemanticType:[ftcn] PreferredName:Relative Risk SemanticType:[qnco] POS:JJ POS:NN POS:NN 
[sentNum: 222]<Annotation Id="18990" Type="Sentence" StartNode="29819" EndNode="29831">&gt;4.0	 Female PreferredName:Woman SemanticType:[popg] POS:JJR POS:CD POS:. POS:CD POS:JJ 
[sentNum: 223]<Annotation Id="18991" Type="Sentence" StartNode="29834" EndNode="29956">Age (65+ vs &lt;65years, although risk increases across all ages until age 80) Certain inherited genetic mutations for breast PreferredName:Age SemanticType:[orga] PreferredName:Risk SemanticType:[qlco] PreferredName:Arabic numeral 65 SemanticType:[inpr] PreferredName:Age SemanticType:[orga] PreferredName:Increase SemanticType:[ftcn] PreferredName:Breast Cancer, Familial SemanticType:[neop] PreferredName:Definitely Related to Intervention SemanticType:[qlco] PreferredName:Mutation SemanticType:[genf] POS:NNP POS:CD POS:CD POS:CC POS:CC POS:JJR POS:CD POS:NNS POS:, POS:IN POS:NN POS:VBZ POS:IN POS:DT POS:NNS POS:IN POS:NN POS:CD POS:CD POS:JJ POS:VBN POS:JJ POS:NNS POS:IN POS:NN 
[sentNum: 224]<Annotation Id="18992" Type="Sentence" StartNode="29959" EndNode="29985">cancer(BRCA1 and/or BRCA2) PreferredName:BRCA2 gene SemanticType:[gngm] POS:NN POS:CD POS:NN POS:CD POS:CC POS:: POS:CC POS:NNP POS:CD POS:CD 
[sentNum: 225]<Annotation Id="18993" Type="Sentence" StartNode="29988" EndNode="30166">Two or more first-degree relatives with breast cancer diagnosed at an early age Personal history of breast cancer High breast tissue density Biopsy-confirmed atypical hyperplasia PreferredName:More SemanticType:[ftcn] PreferredName:Two SemanticType:[qnco] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Number of First Degree Relatives (Affected) SemanticType:[qnco] PreferredName:Early SemanticType:[tmco] PreferredName:Diagnosis SemanticType:[fndg] PreferredName:Social and personal history SemanticType:[fndg] PreferredName:Age SemanticType:[orga] PreferredName:Cancer confirmed SemanticType:[fndg] PreferredName:Atypical hyperplasia of breast SemanticType:[patf] PreferredName:Body tissue SemanticType:[tisu] PreferredName:Abnormally high SemanticType:[qlco] PreferredName:Biopsy SemanticType:[diap] PreferredName:density SemanticType:[qnco] POS:CD POS:CC POS:JJR POS:JJ POS:NNS POS:IN POS:NN POS:NN POS:VBD POS:IN POS:DT POS:JJ POS:NN POS:JJ POS:NN POS:IN POS:NN POS:NN POS:JJ POS:NN POS:NN POS:NN POS:JJ POS:JJ POS:NN 
[sentNum: 226]<Annotation Id="18994" Type="Sentence" StartNode="30169" EndNode="30286">2.1&#x2013;4.0	 One first-degree relative with breast cancer High-dose radiation to chest High bone density (postmenopausal) PreferredName:First Degree Relative SemanticType:[famg] PreferredName:One SemanticType:[qnco] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:With - dosing instruction fragment SemanticType:[inpr] PreferredName:Bone Density SemanticType:[clna] PreferredName:High-LET Radiotherapy SemanticType:[topp] PreferredName:Postmenopausal state SemanticType:[tmco] POS:LS POS:. POS:CD POS:CD POS:CD POS:. POS:CD POS:CD POS:JJ POS:JJ POS:IN POS:NN POS:NN POS:JJ POS:NN POS:TO POS:NN POS:JJ POS:NN POS:NN POS:CD POS:JJ POS:NN 
[sentNum: 227]<Annotation Id="18995" Type="Sentence" StartNode="30289" EndNode="30360">1.1&#x2013;2.0	 Lateageatfirstfull-termpregnancy(&gt;30years) Factors that affect PreferredName:Factor SemanticType:[ftcn] PreferredName:Affect (mental function) SemanticType:[menp] POS:LS POS:. POS:CD POS:NN POS:CD POS:. POS:CD POS:NN POS:CD POS:JJR POS:CD POS:NNS POS:CD POS:NNS POS:WDT POS:VBP 
[sentNum: 228]<Annotation Id="18996" Type="Sentence" StartNode="30363" EndNode="30388">Early menarche(&lt;12 years) PreferredName:Early menarche SemanticType:[fndg] PreferredName:year SemanticType:[tmco] POS:RB POS:NN POS:NN POS:JJR POS:CD POS:NNS POS:IN 
[sentNum: 229]<Annotation Id="18997" Type="Sentence" StartNode="30391" EndNode="30556">circulating hormones Late menopause(&gt;55 years) No full-term pregnancies Never breastfeda child Recent oral contraceptive use Recent and long-term use of estrogen and	PreferredName:Circulating SemanticType:[ftcn] PreferredName:Late SemanticType:[tmco] PreferredName:Hormones SemanticType:[horm] PreferredName:Arabic numeral 55 SemanticType:[inpr] PreferredName:Menopause SemanticType:[phsf] PreferredName:Full Term finding SemanticType:[fndg] PreferredName:year SemanticType:[tmco] PreferredName:Never (frequency) SemanticType:[tmco] PreferredName:Pregnancy SemanticType:[orgf] PreferredName:Recent SemanticType:[tmco] PreferredName:Offspring SemanticType:[famg] PreferredName:Recent SemanticType:[tmco] PreferredName:ORAL CONTRACEPTIVE INGESTION SemanticType:[fndg] PreferredName:Use of SemanticType:[ftcn] PreferredName:Long-term SemanticType:[tmco] PreferredName:Estrogens SemanticType:[horm, phsu, strd] POS:VBG POS:NNS POS:RB POS:NN POS:CD POS:JJR POS:CD POS:NNS POS:RB POS:DT POS:JJ POS:NNS POS:RB POS:JJ POS:NN POS:JJ POS:JJ POS:JJ POS:NN POS:JJ POS:CC POS:JJ POS:NN POS:IN POS:NN POS:CC 
[sentNum: 230]<Annotation Id="18998" Type="Sentence" StartNode="30560" EndNode="30594">progestin Obesity (postmenopausal) PreferredName:Progestins SemanticType:[horm, phsu, strd] PreferredName:Postmenopausal state SemanticType:[tmco] PreferredName:Obesity SemanticType:[dsyn] POS:NN POS:NN POS:CD POS:JJ POS:NN 
[sentNum: 231]<Annotation Id="18999" Type="Sentence" StartNode="30597" EndNode="30748">Other factors	 Personal history of endometrial or ovarian	 cancer Alcohol consumption Height (tall) High socioeconomic status Ashkenazi Jewish heritage PreferredName:Factor SemanticType:[ftcn] PreferredName:Other Personal Medical History SemanticType:[orga] PreferredName:Endometrial SemanticType:[spco] PreferredName:Personal Attribute SemanticType:[orga] PreferredName:Alcohol consumption SemanticType:[inbe] PreferredName:Malignant neoplasm of ovary SemanticType:[neop] PreferredName:Precursor T-Cell Lymphoblastic Leukemia-Lymphoma SemanticType:[neop] PreferredName:Height SemanticType:[orga] PreferredName:Socioeconomic Status SemanticType:[qlco] PreferredName:Abnormally high SemanticType:[qlco] PreferredName:Heritage SemanticType:[clas] PreferredName:Ashkenazi Jew, follower of religion SemanticType:[popg] POS:JJ POS:NNS POS:JJ POS:NN POS:IN POS:JJ POS:CC POS:JJ POS:NN POS:NN POS:NN POS:NN POS:CD POS:JJ POS:NN POS:JJ POS:JJ POS:NN POS:NNP POS:NNP POS:NN 
[sentNum: 232]<Annotation Id="19000" Type="Sentence" StartNode="30751" EndNode="30806">Reprinted with permission from American Cancer Society. PreferredName:Authorization documentation SemanticType:[inpr] PreferredName:Reprint SemanticType:[inpr] PreferredName:American Cancer Society SemanticType:[pros] POS:VBN POS:IN POS:NN POS:IN POS:NNP POS:NNP POS:NNP POS:. 
[sentNum: 233]<Annotation Id="19001" Type="Sentence" StartNode="30807" EndNode="30847">Breast Cancer Facts &amp; Figures 2009-2010. PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:2010s SemanticType:[tmco] POS:NN POS:NN POS:NNP POS:CC POS:NNS POS:CD POS:: POS:CD POS:. 
[sentNum: 234]<Annotation Id="19002" Type="Sentence" StartNode="30848" EndNode="30886">Atlanta: American Cancer Society, Inc. PreferredName:Atlanta SemanticType:[euka] PreferredName:American Cancer Society SemanticType:[pros] POS:NNP POS:: POS:NNP POS:NNP POS:NNP POS:, POS:NNP POS:. 
[sentNum: 235]<Annotation Id="19003" Type="Sentence" StartNode="30887" EndNode="30937">Adapted with permission from Hulka BS, Moorman PG. PreferredName:Adapt (substance) SemanticType:[orch] PreferredName:Moorman SemanticType:[hcro] PreferredName:Authorization documentation SemanticType:[inpr] PreferredName:Prostaglandin measurement SemanticType:[lbpr] POS:VBN POS:IN POS:NN POS:IN POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:. 
[sentNum: 236]<Annotation Id="19004" Type="Sentence" StartNode="30938" EndNode="30985">Breast cancer: hormones and other risk factors. PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:risk factors SemanticType:[qnco] PreferredName:Hormones SemanticType:[horm] POS:NN POS:NN POS:: POS:NNS POS:CC POS:JJ POS:NN POS:NNS POS:. 
[sentNum: 237]<Annotation Id="19005" Type="Sentence" StartNode="30986" EndNode="30996">Maturitas. POS:NNP POS:. 
[sentNum: 238]<Annotation Id="19006" Type="Sentence" StartNode="30997" EndNode="31042">Feb28 2001;38(1):103&#x2013;113; discussion 113&#x2013;106. PreferredName:Discussion (procedure) SemanticType:[topp] PreferredName:1+ Score, WHO SemanticType:[clas] POS:NNP POS:CD POS:CD POS:: POS:CD POS:CD POS:CD POS:NN POS:: POS:CD POS:NN POS:CD POS:: POS:NN POS:CD POS:NN POS:CD POS:. 
[sentNum: 239]<Annotation Id="19007" Type="Sentence" StartNode="31047" EndNode="31073">ing(seePracticeBulletinNo.103POS:VBG POS:CD POS:NN POS:. 
[sentNum: 240]<Annotation Id="19008" Type="Sentence" StartNode="31073" EndNode="31134">103,Hereditary Breast and Ovarian Cancer Syndrome,April2009). PreferredName:Breast SemanticType:[bpoc] PreferredName:Hereditary SemanticType:[ftcn] PreferredName:Syndrome SemanticType:[dsyn] PreferredName:Malignant neoplasm of ovary SemanticType:[neop] POS:CD POS:, POS:JJ POS:NN POS:CC POS:JJ POS:NN POS:NN POS:, POS:NNP POS:CD POS:CD POS:. 
[sentNum: 241]<Annotation Id="19009" Type="Sentence" StartNode="31141" EndNode="31157">Combined Factors PreferredName:Factor SemanticType:[ftcn] PreferredName:Combined SemanticType:[qlco] POS:VBN POS:NNS 
[sentNum: 242]<Annotation Id="19010" Type="Sentence" StartNode="31162" EndNode="31411">The Gail Model is a risk assessment tool that uses patient age, some reproductive factors, limited family history (breast cancer in first-degree female relatives), and a history of breast biopsies to estimate 5-year and lifetime breast cancer risks. PreferredName:Risk Assessment SemanticType:[hlca] PreferredName:Gail Risk Model SemanticType:[inpr] PreferredName:utilization qualifier SemanticType:[ftcn] PreferredName:Scientific Equipment SemanticType:[mnob] PreferredName:Age SemanticType:[orga] PreferredName:Patients SemanticType:[podg] PreferredName:Limited (extensiveness) SemanticType:[ftcn] PreferredName:Reproductive History SemanticType:[fndg] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Family history SemanticType:[fndg] PreferredName:Woman SemanticType:[popg] PreferredName:Number of First Degree Relatives (Affected) SemanticType:[qnco] PreferredName:Biopsy of breast SemanticType:[diap] PreferredName:History of previous events SemanticType:[fndg] PreferredName:&gt;5 SemanticType:[qnco] PreferredName:Estimated SemanticType:[qnco] PreferredName:Lifetime Risk SemanticType:[qnco] PreferredName:per year SemanticType:[tmco] PreferredName:Malignant neoplasm of breast SemanticType:[neop] POS:DT POS:NN POS:NNP POS:VBZ POS:DT POS:NN POS:NN POS:NN POS:WDT POS:VBZ POS:NN POS:NN POS:, POS:DT POS:JJ POS:NNS POS:, POS:JJ POS:NN POS:NN POS:CD POS:NN POS:NN POS:IN POS:JJ POS:JJ POS:NNS POS:VBP POS:, POS:CC POS:DT POS:NN POS:IN POS:NN POS:NNS POS:TO POS:VB POS:LS POS:: POS:NN POS:CC POS:NN POS:NN POS:NN POS:NNS POS:. 
[sentNum: 243]<Annotation Id="19011" Type="Sentence" StartNode="31412" EndNode="31511">This model has been validated in Caucasian women and studied extensively in African American women. PreferredName:Model SemanticType:[inpr] PreferredName:Woman SemanticType:[popg] PreferredName:Caucasoid Race SemanticType:[popg] PreferredName:African American SemanticType:[popg] PreferredName:Study SemanticType:[resa] PreferredName:Woman SemanticType:[popg] POS:DT POS:NN POS:VBZ POS:VBN POS:VBN POS:IN POS:JJ POS:NNS POS:CC POS:VBN POS:RB POS:IN POS:JJ POS:JJ POS:NNS POS:. 
[sentNum: 244]<Annotation Id="19012" Type="Sentence" StartNode="31512" EndNode="31614">The assessment can be completed in less than a minute, and is available at www.cancer.gov/ bcrisktool. PreferredName:Assessed SemanticType:[acty] PreferredName:/minute SemanticType:[tmco] PreferredName:Complete SemanticType:[qlco] PreferredName:Internet SemanticType:[mnob] PreferredName:Availability of SemanticType:[ftcn] PreferredName:RAB3D gene SemanticType:[gngm] PreferredName:Primary malignant neoplasm SemanticType:[neop] POS:DT POS:NN POS:MD POS:VB POS:VBN POS:IN POS:JJR POS:IN POS:DT POS:NN POS:, POS:CC POS:VBZ POS:JJ POS:IN POS:NN POS:. POS:NN POS:. POS:NN POS:: POS:NN POS:. 
[sentNum: 245]<Annotation Id="19013" Type="Sentence" StartNode="31615" EndNode="31929">Women estimated to have a 5-year breast cancer risk of 1.7% or greater (equivalent to the average riskfora womenaged60years)ora lifetimeriskof20% or greater may be offered enhanced screening, including a clinical breast examination every6&#x2013;12 months, yearly mammography, and instruction in breast self-examina­tion. PreferredName:Estimated SemanticType:[qnco] PreferredName:Woman SemanticType:[popg] PreferredName:A 7 SemanticType:[orch, phsu] PreferredName:To SemanticType:[qlco] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:per year SemanticType:[tmco] PreferredName:Greater SemanticType:[qnco] PreferredName:Risk SemanticType:[qlco] PreferredName:Average SemanticType:[qnco] PreferredName:Equal SemanticType:[qlco] PreferredName:Offered SemanticType:[fndg] PreferredName:Greater SemanticType:[qnco] PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:Enhance (action) SemanticType:[acty] PreferredName:Clinical Breast Examination SemanticType:[topp] PreferredName:Including (qualifier) SemanticType:[ftcn] PreferredName:per year SemanticType:[tmco] PreferredName:month SemanticType:[tmco] PreferredName:Educational process of instructing SemanticType:[edac] PreferredName:Mammography SemanticType:[diap] PreferredName:subscriber - self SemanticType:[inpr] PreferredName:Entire breast SemanticType:[bpoc] POS:NNS POS:VBN POS:TO POS:VB POS:DT POS:LS POS:: POS:NN POS:NN POS:NN POS:NN POS:IN POS:CD POS:. POS:CD POS:NN POS:CC POS:JJR POS:NN POS:NN POS:TO POS:DT POS:JJ POS:NN POS:VBD POS:CD POS:NNS POS:CD POS:NN POS:NN POS:CD POS:NN POS:CC POS:JJR POS:MD POS:VB POS:VBN POS:VBN POS:NN POS:, POS:VBG POS:DT POS:JJ POS:NN POS:NN POS:DT POS:CD POS:NN POS:CD POS:NNS POS:, POS:JJ POS:NN POS:, POS:CC POS:NN POS:IN POS:NN POS:NN POS:. 
[sentNum: 246]<Annotation Id="19014" Type="Sentence" StartNode="31930" EndNode="32169">The Gail model is not a good risk assessment tool when there is a strong family history of breast cancer in women other than the mother and sisters of the patient or a family history of cancer other than breast cancer (eg, ovarian cancer). PreferredName:Negation SemanticType:[ftcn] PreferredName:Gail Risk Model SemanticType:[inpr] PreferredName:Risk Assessment SemanticType:[hlca] PreferredName:Good SemanticType:[qlco] PreferredName:Strong SemanticType:[qlco] PreferredName:Scientific Equipment SemanticType:[mnob] PreferredName:Present SemanticType:[qnco] PreferredName:Family history of breast cancer SemanticType:[fndg] PreferredName:Mother (person) SemanticType:[famg] PreferredName:Woman SemanticType:[popg] PreferredName:Patients SemanticType:[podg] PreferredName:Sister SemanticType:[famg] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Family history of cancer SemanticType:[fndg] PreferredName:Malignant neoplasm of ovary SemanticType:[neop] PreferredName:Egypt SemanticType:[geoa] POS:DT POS:NN POS:NN POS:VBZ POS:RB POS:DT POS:JJ POS:NN POS:NN POS:NN POS:WRB POS:EX POS:VBZ POS:DT POS:JJ POS:NN POS:NN POS:IN POS:NN POS:NN POS:IN POS:NNS POS:JJ POS:IN POS:DT POS:NN POS:CC POS:NNS POS:IN POS:DT POS:NN POS:CC POS:DT POS:NN POS:NN POS:IN POS:NN POS:JJ POS:IN POS:NN POS:NN POS:CD POS:FW POS:, POS:JJ POS:NN POS:NN POS:. 
[sentNum: 247]<Annotation Id="19015" Type="Sentence" StartNode="32170" EndNode="32235">Breast MRI is not typically recom­mended based on the Gail Model. PreferredName:Negation SemanticType:[ftcn] PreferredName:Multisection:Finding:Point in time:Breast:Narrative:MRI SemanticType:[clna] PreferredName:Base - General Qualifier SemanticType:[idcn] PreferredName:MEND ashed powder SemanticType:[orch, phsu] PreferredName:Gail Risk Model SemanticType:[inpr] POS:NN POS:NNP POS:VBZ POS:RB POS:RB POS:JJ POS:VBN POS:IN POS:DT POS:NN POS:NNP POS:. 
[sentNum: 248]<Annotation Id="19016" Type="Sentence" StartNode="32242" EndNode="32295">What screening is appropriate for women at high risk? PreferredName:Disease Screening SemanticType:[diap] PreferredName:Woman SemanticType:[popg] PreferredName:Appropriate SemanticType:[qlco] PreferredName:High risk of SemanticType:[qlco] POS:WDT POS:NN POS:VBZ POS:JJ POS:IN POS:NNS POS:IN POS:JJ POS:NN POS:. 
[sentNum: 249]<Annotation Id="19017" Type="Sentence" StartNode="32298" EndNode="32589">ForwomenwhotestpositiveforBRCA1 or BRCA2 muta­tions, enhanced screening should be recommended and riskreductionmethodsdiscussed.Enhancedscreeningfor these womenincludestwice-yearly clinicalbreast exami­nations, annual mammography, annual breast MRI, and instructioninbreast self-examination.(PreferredName:BRCA2 gene SemanticType:[gngm] PreferredName:Disease Screening SemanticType:[diap] PreferredName:Enhance (action) SemanticType:[acty] PreferredName:Annual SemanticType:[tmco] PreferredName:Recommendation SemanticType:[idcn] PreferredName:Annual SemanticType:[tmco] PreferredName:Nation SemanticType:[orgt] PreferredName:Annual SemanticType:[tmco] PreferredName:Mammography SemanticType:[diap] PreferredName:Self-Examination SemanticType:[diap] PreferredName:Multisection:Finding:Point in time:Breast:Narrative:MRI SemanticType:[clna] POS:NN POS:CD POS:CC POS:NN POS:CD POS:NNS POS:, POS:VBD POS:NN POS:MD POS:VB POS:VBN POS:CC POS:VBN POS:. POS:NNP POS:DT POS:JJ POS:NN POS:NNS POS:, POS:JJ POS:NN POS:, POS:JJ POS:NN POS:NNP POS:, POS:CC POS:NN POS:NN POS:. 
[sentNum: 250]<Annotation Id="19018" Type="Sentence" StartNode="32589" EndNode="32685">(Details regarding the management of women with BRCA mutations are reviewedinPracticeBulletinNo.103PreferredName:Management procedure SemanticType:[ocac] PreferredName:Details SemanticType:[qlco] PreferredName:Mutation SemanticType:[genf] PreferredName:Woman SemanticType:[popg] POS:NN POS:NNS POS:VBG POS:DT POS:NN POS:IN POS:NNS POS:IN POS:NN POS:NNS POS:VBP POS:NNP POS:. 
[sentNum: 251]<Annotation Id="19019" Type="Sentence" StartNode="32685" EndNode="32748">103, Hereditary Breast and Ovarian Cancer Syndrome, April 2009.)PreferredName:Entire breast SemanticType:[bpoc] PreferredName:Hereditary SemanticType:[ftcn] PreferredName:Syndrome SemanticType:[dsyn] PreferredName:Ovarian Carcinoma SemanticType:[neop] POS:CD POS:, POS:JJ POS:NN POS:CC POS:JJ POS:NN POS:NN POS:, POS:NNP POS:CD POS:. 
[sentNum: 252]<Annotation Id="19020" Type="Sentence" StartNode="32748" EndNode="32909">) Women whohavefirst-degree relatives with these mutationsbut who are untested aregenerally managed asif they carry these mutations untiltheirBRCA statusisknown. PreferredName:Degree or extent SemanticType:[qnco] PreferredName:Woman SemanticType:[popg] PreferredName:Management procedure SemanticType:[ocac] PreferredName:Relative (related person) SemanticType:[famg] PreferredName:Carrying SemanticType:[acty] PreferredName:aldosterone secretion inhibitory factor SemanticType:[aapp, phsu] PreferredName:Mutation SemanticType:[genf] POS:NN POS:NNS POS:JJ POS:NNS POS:IN POS:DT POS:NN POS:WP POS:VBP POS:JJ POS:RB POS:VBN POS:IN POS:PRP POS:VBP POS:DT POS:NNS POS:JJ POS:NN POS:. 
[sentNum: 253]<Annotation Id="19021" Type="Sentence" StartNode="32912" EndNode="33253">Women who are estimated to have a lifetime risk of breast cancer of 20% or greater, based on risk models that rely largely on family history (such as BRCAPRO, BODACEA, or Claus), but who are either untested or test negative for BRCA gene mutations, can be offered enhanced screening as described previously for carriers of the BRCA mutation. PreferredName:Woman SemanticType:[popg] PreferredName:To SemanticType:[qlco] PreferredName:Estimated SemanticType:[qnco] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Lifetime Risk SemanticType:[qnco] PreferredName:Base - General Qualifier SemanticType:[idcn] PreferredName:Largest SemanticType:[qnco] PreferredName:Model SemanticType:[inpr] PreferredName:Risk SemanticType:[qlco] PreferredName:BRCAPRO SemanticType:[inpr] PreferredName:Family history SemanticType:[fndg] PreferredName:Negative SemanticType:[qlco] PreferredName:Testing SemanticType:[ftcn] PreferredName:Mutation SemanticType:[genf] PreferredName:brca gene SemanticType:[gngm] PreferredName:Enhance (action) SemanticType:[acty] PreferredName:Offered SemanticType:[fndg] PreferredName:described SemanticType:[idcn] PreferredName:Disease Screening SemanticType:[diap] PreferredName:Mutation Carrier SemanticType:[humn] POS:NNS POS:WP POS:VBP POS:VBN POS:TO POS:VB POS:DT POS:NN POS:NN POS:IN POS:NN POS:NN POS:IN POS:CD POS:NN POS:CC POS:JJR POS:, POS:VBN POS:IN POS:NN POS:NNS POS:WDT POS:VBP POS:RB POS:IN POS:NN POS:NN POS:CD POS:JJ POS:IN POS:NNP POS:, POS:NNP POS:, POS:CC POS:NNP POS:NNP POS:, POS:CC POS:WP POS:VBP POS:CC POS:JJ POS:CC POS:NN POS:JJ POS:IN POS:NN POS:NN POS:NNS POS:, POS:MD POS:VB POS:VBN POS:VBN POS:VBG POS:IN POS:VBN POS:RB POS:IN POS:NNS POS:IN POS:DT POS:NN POS:NN POS:. 
[sentNum: 254]<Annotation Id="19022" Type="Sentence" StartNode="33254" EndNode="33319">Risk-reduction strategies also may be considered for these women. PreferredName:Risk Reduction SemanticType:[inbe] PreferredName:consider SemanticType:[idcn] PreferredName:strategy SemanticType:[menp] PreferredName:Woman SemanticType:[popg] POS:NN POS:NNS POS:RB POS:MD POS:VB POS:VBN POS:IN POS:DT POS:NNS POS:. 
[sentNum: 255]<Annotation Id="19023" Type="Sentence" StartNode="33322" EndNode="33530">Other women considered at high risk of develop­ment of future cases of breast cancer are those who received thoracic irradiation (typically as a treatment for lymphoma) between the ages 10 years and 30 years. PreferredName:Woman SemanticType:[popg] PreferredName:High risk of SemanticType:[qlco] PreferredName:consider SemanticType:[idcn] PreferredName:Case unit dose SemanticType:[qnco] PreferredName:Future SemanticType:[tmco] PreferredName:Receive SemanticType:[qlco] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Therapeutic procedure SemanticType:[topp] PreferredName:Therapeutic radiology procedure SemanticType:[topp] PreferredName:Age-Years SemanticType:[tmco] PreferredName:Lymphoma SemanticType:[neop] PreferredName:year SemanticType:[tmco] POS:JJ POS:NNS POS:VBN POS:IN POS:JJ POS:NN POS:IN POS:NN POS:IN POS:JJ POS:NNS POS:IN POS:NN POS:NN POS:VBP POS:DT POS:WP POS:VBD POS:JJ POS:NN POS:NN POS:RB POS:IN POS:DT POS:NN POS:IN POS:NN POS:NN POS:IN POS:DT POS:NNS POS:CD POS:NNS POS:CC POS:CD POS:NNS POS:. 
[sentNum: 256]<Annotation Id="19024" Type="Sentence" StartNode="33531" EndNode="33759">These women should be advised to receive annual mam­mography, annual MRI, and screening clinical breast examination every 6&#x2013;12 months beginning 8&#x2013;10 years after they received treatment or at age 25 years, which­ever occurs last. PreferredName:Woman SemanticType:[popg] PreferredName:Receive SemanticType:[qlco] PreferredName:To SemanticType:[qlco] PreferredName:Mammography SemanticType:[diap] PreferredName:Annual SemanticType:[tmco] PreferredName:Magnetic Resonance Imaging SemanticType:[diap] PreferredName:Annual SemanticType:[tmco] PreferredName:Clinical Breast Examination SemanticType:[topp] PreferredName:Disease Screening SemanticType:[diap] PreferredName:month SemanticType:[tmco] PreferredName:Distance vision 6/12 SemanticType:[fndg] PreferredName:year SemanticType:[tmco] PreferredName:Beginning SemanticType:[tmco] PreferredName:Therapeutic procedure SemanticType:[topp] PreferredName:Receive SemanticType:[qlco] PreferredName:Occurrence SemanticType:[tmco] PreferredName:Age-Years SemanticType:[tmco] PreferredName:Last SemanticType:[qlco] POS:DT POS:NNS POS:MD POS:VB POS:VBN POS:TO POS:VB POS:JJ POS:NN POS:, POS:JJ POS:NNP POS:, POS:CC POS:VBG POS:JJ POS:NN POS:NN POS:DT POS:CD POS:NN POS:CD POS:NNS POS:VBG POS:CD POS:CD POS:CD POS:NNS POS:IN POS:PRP POS:VBD POS:NN POS:CC POS:IN POS:NN POS:CD POS:NNS POS:, POS:NN POS:VBZ POS:JJ POS:. 
[sentNum: 257]<Annotation Id="19025" Type="Sentence" StartNode="33762" EndNode="33931">Women with a personal history of high-risk breast biopsyresults,including atypicalhyperplasia andlobular carcinoma in situ are at increased risk of future breast cancer. PreferredName:Social and personal history SemanticType:[fndg] PreferredName:Female breast SemanticType:[bpoc] PreferredName:High risk of SemanticType:[qlco] PreferredName:Carcinoma in Situ SemanticType:[neop] PreferredName:Including (qualifier) SemanticType:[ftcn] PreferredName:Increase SemanticType:[ftcn] PreferredName:are unit of measure SemanticType:[qnco] PreferredName:Future SemanticType:[tmco] PreferredName:Risk SemanticType:[qlco] PreferredName:Malignant neoplasm of breast SemanticType:[neop] POS:NNS POS:IN POS:DT POS:JJ POS:NN POS:IN POS:JJ POS:NN POS:NNS POS:, POS:VBG POS:NN POS:JJ POS:NN POS:FW POS:FW POS:VBP POS:IN POS:VBN POS:NN POS:IN POS:JJ POS:NN POS:NN POS:. 
[sentNum: 258]<Annotation Id="19026" Type="Sentence" StartNode="33932" EndNode="34214">These women should receive enhanced screen­ing, including annual mammography, clinical breast examination every 6&#x2013;12 months, and instruction in breastself-examination.YearlybreastMRIalsohasbeen recommendedfor women with ahistory oflobular carci­nomain situby some organizations(43).WomenPreferredName:Woman SemanticType:[popg] PreferredName:Enhance (action) SemanticType:[acty] PreferredName:Receive SemanticType:[qlco] PreferredName:Including (qualifier) SemanticType:[ftcn] PreferredName:Screening procedure SemanticType:[hlca] PreferredName:Mammography SemanticType:[diap] PreferredName:Annual SemanticType:[tmco] PreferredName:Distance vision 6/12 SemanticType:[fndg] PreferredName:Clinical Breast Examination SemanticType:[topp] PreferredName:Educational process of instructing SemanticType:[edac] PreferredName:month SemanticType:[tmco] PreferredName:Organization administrative structures SemanticType:[orgt] PreferredName:Woman SemanticType:[popg] POS:DT POS:NNS POS:MD POS:VB POS:VBN POS:VBG POS:, POS:VBG POS:JJ POS:NN POS:, POS:JJ POS:NN POS:NN POS:DT POS:CD POS:NN POS:CD POS:NNS POS:, POS:CC POS:NN POS:IN POS:NN POS:. POS:NN POS:NN POS:NNS POS:IN POS:JJ POS:JJ POS:NN POS:VBP POS:DT POS:NNS POS:VBP POS:CD POS:CD POS:. 
[sentNum: 259]<Annotation Id="19027" Type="Sentence" StartNode="34214" EndNode="34385">Women with a personal history of ductal carcinoma in situ or invasive breast cancer should be monitored similarly, although MRIis notroutinely recommendedinthispopulation. PreferredName:Personal Attribute SemanticType:[orga] PreferredName:Woman SemanticType:[popg] PreferredName:Ductal SemanticType:[qlco] PreferredName:H/O: carcinoma SemanticType:[fndg] PreferredName:Invasive Breast Carcinoma SemanticType:[neop] PreferredName:In situ SemanticType:[spco] PreferredName:Anti-Mullerian Hormone Receptor Type II SemanticType:[aapp, rcpt] PreferredName:Preventive monitoring SemanticType:[hlca] POS:NNS POS:IN POS:DT POS:JJ POS:NN POS:IN POS:JJ POS:NN POS:FW POS:FW POS:CC POS:JJ POS:NN POS:NN POS:MD POS:VB POS:VBN POS:RB POS:, POS:IN POS:NN POS:RB POS:NN POS:. 
[sentNum: 260]<Annotation Id="19028" Type="Sentence" StartNode="34392" EndNode="34472">Isthere an upper age range at whichthe risks of mammography outweighthebenefits? PreferredName:Age SemanticType:[orga] PreferredName:Upper SemanticType:[spco] PreferredName:Risk SemanticType:[qlco] PreferredName:Range SemanticType:[qnco] PreferredName:Mammography SemanticType:[diap] POS:NNP POS:DT POS:JJ POS:NN POS:NN POS:IN POS:JJ POS:NNS POS:IN POS:NN POS:NNS POS:. 
[sentNum: 261]<Annotation Id="19029" Type="Sentence" StartNode="34475" EndNode="34534">Aconsensus of recommendations on this issue does not exist. PreferredName:Recommendation SemanticType:[idcn] PreferredName:Negation SemanticType:[ftcn] PreferredName:Problem SemanticType:[fndg] PreferredName:Exist SemanticType:[cnce] POS:NN POS:IN POS:NNS POS:IN POS:DT POS:NN POS:VBZ POS:RB POS:VB POS:. 
[sentNum: 262]<Annotation Id="19030" Type="Sentence" StartNode="34535" EndNode="34781">Medical comorbidity and life expectancy should be considered in a breast cancer screening program for women aged 75 years or older because the benefit of screening mammography decreases compared with the harms of overtreatment with advancing age. PreferredName:Medical SemanticType:[ftcn] PreferredName:Life Expectancy SemanticType:[grpa] PreferredName:Comorbidity SemanticType:[idcn] PreferredName:Screening for malignant neoplasm of breast SemanticType:[topp] PreferredName:consider SemanticType:[idcn] PreferredName:Woman SemanticType:[popg] PreferredName:Program SemanticType:[phsu] PreferredName:year SemanticType:[tmco] PreferredName:Old age SemanticType:[popg] PreferredName:Benefits SemanticType:[qnco] PreferredName:Old SemanticType:[tmco] PreferredName:Decrease SemanticType:[qnco] PreferredName:Screening mammography SemanticType:[topp] PreferredName:Advance SemanticType:[medd] PreferredName:Comparison SemanticType:[acty] PreferredName:Age SemanticType:[orga] POS:JJ POS:NN POS:CC POS:NN POS:NN POS:MD POS:VB POS:VBN POS:IN POS:DT POS:NN POS:NN POS:NN POS:NN POS:IN POS:NNS POS:JJ POS:CD POS:NNS POS:CC POS:JJR POS:IN POS:DT POS:NN POS:IN POS:NN POS:NN POS:VBZ POS:VBN POS:IN POS:DT POS:NNS POS:IN POS:NN POS:IN POS:VBG POS:NN POS:. 
[sentNum: 263]<Annotation Id="19031" Type="Sentence" StartNode="34782" EndNode="34921">Women aged 75 years or older should, in consultation with their physicians, decide whether or not to continue mammo­graphic screening (17). PreferredName:Woman SemanticType:[popg] PreferredName:year SemanticType:[tmco] PreferredName:Old age SemanticType:[popg] PreferredName:Within SemanticType:[spco] PreferredName:Old SemanticType:[tmco] PreferredName:Physicians SemanticType:[prog] PreferredName:Consultation SemanticType:[hlca] PreferredName:Continuous SemanticType:[idcn] PreferredName:Negation SemanticType:[ftcn] PreferredName:Disease Screening SemanticType:[diap] POS:NNS POS:JJ POS:CD POS:NNS POS:CC POS:JJR POS:MD POS:, POS:IN POS:NN POS:IN POS:PRP$ POS:NNS POS:, POS:VB POS:IN POS:CC POS:RB POS:TO POS:VB POS:JJ POS:NN POS:NN POS:CD POS:NN POS:. 
[sentNum: 264]<Annotation Id="19032" Type="Sentence" StartNode="34924" EndNode="35066">Figure1illustrates the progressively increasing inci-	 dence and mortality rates of invasive breast cancer by race and age up to 84 years (3). PreferredName:Increasing SemanticType:[ftcn] PreferredName:Invasive SemanticType:[qlco] PreferredName:Mortality Vital Statistics SemanticType:[qnco] PreferredName:Racial group SemanticType:[popg] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:&lt;3 (qualifier value) SemanticType:[qnco] PreferredName:Age-Years SemanticType:[tmco] POS:NNP POS:CD POS:VBZ POS:DT POS:RB POS:VBG POS:JJ POS:NN POS:CC POS:NN POS:NNS POS:IN POS:JJ POS:NN POS:NN POS:IN POS:NN POS:CC POS:NN POS:RB POS:TO POS:CD POS:NNS POS:CD POS:CD POS:NN POS:. 
[sentNum: 265]<Annotation Id="19033" Type="Sentence" StartNode="35067" EndNode="35183">Most of the screening mammography clinical trials had an upper age limit criteria ranging from 64 years to 74 years. PreferredName:Mammography SemanticType:[diap] PreferredName:Most SemanticType:[qnco] PreferredName:Upper SemanticType:[spco] PreferredName:Trial Screening SemanticType:[resa] PreferredName:Limited (extensiveness) SemanticType:[ftcn] PreferredName:Age SemanticType:[orga] PreferredName:Range SemanticType:[qnco] PreferredName:criteria SemanticType:[inpr] PreferredName:year SemanticType:[tmco] PreferredName:year SemanticType:[tmco] POS:JJS POS:IN POS:DT POS:NN POS:NN POS:JJ POS:NNS POS:VBD POS:DT POS:JJ POS:NN POS:NN POS:NNS POS:VBG POS:IN POS:CD POS:NNS POS:TO POS:CD POS:NNS POS:. 
[sentNum: 266]<Annotation Id="19034" Type="Sentence" StartNode="35184" EndNode="35353">However, a meta-analysis concluded that screening mammography in women aged 70&#x2013;79 years is moderately cost-effective and yields a small increase in life expectancy (54). PreferredName:Conclude Resin SemanticType:[bodm, orch] PreferredName:Meta-Analysis (publications) SemanticType:[inpr] PreferredName:Woman SemanticType:[popg] PreferredName:Screening mammography SemanticType:[topp] PreferredName:year SemanticType:[tmco] PreferredName:Old age SemanticType:[popg] PreferredName:Cost Effectiveness SemanticType:[qnco] PreferredName:Moderation SemanticType:[qlco] PreferredName:Increase SemanticType:[ftcn] PreferredName:Small SemanticType:[qnco] PreferredName:Life Expectancy SemanticType:[grpa] POS:RB POS:, POS:DT POS:NN POS:VBD POS:IN POS:VBG POS:NN POS:IN POS:NNS POS:JJ POS:CD POS:CD POS:CD POS:NNS POS:VBZ POS:RB POS:JJ POS:CC POS:VBZ POS:DT POS:JJ POS:NN POS:IN POS:NN POS:NN POS:CD POS:CD POS:NN POS:. 
[sentNum: 267]<Annotation Id="19035" Type="Sentence" StartNode="35362" EndNode="35404">Summary of Recommendations and Conclusions PreferredName:Summary (document) SemanticType:[inpr] PreferredName:Conclusion SemanticType:[idcn] PreferredName:Recommendation SemanticType:[idcn] POS:NN POS:IN POS:NNS POS:CC POS:NNS 
[sentNum: 268]<Annotation Id="19036" Type="Sentence" StartNode="35407" EndNode="35506">The following recommendations are based on lim­ited and inconsistent scientific evidence (Level B): PreferredName:Recommendation SemanticType:[idcn] PreferredName:Following SemanticType:[tmco] PreferredName:PDLIM5 gene SemanticType:[gngm] PreferredName:Base - General Qualifier SemanticType:[idcn] PreferredName:Science SemanticType:[ocdi] PreferredName:Inconsistent SemanticType:[qlco] PreferredName:Levels (qualifier value) SemanticType:[qlco] PreferredName:Evidence of SemanticType:[ftcn] POS:DT POS:JJ POS:NNS POS:VBP POS:VBN POS:IN POS:VBN POS:CC POS:JJ POS:JJ POS:NN POS:NN POS:NN POS:NN POS:CD POS:: 
[sentNum: 269]<Annotation Id="19037" Type="Sentence" StartNode="35511" EndNode="35751">Based on the incidence of breast cancer, the sojourn time for breast cancer growth, and the potential reduction in breast cancer mortality, the College recommends that women aged 40 years and older be offered screening mammography annually. PreferredName:incidence of cases SemanticType:[ftcn] PreferredName:Base - General Qualifier SemanticType:[idcn] PreferredName:Sojourn SemanticType:[orch, phsu] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Time SemanticType:[tmco] PreferredName:Potential SemanticType:[qlco] PreferredName:growth aspects SemanticType:[phsf] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Reduction - action SemanticType:[topp] PreferredName:College SemanticType:[mnob] PreferredName:Mortality Vital Statistics SemanticType:[qnco] PreferredName:Woman SemanticType:[popg] PreferredName:Recommendation SemanticType:[idcn] PreferredName:/40 SemanticType:[tmco] PreferredName:Old age SemanticType:[popg] PreferredName:Old SemanticType:[tmco] PreferredName:year SemanticType:[tmco] PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:Offered SemanticType:[fndg] PreferredName:Annual SemanticType:[tmco] PreferredName:Mammography SemanticType:[diap] POS:VBN POS:IN POS:DT POS:NN POS:IN POS:NN POS:NN POS:, POS:DT POS:NN POS:NN POS:IN POS:NN POS:NN POS:NN POS:, POS:CC POS:DT POS:JJ POS:NN POS:IN POS:NN POS:NN POS:NN POS:, POS:DT POS:NNP POS:VBZ POS:IN POS:NNS POS:JJ POS:CD POS:NNS POS:CC POS:JJR POS:VB POS:VBN POS:JJ POS:NN POS:RB POS:. 
[sentNum: 270]<Annotation Id="19038" Type="Sentence" StartNode="35758" EndNode="35844">Thefollowingrecommendations arebasedprimar­ilyon consensus and expert opinion(LevelC): PreferredName:Expert Opinion SemanticType:[cnce] PreferredName:Consensus SemanticType:[socb] POS:NNS POS:RB POS:NN POS:CC POS:JJ POS:NN POS:NN POS:NN POS:CD POS:: 
[sentNum: 271]<Annotation Id="19039" Type="Sentence" StartNode="35849" EndNode="35940">Clinical breast examination should be performed annually for women aged 40 years and older. PreferredName:Performed SemanticType:[ftcn] PreferredName:Clinical Breast Examination SemanticType:[topp] PreferredName:Woman SemanticType:[popg] PreferredName:Annual SemanticType:[tmco] PreferredName:/40 SemanticType:[tmco] PreferredName:Old age SemanticType:[popg] PreferredName:Old SemanticType:[tmco] PreferredName:year SemanticType:[tmco] POS:JJ POS:NN POS:NN POS:MD POS:VB POS:VBN POS:RB POS:IN POS:NNS POS:JJ POS:CD POS:NNS POS:CC POS:JJR POS:. 
[sentNum: 272]<Annotation Id="19040" Type="Sentence" StartNode="35943" EndNode="36033">For women aged 20&#x2013;39 years, clinical breast exam­inations are recommended every 1&#x2013;3 years. PreferredName:Old age SemanticType:[popg] PreferredName:Woman SemanticType:[popg] PreferredName:Clinical Breast Examination SemanticType:[topp] PreferredName:year SemanticType:[tmco] PreferredName:1+ Score SemanticType:[qnco] PreferredName:Recommendation SemanticType:[idcn] PreferredName:year SemanticType:[tmco] POS:IN POS:NNS POS:JJ POS:CD POS:CD POS:CD POS:NNS POS:, POS:JJ POS:NN POS:NNS POS:VBP POS:VBN POS:DT POS:CD POS:NN POS:CD POS:NNS POS:. 
[sentNum: 273]<Annotation Id="19041" Type="Sentence" StartNode="36036" EndNode="36119">Breast self-awareness should be encouraged and can include breast self-examination. PreferredName:Entire breast SemanticType:[bpoc] PreferredName:Include (action) SemanticType:[acty] PreferredName:Self awareness SemanticType:[menp] PreferredName:Breast Self-Examination SemanticType:[diap] POS:NN POS:NN POS:MD POS:VB POS:VBN POS:CC POS:MD POS:VB POS:NN POS:NN POS:. 
[sentNum: 274]<Annotation Id="19042" Type="Sentence" StartNode="36120" EndNode="36200">Women should report any changes in their breasts to their health care providers. PreferredName:Woman SemanticType:[popg] PreferredName:Breast changes SemanticType:[fndg] PreferredName:Report (document) SemanticType:[inpr] PreferredName:Health Personnel SemanticType:[prog] POS:NNS POS:MD POS:VB POS:DT POS:NNS POS:IN POS:PRP$ POS:NNS POS:TO POS:PRP$ POS:NN POS:NN POS:NNS POS:. 
[sentNum: 275]<Annotation Id="19043" Type="Sentence" StartNode="36205" EndNode="36351">Women should be educated on the predictive value of screening mammography and the potential for false-positive results and false-negative results. PreferredName:Woman SemanticType:[popg] PreferredName:Predictive Value SemanticType:[qlco] PreferredName:Educational process of instructing SemanticType:[edac] PreferredName:Potential SemanticType:[qlco] PreferredName:Screening mammography SemanticType:[topp] PreferredName:False Negative Result Medical Device Problem SemanticType:[fndg] PreferredName:False Positive SemanticType:[lbtr] POS:NNS POS:MD POS:VB POS:VBN POS:IN POS:DT POS:JJ POS:NN POS:IN POS:VBG POS:NN POS:CC POS:DT POS:NN POS:IN POS:JJ POS:NNS POS:CC POS:JJ POS:NNS POS:. 
[sentNum: 276]<Annotation Id="19044" Type="Sentence" StartNode="36352" EndNode="36397">Women should be informed of the potential for PreferredName:Informed SemanticType:[qlco] PreferredName:Woman SemanticType:[popg] PreferredName:Potential SemanticType:[qlco] POS:NNS POS:MD POS:VB POS:VBN POS:IN POS:DT POS:NN POS:IN 
[sentNum: 277]<Annotation Id="19045" Type="Sentence" StartNode="36402" EndNode="36405">600	POS:CD 
[sentNum: 278]<Annotation Id="19046" Type="Sentence" StartNode="36408" EndNode="36411">500	POS:CD 
[sentNum: 279]<Annotation Id="19047" Type="Sentence" StartNode="36414" EndNode="36417">400	POS:CD 
[sentNum: 280]<Annotation Id="19048" Type="Sentence" StartNode="36420" EndNode="36423">300	POS:CD 
[sentNum: 281]<Annotation Id="19049" Type="Sentence" StartNode="36426" EndNode="36429">200	POS:CD 
[sentNum: 282]<Annotation Id="19050" Type="Sentence" StartNode="36432" EndNode="36435">100	POS:CD 
[sentNum: 283]<Annotation Id="19051" Type="Sentence" StartNode="36442" EndNode="36456">0	 Age Fig. 1. PreferredName:Age SemanticType:[orga] PreferredName:1+ Score SemanticType:[qnco] PreferredName:Fig Flavor SemanticType:[food] POS:CD POS:NNP POS:NNP POS:. POS:LS POS:. 
[sentNum: 284]<Annotation Id="19052" Type="Sentence" StartNode="36457" EndNode="36550">Female Breast Cancer&#x2014;Incidence and Mortality Rates by Age and Race, United States, 2002&#x2013;2006. PreferredName:incidence of cases SemanticType:[ftcn] PreferredName:Female Breast Carcinoma SemanticType:[neop] PreferredName:Age SemanticType:[orga] PreferredName:Death Rate SemanticType:[qnco] PreferredName:United States SemanticType:[geoa] PreferredName:Racial group SemanticType:[popg] POS:JJ POS:NN POS:NN POS:NN POS:CC POS:NNP POS:NNP POS:IN POS:NNP POS:CC POS:NNP POS:, POS:NNP POS:NNPS POS:, POS:CD POS:CD POS:CD POS:. 
[sentNum: 285]<Annotation Id="19053" Type="Sentence" StartNode="36551" EndNode="36633">Data from Incidence&#x2014;North American Association of Central Cancer Registries, 2009. PreferredName:incidence of cases SemanticType:[ftcn] PreferredName:Data SemanticType:[idcn] PreferredName:North American Association of Central Cancer Registries SemanticType:[prog] POS:NNS POS:IN POS:NNP POS:NNP POS:NNP POS:NNP POS:IN POS:NNP POS:NNP POS:NNPS POS:, POS:CD POS:. 
[sentNum: 286]<Annotation Id="19054" Type="Sentence" StartNode="36634" EndNode="36733">Mortality&#x2013;&#x2013;National Center for Health Statistics, Centers for Disease Control and Prevention, 2009. PreferredName:Mortality Vital Statistics SemanticType:[qnco] PreferredName:Centers for Disease Control and Prevention (U.S.) SemanticType:[hcro] PreferredName:National Center for Health Statistics (U.S.) SemanticType:[hcro] POS:NNP POS:NNP POS:NNP POS:IN POS:NNP POS:NNPS POS:, POS:NNPS POS:IN POS:NNP POS:NNP POS:CC POS:NNP POS:, POS:CD POS:. 
[sentNum: 287]<Annotation Id="19055" Type="Sentence" StartNode="36734" EndNode="36789">Reprinted with permission from American Cancer Society. PreferredName:Authorization documentation SemanticType:[inpr] PreferredName:Reprint SemanticType:[inpr] PreferredName:American Cancer Society SemanticType:[pros] POS:VBN POS:IN POS:NN POS:IN POS:NNP POS:NNP POS:NNP POS:. 
[sentNum: 288]<Annotation Id="19056" Type="Sentence" StartNode="36790" EndNode="36829">Breast Cancer Facts&amp; Figures 2009&#x2013;2010. PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:2010s SemanticType:[tmco] POS:NN POS:NN POS:NNP POS:CC POS:NNS POS:CD POS:CD POS:CD POS:. 
[sentNum: 289]<Annotation Id="19057" Type="Sentence" StartNode="36830" EndNode="36838">Atlanta: PreferredName:Atlanta SemanticType:[euka] POS:NNP POS:: 
[sentNum: 290]<Annotation Id="19058" Type="Sentence" StartNode="36841" EndNode="36857">Rate per 100,000 PreferredName:Rate SemanticType:[qnco] POS:NN POS:IN POS:CD POS:, POS:CD 
[sentNum: 291]<Annotation Id="19059" Type="Sentence" StartNode="36864" EndNode="36893">American Cancer Society, Inc. PreferredName:American Cancer Society SemanticType:[pros] POS:NNP POS:NNP POS:NNP POS:, POS:NNP POS:. 
[sentNum: 292]<Annotation Id="19060" Type="Sentence" StartNode="36896" EndNode="36979">additional imaging or biopsies that may be recom­mended based on screening results. PreferredName:Imaging Techniques SemanticType:[diap] PreferredName:Additional SemanticType:[ftcn] PreferredName:MEND ashed powder SemanticType:[orch, phsu] PreferredName:Biopsy SemanticType:[diap] PreferredName:Growth Inhibition Screening Result SemanticType:[cnce] PreferredName:Base - General Qualifier SemanticType:[idcn] POS:JJ POS:NN POS:CC POS:NNS POS:WDT POS:MD POS:VB POS:VBN POS:VBN POS:IN POS:NN POS:NNS POS:. 
[sentNum: 293]<Annotation Id="19061" Type="Sentence" StartNode="36984" EndNode="37268">Women who are estimated to have a lifetime risk of breast cancer of 20% or greater, based on risk mod­els that rely largely on family history (such as BRCAPRO, BODACEA, or Claus), but who are either untested or test negative for BRCA gene mutations, can be offered enhanced screening. PreferredName:Estimated SemanticType:[qnco] PreferredName:Woman SemanticType:[popg] PreferredName:Lifetime Risk SemanticType:[qnco] PreferredName:To SemanticType:[qlco] PreferredName:Largest SemanticType:[qnco] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Risk SemanticType:[qlco] PreferredName:Base - General Qualifier SemanticType:[idcn] PreferredName:Family History Domain SemanticType:[idcn] PreferredName:Diabetes Mellitus, Non-Insulin-Dependent SemanticType:[dsyn] PreferredName:Testing SemanticType:[ftcn] PreferredName:BRCAPRO SemanticType:[inpr] PreferredName:brca gene SemanticType:[gngm] PreferredName:Negative SemanticType:[qlco] PreferredName:Offered SemanticType:[fndg] PreferredName:Mutation SemanticType:[genf] PreferredName:Disease Screening SemanticType:[diap] PreferredName:Enhance (action) SemanticType:[acty] POS:NNS POS:WP POS:VBP POS:VBN POS:TO POS:VB POS:DT POS:NN POS:NN POS:IN POS:NN POS:NN POS:IN POS:CD POS:NN POS:CC POS:JJR POS:, POS:VBN POS:IN POS:NN POS:NNS POS:WDT POS:VBP POS:RB POS:IN POS:NN POS:NN POS:CD POS:JJ POS:IN POS:NNP POS:, POS:NNP POS:, POS:CC POS:NNP POS:NNP POS:, POS:CC POS:WP POS:VBP POS:CC POS:JJ POS:CC POS:NN POS:JJ POS:IN POS:NN POS:NN POS:NNS POS:, POS:MD POS:VB POS:VBN POS:VBN POS:NN POS:. 
[sentNum: 294]<Annotation Id="19062" Type="Sentence" StartNode="37273" EndNode="37367">Breast MRI is not recommended for screening women at average risk of developing breast cancer. PreferredName:Negation SemanticType:[ftcn] PreferredName:Multisection:Finding:Point in time:Breast:Narrative:MRI SemanticType:[clna] PreferredName:Disease Screening SemanticType:[diap] PreferredName:Recommendation SemanticType:[idcn] PreferredName:At risk SemanticType:[qlco] PreferredName:Woman SemanticType:[popg] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Average SemanticType:[qnco] POS:NN POS:NNP POS:VBZ POS:RB POS:VBN POS:IN POS:VBG POS:NNS POS:IN POS:JJ POS:NN POS:IN POS:VBG POS:NN POS:NN POS:. 
[sentNum: 295]<Annotation Id="19063" Type="Sentence" StartNode="37370" EndNode="37503">For women whotestpositiveforBRCA1 and BRCA2 mutations, enhanced screening should be recom­mended and risk reduction methodsdiscussed. PreferredName:BRCA2 Gene Mutation SemanticType:[comd] PreferredName:Woman SemanticType:[popg] PreferredName:Disease Screening SemanticType:[diap] PreferredName:Enhance (action) SemanticType:[acty] PreferredName:Risk Reduction SemanticType:[inbe] PreferredName:MEND ashed powder SemanticType:[orch, phsu] POS:IN POS:NNS POS:NN POS:CD POS:CC POS:NN POS:CD POS:NNS POS:, POS:VBD POS:NN POS:MD POS:VB POS:VBN POS:CC POS:VB POS:NN POS:VBN POS:. 
[sentNum: 296]<Annotation Id="19064" Type="Sentence" StartNode="37512" EndNode="37522">References PreferredName:Reference Object SemanticType:[cnce] POS:NNS 
[sentNum: 297]<Annotation Id="19065" Type="Sentence" StartNode="37525" EndNode="37527">1.	PreferredName:1+ Score, WHO SemanticType:[clas] POS:LS POS:. 
[sentNum: 298]<Annotation Id="19066" Type="Sentence" StartNode="37529" EndNode="37577">Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. PreferredName:Act Code - Ward SemanticType:[idcn] PreferredName:R prime SemanticType:[clna] PreferredName:MJ SemanticType:[medd] PreferredName:hydroxylamine oxidase activity SemanticType:[moft] POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NN POS:, POS:NN POS:NN POS:, POS:NNP POS:NNP POS:. 
[sentNum: 299]<Annotation Id="19067" Type="Sentence" StartNode="37578" EndNode="37602">Cancer statistics, 2009. PreferredName:Science of Statistics SemanticType:[ocdi] PreferredName:Primary malignant neoplasm SemanticType:[neop] POS:NN POS:NNS POS:, POS:CD POS:. 
[sentNum: 300]<Annotation Id="19068" Type="Sentence" StartNode="37603" EndNode="37631">CA CancerJ Clin 2009;59:225&#x2013; PreferredName:CLIN SemanticType:[inpr] POS:NNP POS:NNP POS:NNP POS:CD POS:: POS:CD POS:: POS:CD POS:NN 
[sentNum: 301]<Annotation Id="19069" Type="Sentence" StartNode="37634" EndNode="37637">49. POS:CD POS:. 
[sentNum: 302]<Annotation Id="19070" Type="Sentence" StartNode="37638" EndNode="37650">(Level II-3) PreferredName:Level 3 SemanticType:[inpr] POS:NN POS:NN POS:NN POS:CD POS:NN 
[sentNum: 303]<Annotation Id="19071" Type="Sentence" StartNode="37653" EndNode="37655">2.	PreferredName:Integer +2 SemanticType:[qnco] POS:LS POS:. 
[sentNum: 304]<Annotation Id="19072" Type="Sentence" StartNode="37659" EndNode="37739">Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, WaldronW et al, editors. PreferredName:Chloride Ion SemanticType:[elii] PreferredName:R prime SemanticType:[clna] PreferredName:M+ (tumor staging) SemanticType:[inpr] PreferredName:Editor SemanticType:[ocdi] POS:NNP POS:NNP POS:, POS:NNP POS:NN POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:FW POS:FW POS:, POS:NNS POS:. 
[sentNum: 305]<Annotation Id="19073" Type="Sentence" StartNode="37740" EndNode="37782">SEER cancer stat-	istics review,1975-2007.BethesdaPreferredName:Surveillance, Epidemiology, and End Results (SEER) Program SemanticType:[hcro] PreferredName:Stat (do immediately) SemanticType:[tmco] PreferredName:Primary malignant neoplasm SemanticType:[neop] PreferredName:Act Class - review SemanticType:[idcn] POS:NN POS:NN POS:JJ POS:NNS POS:NN POS:, POS:CD POS:: POS:CD POS:. 
[sentNum: 306]<Annotation Id="19074" Type="Sentence" StartNode="37782" EndNode="37826">Bethesda(MD):NationalCancer Institute; 2011. PreferredName:Institutes SemanticType:[orgt] POS:NNP POS:CD POS:NN POS:CD POS:: POS:NNP POS:NNP POS:: POS:CD POS:. 
[sentNum: 307]<Annotation Id="19075" Type="Sentence" StartNode="37827" EndNode="37880">Available at: http://seer.cancer.gov/csr/	 1975_2007. PreferredName:HTTP SemanticType:[idcn] PreferredName:Availability of SemanticType:[ftcn] PreferredName:Primary malignant neoplasm SemanticType:[neop] PreferredName:Surveillance, Epidemiology, and End Results (SEER) Program SemanticType:[hcro] PreferredName:RAB3D gene SemanticType:[gngm] POS:JJ POS:IN POS:: POS:NN POS:: POS:: POS:: POS:NN POS:. POS:NN POS:. POS:NN POS:: POS:NN POS:: POS:CD POS:CD POS:CD POS:. 
[sentNum: 308]<Annotation Id="19076" Type="Sentence" StartNode="37881" EndNode="37909">Retrieved February 17, 2011. POS:VBN POS:NNP POS:CD POS:, POS:CD POS:. 
[sentNum: 309]<Annotation Id="19077" Type="Sentence" StartNode="37910" EndNode="37922">(Level II-3) PreferredName:Level 3 SemanticType:[inpr] POS:NN POS:NN POS:NN POS:CD POS:NN 
[sentNum: 310]<Annotation Id="19078" Type="Sentence" StartNode="37927" EndNode="37929">3.	PreferredName:&lt;3 (qualifier value) SemanticType:[qnco] POS:LS POS:. 
[sentNum: 311]<Annotation Id="19079" Type="Sentence" StartNode="37933" EndNode="37957">American Cancer Society. PreferredName:American Cancer Society SemanticType:[pros] POS:NNP POS:NNP POS:NNP POS:. 
[sentNum: 312]<Annotation Id="19080" Type="Sentence" StartNode="37958" EndNode="37998">Breast cancer facts&amp; figures: 2009-2010. PreferredName:2010s SemanticType:[tmco] PreferredName:Malignant neoplasm of breast SemanticType:[neop] POS:NN POS:NN POS:NNS POS:CC POS:NNS POS:: POS:CD POS:: POS:CD POS:. 
[sentNum: 313]<Annotation Id="19081" Type="Sentence" StartNode="37999" EndNode="38023">Atlanta (GA): ACS; 2009. PreferredName:Atlanta SemanticType:[euka] POS:NNP POS:RB POS:NN POS:CD POS:: POS:NN POS:: POS:CD POS:. 
[sentNum: 314]<Annotation Id="19082" Type="Sentence" StartNode="38024" EndNode="38131">Available at: http://	 www.cancer.org/acs/groups/content/@nho/documents/ document/f861009final90809pdf.pdf. PreferredName:Availability of SemanticType:[ftcn] PreferredName:Internet SemanticType:[mnob] PreferredName:HTTP SemanticType:[idcn] PreferredName:Professional Organization or Group SemanticType:[prog] PreferredName:Primary malignant neoplasm SemanticType:[neop] PreferredName:Contents SemanticType:[cnce] PreferredName:Groups SemanticType:[idcn] PreferredName:Act Relationship Type - documents SemanticType:[inpr] POS:JJ POS:IN POS:: POS:NN POS:: POS:: POS:: POS:NN POS:. POS:NN POS:. POS:NN POS:: POS:NNS POS:: POS:NNS POS:: POS:JJ POS:: POS:SYM POS:FW POS:: POS:NNS POS:: POS:NN POS:: POS:LS POS:CD POS:JJ POS:CD POS:NN POS:. POS:NN POS:. 
[sentNum: 315]<Annotation Id="19083" Type="Sentence" StartNode="38132" EndNode="38160">Retrieved February 17, 2011. POS:VBN POS:NNP POS:CD POS:, POS:CD POS:. 
[sentNum: 316]<Annotation Id="19084" Type="Sentence" StartNode="38161" EndNode="38173">(Level II-3) PreferredName:Level 3 SemanticType:[inpr] POS:NN POS:NN POS:NN POS:CD POS:NN 
[sentNum: 317]<Annotation Id="19085" Type="Sentence" StartNode="38180" EndNode="38182">4.	POS:LS POS:. 
[sentNum: 318]<Annotation Id="19086" Type="Sentence" StartNode="38186" EndNode="38330">Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ, et al. The decrease in breast-cancer incidence in 2003 in the United States. PreferredName:Decrease SemanticType:[qnco] PreferredName:Ej SemanticType:[imft] PreferredName:incidence of cases SemanticType:[ftcn] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:United States SemanticType:[geoa] POS:NNP POS:NNP POS:, POS:NNP POS:NN POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NN POS:, POS:NNP POS:NNP POS:, POS:FW POS:FW POS:. POS:DT POS:NN POS:IN POS:JJ POS:NN POS:IN POS:CD POS:IN POS:DT POS:NNP POS:NNPS POS:. 
[sentNum: 319]<Annotation Id="19087" Type="Sentence" StartNode="38331" EndNode="38360">N Engl J Med 2007;356:1670&#x2013;4. PreferredName:N not otherwise specified Antibody SemanticType:[aapp, imft] PreferredName:EXOG gene SemanticType:[gngm] POS:NN POS:NNP POS:NNP POS:VBD POS:CD POS:: POS:CD POS:: POS:CD POS:CD POS:CD POS:. 
[sentNum: 320]<Annotation Id="19088" Type="Sentence" StartNode="38361" EndNode="38372">(Level III) PreferredName:Level III SemanticType:[inpr] POS:NN POS:NN POS:CD POS:NN 
[sentNum: 321]<Annotation Id="19089" Type="Sentence" StartNode="38377" EndNode="38379">5.	PreferredName:Integer +5 SemanticType:[qnco] POS:CD POS:. 
[sentNum: 322]<Annotation Id="19090" Type="Sentence" StartNode="38383" EndNode="38428">Glass AG, Lacey JV Jr, Carreon JD, Hoover RN. PreferredName:Glass (substance) SemanticType:[mnob] PreferredName:Doctor of Law SemanticType:[inpr] PreferredName:Junior SemanticType:[idcn] PreferredName:U2AF1 wt Allele SemanticType:[gngm] POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:. 
[sentNum: 323]<Annotation Id="19091" Type="Sentence" StartNode="38429" EndNode="38565">Breast	 cancer incidence, 1980-2006: combined roles of meno­pausal hormone therapy, screening mammography, and estrogen receptor status. PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:1980s SemanticType:[tmco] PreferredName:incidence of cases SemanticType:[ftcn] PreferredName:Social Role SemanticType:[socb] PreferredName:Psychotherapy, Multiple SemanticType:[topp] PreferredName:Hormones SemanticType:[horm] PreferredName:Pauses:Number = Count/Time:Duration of the study:Heart:Quantitative:EKG SemanticType:[clna] PreferredName:Mammography SemanticType:[diap] PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:Encounter due to estrogen receptor status SemanticType:[fndg] POS:NN POS:NN POS:NN POS:, POS:CD POS:: POS:CD POS:: POS:VBN POS:NNS POS:IN POS:JJ POS:NN POS:NN POS:, POS:VBG POS:NN POS:, POS:CC POS:NN POS:NN POS:NN POS:. 
[sentNum: 324]<Annotation Id="19092" Type="Sentence" StartNode="38566" EndNode="38603">J Natl Cancer Inst 2007;99:	 1152&#x2013;61. PreferredName:Primary malignant neoplasm SemanticType:[neop] POS:NNP POS:NNP POS:NNP POS:NNP POS:CD POS:: POS:CD POS:: POS:CD POS:CD POS:CD POS:. 
[sentNum: 325]<Annotation Id="19093" Type="Sentence" StartNode="38604" EndNode="38616">(Level II-3) PreferredName:Level 3 SemanticType:[inpr] POS:NN POS:NN POS:NN POS:CD POS:NN 
[sentNum: 326]<Annotation Id="19094" Type="Sentence" StartNode="38621" EndNode="38623">6.	POS:CD POS:. 
[sentNum: 327]<Annotation Id="19095" Type="Sentence" StartNode="38627" EndNode="38657">Rosen PP, Groshen S, Kinne DW. POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:. 
[sentNum: 328]<Annotation Id="19096" Type="Sentence" StartNode="38658" EndNode="38762">Survival and prog­nostic factors in node-negative breast cancer: results of long-term follow-up studies. PreferredName:Continuance of life SemanticType:[acty] PreferredName:Negative Lymph Node SemanticType:[fndg] PreferredName:Factor SemanticType:[ftcn] PreferredName:research outcome SemanticType:[fndg] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Longterm Follow-up SemanticType:[hlca] POS:NN POS:CC POS:JJ POS:NNS POS:IN POS:JJ POS:NN POS:NN POS:: POS:NNS POS:IN POS:JJ POS:JJ POS:NNS POS:. 
[sentNum: 329]<Annotation Id="19097" Type="Sentence" StartNode="38763" EndNode="38806">J Natl Cancer Inst Monogr 1992;(11):159&#x2013;62. PreferredName:Primary malignant neoplasm SemanticType:[neop] POS:NNP POS:NNP POS:NNP POS:NNP POS:NNP POS:CD POS:: POS:CD POS:CD POS:NN POS:: POS:CD POS:CD POS:CD POS:. 
[sentNum: 330]<Annotation Id="19098" Type="Sentence" StartNode="38807" EndNode="38818">(Level III) PreferredName:Level III SemanticType:[inpr] POS:NN POS:NN POS:CD POS:NN 
[sentNum: 331]<Annotation Id="19099" Type="Sentence" StartNode="38823" EndNode="38825">7.	POS:CD POS:. 
[sentNum: 332]<Annotation Id="19100" Type="Sentence" StartNode="38829" EndNode="39064">TabarL,ChenHH,DuffySW,YenMF,ChiangCF,DeanPB,	 et al.Anovel method for predictionof long-term outcome of women with T1a, T1b, and 10-14 mm invasive breast cancers: a prospective study [published erratum appears in Lancet 2000;355:1372]. PreferredName:Test Method SemanticType:[lbpr] PreferredName:Result SemanticType:[ftcn] PreferredName:Long-term SemanticType:[tmco] PreferredName:Tumor stage T1a SemanticType:[clas] PreferredName:Woman SemanticType:[popg] PreferredName:Invasive Breast Carcinoma SemanticType:[neop] PreferredName:Tumor stage T1b SemanticType:[clas] PreferredName:Published Erratum SemanticType:[inpr] PreferredName:Prospective Studies SemanticType:[resa] PreferredName:Lancet SemanticType:[medd] PreferredName:Appearance SemanticType:[qlco] PreferredName:2000s SemanticType:[tmco] POS:NNP POS:, POS:NNP POS:, POS:NNP POS:, POS:NN POS:, POS:NN POS:, POS:NN POS:, POS:FW POS:FW POS:. POS:NN POS:NN POS:IN POS:JJ POS:JJ POS:NN POS:IN POS:NNS POS:IN POS:NN POS:CD POS:DT POS:, POS:NN POS:CD POS:NN POS:, POS:CC POS:CD POS:: POS:CD POS:NN POS:JJ POS:NN POS:NNS POS:: POS:DT POS:JJ POS:NN POS:NN POS:VBN POS:NN POS:VBZ POS:IN POS:NNP POS:CD POS:: POS:CD POS:: POS:CD POS:CD POS:. 
[sentNum: 333]<Annotation Id="19101" Type="Sentence" StartNode="39065" EndNode="39088">Lancet 2000;355:429&#x2013;33. PreferredName:Lancet SemanticType:[medd] PreferredName:2000s SemanticType:[tmco] POS:NNP POS:CD POS:: POS:CD POS:: POS:CD POS:CD POS:CD POS:. 
[sentNum: 334]<Annotation Id="19102" Type="Sentence" StartNode="39089" EndNode="39101">(Level II-3) PreferredName:Level 3 SemanticType:[inpr] POS:NN POS:NN POS:NN POS:CD POS:NN 
[sentNum: 335]<Annotation Id="19103" Type="Sentence" StartNode="39106" EndNode="39108">8.	POS:CD POS:. 
[sentNum: 336]<Annotation Id="19104" Type="Sentence" StartNode="39112" EndNode="39196">TabarL,DeanPB, KaufmanCS,DuffySW,ChenHH.A new era in the diagnosis of breast cancer. PreferredName:Diagnosis Study SemanticType:[resa] PreferredName:New SemanticType:[tmco] PreferredName:Malignant neoplasm of breast SemanticType:[neop] POS:NN POS:, POS:NN POS:, POS:NN POS:, POS:NN POS:, POS:NN POS:. POS:DT POS:JJ POS:NN POS:IN POS:DT POS:NN POS:IN POS:NN POS:NN POS:. 
[sentNum: 337]<Annotation Id="19105" Type="Sentence" StartNode="39197" EndNode="39231">Surg Oncol Clin NAm 2000;9:233&#x2013;77. PreferredName:Surg SemanticType:[tmco] PreferredName:Laboratory Vendor Name SemanticType:[inpr] PreferredName:CLIN SemanticType:[inpr] PreferredName:2000s SemanticType:[tmco] POS:NNP POS:NNP POS:NNP POS:NNP POS:CD POS:: POS:CD POS:: POS:CD POS:CD POS:CD POS:. 
[sentNum: 338]<Annotation Id="19106" Type="Sentence" StartNode="39232" EndNode="39243">(Level III) PreferredName:Level III SemanticType:[inpr] POS:NN POS:NN POS:CD POS:NN 
[sentNum: 339]<Annotation Id="19107" Type="Sentence" StartNode="39248" EndNode="39250">9.	POS:CD POS:. 
[sentNum: 340]<Annotation Id="19108" Type="Sentence" StartNode="39254" EndNode="39337">Joensuu H, Pylkkanen L, Toikkanen S. Late mortal­ity from pT1N0M0 breast carcinoma. PreferredName:Late SemanticType:[tmco] PreferredName:Protons SemanticType:[elii] PreferredName:Breast Carcinoma SemanticType:[neop] POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NN POS:. POS:JJ POS:NN POS:IN POS:NN POS:CD POS:NN POS:CD POS:NN POS:CD POS:NN POS:NN POS:. 
[sentNum: 341]<Annotation Id="19109" Type="Sentence" StartNode="39338" EndNode="39362">Cancer 1999;85:	 2183&#x2013;9. PreferredName:Primary malignant neoplasm SemanticType:[neop] POS:NN POS:CD POS:: POS:CD POS:: POS:CD POS:CD POS:CD POS:. 
[sentNum: 342]<Annotation Id="19110" Type="Sentence" StartNode="39363" EndNode="39375">(Level II-3) PreferredName:Level 3 SemanticType:[inpr] POS:NN POS:NN POS:NN POS:CD POS:NN 
[sentNum: 343]<Annotation Id="19111" Type="Sentence" StartNode="39380" EndNode="39383">10.	POS:CD POS:. 
[sentNum: 344]<Annotation Id="19112" Type="Sentence" StartNode="39387" EndNode="39406">Lopez MJ, Smart CR. PreferredName:MJ SemanticType:[medd] PreferredName:Creatinine measurement SemanticType:[lbpr] POS:NNP POS:NNP POS:, POS:NNP POS:NN POS:. 
[sentNum: 345]<Annotation Id="19113" Type="Sentence" StartNode="39407" EndNode="39510">Twenty-year follow-up of mini­mal breast cancer from the Breast Cancer Detection Demonstration Project. PreferredName:twenty twenty SemanticType:[orch, phsu] PreferredName:follow-up SemanticType:[hlca] PreferredName:per year SemanticType:[tmco] PreferredName:CD8A wt Allele SemanticType:[gngm] PreferredName:Mini SemanticType:[orga] PreferredName:Breast Cancer Detection Research SemanticType:[hlca] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Project SemanticType:[cnce] POS:JJ POS:NN POS:IN POS:JJ POS:NN POS:NN POS:IN POS:DT POS:NN POS:NN POS:NN POS:NN POS:NN POS:. 
[sentNum: 346]<Annotation Id="19114" Type="Sentence" StartNode="39511" EndNode="39549">Surg Oncol Clin N Am 1997;6:	 393&#x2013;401. PreferredName:Surg SemanticType:[tmco] PreferredName:CLIN SemanticType:[inpr] POS:NNP POS:NNP POS:NNP POS:NNP POS:VBP POS:CD POS:: POS:CD POS:: POS:CD POS:NN POS:CD POS:. 
[sentNum: 347]<Annotation Id="19115" Type="Sentence" StartNode="39550" EndNode="39562">(Level II-3) PreferredName:Level 3 SemanticType:[inpr] POS:NN POS:NN POS:NN POS:CD POS:NN 
[sentNum: 348]<Annotation Id="19116" Type="Sentence" StartNode="39567" EndNode="39570">11.	POS:CD POS:. 
[sentNum: 349]<Annotation Id="19117" Type="Sentence" StartNode="39574" EndNode="39671">Arnesson LG, Smeds S, Fagerberg G. Recurrence-free survival in patients with small breast cancer. PreferredName:Surviving free of recurrence of neoplastic disease SemanticType:[fndg] PreferredName:Gram per Deciliter SemanticType:[qnco] PreferredName:Small breast SemanticType:[fndg] PreferredName:Patients SemanticType:[podg] PreferredName:Primary malignant neoplasm SemanticType:[neop] POS:NNP POS:NNP POS:, POS:NNP POS:NN POS:, POS:NNP POS:NNP POS:. POS:JJ POS:NN POS:IN POS:NNS POS:IN POS:JJ POS:NN POS:NN POS:. 
[sentNum: 350]<Annotation Id="19118" Type="Sentence" StartNode="39672" EndNode="39747">An analy­sis of cancers 10 mm or less detected clinically and by screening. PreferredName:PDGFB wt Allele SemanticType:[gngm] PreferredName:Less Than SemanticType:[inpr] PreferredName:Primary malignant neoplasm SemanticType:[neop] PreferredName:And SemanticType:[idcn] PreferredName:Detection SemanticType:[topp] PreferredName:Aspects of disease screening SemanticType:[ftcn] POS:DT POS:NN POS:IN POS:NNS POS:CD POS:NN POS:CC POS:JJR POS:VBN POS:RB POS:CC POS:IN POS:NN POS:. 
[sentNum: 351]<Annotation Id="19119" Type="Sentence" StartNode="39748" EndNode="39772">EurJSurg 1994;160:271&#x2013;6. POS:NNP POS:CD POS:: POS:CD POS:: POS:CD POS:RB POS:CD POS:. 
[sentNum: 352]<Annotation Id="19120" Type="Sentence" StartNode="39773" EndNode="39781">(LevelI) POS:NN POS:NN POS:CD 
[sentNum: 353]<Annotation Id="19121" Type="Sentence" StartNode="39790" EndNode="39793">12.	POS:CD POS:. 
[sentNum: 354]<Annotation Id="19122" Type="Sentence" StartNode="39797" EndNode="39851">Macdonald I. The natural history of mammary carcinoma. PreferredName:Iodides SemanticType:[inch] PreferredName:H/O: carcinoma SemanticType:[fndg] PreferredName:Natural SemanticType:[ftcn] PreferredName:Breast SemanticType:[bpoc] POS:NNP POS:PRP POS:. POS:DT POS:JJ POS:NN POS:IN POS:JJ POS:NN POS:. 
[sentNum: 355]<Annotation Id="19123" Type="Sentence" StartNode="39852" EndNode="39876">AmJSurg 1966;111:435&#x2013;42. POS:NNP POS:CD POS:: POS:CD POS:: POS:CD POS:CD POS:CD POS:. 
[sentNum: 356]<Annotation Id="19124" Type="Sentence" StartNode="39877" EndNode="39888">(Level III) PreferredName:Level III SemanticType:[inpr] POS:NN POS:NN POS:CD POS:NN 
[sentNum: 357]<Annotation Id="19125" Type="Sentence" StartNode="39893" EndNode="39896">13.	POS:CD POS:. 
[sentNum: 358]<Annotation Id="19126" Type="Sentence" StartNode="39900" EndNode="39911">Gullino PM. POS:NNP POS:NNP POS:. 
[sentNum: 359]<Annotation Id="19127" Type="Sentence" StartNode="39912" EndNode="39945">Natural history of breast cancer. PreferredName:History of malignant neoplasm of breast SemanticType:[fndg] PreferredName:Natural SemanticType:[ftcn] POS:JJ POS:NN POS:IN POS:NN POS:NN POS:. 
[sentNum: 360]<Annotation Id="19128" Type="Sentence" StartNode="39946" EndNode="40018">Progression from hyperplasia to neoplasia as predicted by angiogen­esis. PreferredName:Hyperplasia SemanticType:[patf] PreferredName:Disease Progression SemanticType:[patf] PreferredName:Prediction SemanticType:[idcn] PreferredName:Neoplasm SemanticType:[neop] PreferredName:Electrospray Ionization SemanticType:[lbpr] PreferredName:angiogen SemanticType:[phsu] POS:NN POS:IN POS:NN POS:TO POS:NN POS:IN POS:VBN POS:IN POS:NN POS:. 
[sentNum: 361]<Annotation Id="19129" Type="Sentence" StartNode="40019" EndNode="40043">Cancer 1977;39:2697&#x2013;703. PreferredName:Primary malignant neoplasm SemanticType:[neop] POS:NN POS:CD POS:: POS:CD POS:: POS:CD POS:CD POS:CD POS:. 
[sentNum: 362]<Annotation Id="19130" Type="Sentence" StartNode="40044" EndNode="40055">(Level III) PreferredName:Level III SemanticType:[inpr] POS:NN POS:NN POS:CD POS:NN 
[sentNum: 363]<Annotation Id="19131" Type="Sentence" StartNode="40060" EndNode="40063">14.	POS:CD POS:. 
[sentNum: 364]<Annotation Id="19132" Type="Sentence" StartNode="40067" EndNode="40137">Wertheimer MD, Costanza ME, Dodson TF, D&#x2019;Orsi C, Pastides H, Zapka JG. PreferredName:Protons SemanticType:[elii] POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NN POS:, POS:NN POS:CD POS:NN POS:NN POS:, POS:NNPS POS:NNP POS:, POS:NNP POS:NNP POS:. 
[sentNum: 365]<Annotation Id="19133" Type="Sentence" StartNode="40138" EndNode="40191">Increasing the effort toward breast cancer detection. PreferredName:Increasing SemanticType:[ftcn] PreferredName:Breast Cancer Detection Research SemanticType:[hlca] PreferredName:Exertion SemanticType:[orgf] POS:VBG POS:DT POS:NN POS:IN POS:NN POS:NN POS:NN POS:. 
[sentNum: 366]<Annotation Id="19134" Type="Sentence" StartNode="40192" EndNode="40213">JAMA 1986;255:1311&#x2013;5. PreferredName:F11R gene SemanticType:[gngm] POS:NNP POS:CD POS:: POS:CD POS:: POS:CD POS:CD POS:CD POS:. 
[sentNum: 367]<Annotation Id="19135" Type="Sentence" StartNode="40214" EndNode="40225">(Level III) PreferredName:Level III SemanticType:[inpr] POS:NN POS:NN POS:CD POS:NN 
[sentNum: 368]<Annotation Id="19136" Type="Sentence" StartNode="40230" EndNode="40233">15.	POS:CD POS:. 
[sentNum: 369]<Annotation Id="19137" Type="Sentence" StartNode="40237" EndNode="40255">Walter SD, Day NE. PreferredName:ELANE wt Allele SemanticType:[gngm] PreferredName:day SemanticType:[tmco] POS:NNP POS:NN POS:, POS:NN POS:NN POS:. 
[sentNum: 370]<Annotation Id="19138" Type="Sentence" StartNode="40256" EndNode="40336">Estimation of the duration of a pre-clinical disease state using screening data. PreferredName:Preclinical SemanticType:[qlco] PreferredName:Statistical Estimation SemanticType:[qnco] PreferredName:Geographic state SemanticType:[geoa] PreferredName:illness length SemanticType:[tmco] PreferredName:Disease Screening SemanticType:[diap] PreferredName:Use of SemanticType:[ftcn] PreferredName:Data SemanticType:[idcn] POS:NN POS:IN POS:DT POS:NN POS:IN POS:DT POS:JJ POS:NN POS:NN POS:VBG POS:VBG POS:NNS POS:. 
[sentNum: 371]<Annotation Id="19139" Type="Sentence" StartNode="40337" EndNode="40368">Am J Epidemiol 1983;118:865&#x2013;86. POS:NNP POS:NNP POS:NNP POS:CD POS:: POS:CD POS:: POS:CD POS:CD POS:CD POS:. 
[sentNum: 372]<Annotation Id="19140" Type="Sentence" StartNode="40369" EndNode="40380">(Level III) PreferredName:Level III SemanticType:[inpr] POS:NN POS:NN POS:CD POS:NN 
[sentNum: 373]<Annotation Id="19141" Type="Sentence" StartNode="40385" EndNode="40388">16.	POS:CD POS:. 
[sentNum: 374]<Annotation Id="19142" Type="Sentence" StartNode="40392" EndNode="40434">SmithRA,DuffySW,GabeR,TabarL,YenAM,ChenTH.	POS:NNP POS:, POS:NNP POS:, POS:NNP POS:, POS:NNP POS:, POS:NNP POS:, POS:NNP POS:. 
[sentNum: 375]<Annotation Id="19143" Type="Sentence" StartNode="40436" EndNode="40507">The randomized trials of breast cancer screening: what have we learned? PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Clinical Trials, Randomized SemanticType:[inpr, resa] PreferredName:Learning SemanticType:[menp] PreferredName:Aspects of disease screening SemanticType:[ftcn] POS:DT POS:VBN POS:NNS POS:IN POS:NN POS:NN POS:NN POS:: POS:WP POS:VBP POS:PRP POS:VBN POS:. 
[sentNum: 376]<Annotation Id="19144" Type="Sentence" StartNode="40508" EndNode="40549">Radiol Clin North Am 2004;42:793&#x2013; 806; v. PreferredName:North SemanticType:[spco] PreferredName:CLIN SemanticType:[inpr] POS:NNP POS:NNP POS:NNP POS:VBP POS:CD POS:: POS:CD POS:: POS:CD POS:NN POS:CD POS:: POS:LS POS:. 
[sentNum: 377]<Annotation Id="19145" Type="Sentence" StartNode="40550" EndNode="40561">(Level III) PreferredName:Level III SemanticType:[inpr] POS:NN POS:NN POS:CD POS:NN 
[sentNum: 378]<Annotation Id="19146" Type="Sentence" StartNode="40566" EndNode="40569">17.	POS:CD POS:. 
[sentNum: 379]<Annotation Id="19147" Type="Sentence" StartNode="40573" EndNode="40717">Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. PreferredName:Potassium Ion SemanticType:[elii, phsu] PreferredName:Screening for malignant neoplasm of breast SemanticType:[topp] PreferredName:KNG1 gene SemanticType:[gngm] PreferredName:United States SemanticType:[geoa] PreferredName:Update SemanticType:[tmco] PreferredName:Advisory Committees SemanticType:[gora] PreferredName:Preventive service healthcare SemanticType:[hlca] POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:. POS:NN POS:IN POS:NN POS:NN POS:: POS:DT POS:VBP POS:IN POS:DT POS:NNP POS:. POS:NN POS:. POS:NNP POS:NNPS POS:NNP POS:NNP POS:. 
[sentNum: 380]<Annotation Id="19148" Type="Sentence" StartNode="40718" EndNode="40754">U.S. Preventive Services Task Force. PreferredName:Preventive service healthcare SemanticType:[hlca] PreferredName:United States SemanticType:[geoa] PreferredName:Advisory Committees SemanticType:[gora] POS:NNP POS:. POS:NN POS:. POS:NNP POS:NNPS POS:NNP POS:NNP POS:. 
[sentNum: 381]<Annotation Id="19149" Type="Sentence" StartNode="40755" EndNode="40795">Ann Intern Med 2009;151:727-37; W237&#x2013;42. PreferredName:Intern SemanticType:[prog] POS:NNP POS:NNP POS:NNP POS:CD POS:: POS:CD POS:: POS:CD POS:: POS:CD POS:: POS:NNP POS:CD POS:CD POS:CD POS:. 
[sentNum: 382]<Annotation Id="19150" Type="Sentence" StartNode="40796" EndNode="40807">(Level III) PreferredName:Level III SemanticType:[inpr] POS:NN POS:NN POS:CD POS:NN 
[sentNum: 383]<Annotation Id="19151" Type="Sentence" StartNode="40812" EndNode="40815">18.	POS:CD POS:. 
[sentNum: 384]<Annotation Id="19152" Type="Sentence" StartNode="40819" EndNode="40861">Humphrey LL, Helfand M, Chan BK, Woolf SH. PreferredName:M NOS ANTIBODY SemanticType:[aapp, imft] PreferredName:Saint Helena Islands SemanticType:[geoa] PreferredName:KNG1 gene SemanticType:[gngm] POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:. 
[sentNum: 385]<Annotation Id="19153" Type="Sentence" StartNode="40862" EndNode="40920">Breast cancer screening: a summary of the evidence for the PreferredName:Summary (document) SemanticType:[inpr] PreferredName:Screening for malignant neoplasm of breast SemanticType:[topp] PreferredName:Evidence of SemanticType:[ftcn] POS:NN POS:NN POS:NN POS:: POS:DT POS:NN POS:IN POS:DT POS:NN POS:IN POS:DT 
[sentNum: 386]<Annotation Id="19154" Type="Sentence" StartNode="40925" EndNode="40961">U.S. Preventive Services Task Force. PreferredName:United States SemanticType:[geoa] PreferredName:Advisory Committees SemanticType:[gora] PreferredName:Preventive service healthcare SemanticType:[hlca] POS:NNP POS:. POS:NN POS:. POS:NNP POS:NNPS POS:NNP POS:NNP POS:. 
[sentNum: 387]<Annotation Id="19155" Type="Sentence" StartNode="40962" EndNode="40993">Ann Intern Med 2002;137:347&#x2013;60. PreferredName:Intern SemanticType:[prog] POS:NNP POS:NNP POS:NNP POS:CD POS:: POS:CD POS:: POS:CD POS:CD POS:CD POS:. 
[sentNum: 388]<Annotation Id="19156" Type="Sentence" StartNode="40994" EndNode="41005">(Level III) PreferredName:Level III SemanticType:[inpr] POS:NN POS:NN POS:CD POS:NN 
[sentNum: 389]<Annotation Id="19157" Type="Sentence" StartNode="41010" EndNode="41013">19.	POS:CD POS:. 
[sentNum: 390]<Annotation Id="19158" Type="Sentence" StartNode="41017" EndNode="41074">Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL. PreferredName:Fuchsin acid stain SemanticType:[irda, orch] PreferredName:K Prime SemanticType:[qnco] PreferredName:MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS SemanticType:[dsyn] PreferredName:San Marino SemanticType:[geoa] POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:. 
[sentNum: 391]<Annotation Id="19159" Type="Sentence" StartNode="41075" EndNode="41125">Efficacy of screening mammography.Ameta-analy­sis. PreferredName:Screening mammography SemanticType:[topp] PreferredName:Efficacy Study SemanticType:[resa] PreferredName:PDGFB wt Allele SemanticType:[gngm] POS:NN POS:IN POS:VBG POS:NN POS:. POS:NN POS:. 
[sentNum: 392]<Annotation Id="19160" Type="Sentence" StartNode="41126" EndNode="41147">JAMA 1995;273:149&#x2013;54. PreferredName:F11R gene SemanticType:[gngm] POS:NNP POS:CD POS:: POS:CD POS:: POS:CD POS:CD POS:CD POS:. 
[sentNum: 393]<Annotation Id="19161" Type="Sentence" StartNode="41148" EndNode="41163">(Meta-analysis) PreferredName:Meta Analysis (statistical procedure) SemanticType:[resa] POS:NN POS:NN POS:CD 
[sentNum: 394]<Annotation Id="19162" Type="Sentence" StartNode="41168" EndNode="41171">20.	POS:CD POS:. 
[sentNum: 395]<Annotation Id="19163" Type="Sentence" StartNode="41175" EndNode="41225">Hendrick RE, Smith RA, Rutledge JH, 3rd, Smart CR. PreferredName:Respiratory Domain SemanticType:[idcn] PreferredName:Axial R SemanticType:[spco] PreferredName:Smith (occupation) SemanticType:[prog] PreferredName:Third SemanticType:[qnco] PreferredName:HFE2 gene SemanticType:[gngm] PreferredName:Creatinine measurement SemanticType:[lbpr] POS:NNP POS:NNP POS:, POS:NNP POS:NN POS:, POS:NNP POS:NNP POS:, POS:JJ POS:, POS:NNP POS:NN POS:. 
[sentNum: 396]<Annotation Id="19164" Type="Sentence" StartNode="41226" EndNode="41362">Benefitofscreeningmammographyinwomenaged40-49: a new meta-analysis of randomized controlledtrials.JNatl CancerInstMonogr1997;(22):87&#x2013;92.(PreferredName:New SemanticType:[tmco] PreferredName:Randomization SemanticType:[resa] PreferredName:Meta Analysis (statistical procedure) SemanticType:[resa] POS:VBN POS:CD POS:: POS:CD POS:: POS:DT POS:JJ POS:NN POS:IN POS:VBN POS:NNS POS:. POS:NN POS:NN POS:CD POS:: POS:CD POS:CD POS:NN POS:: POS:CD POS:CD POS:CD POS:. 
[sentNum: 397]<Annotation Id="19165" Type="Sentence" StartNode="41362" EndNode="41377">(Meta-analysis) PreferredName:Meta Analysis (statistical procedure) SemanticType:[resa] POS:NN POS:NN POS:CD 
[sentNum: 398]<Annotation Id="19166" Type="Sentence" StartNode="41382" EndNode="41385">21.	POS:CD POS:. 
[sentNum: 399]<Annotation Id="19167" Type="Sentence" StartNode="41389" EndNode="41410">Olsen O, Gotzsche PC. PreferredName:PROC wt Allele SemanticType:[gngm] POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:. 
[sentNum: 400]<Annotation Id="19168" Type="Sentence" StartNode="41411" EndNode="41527">Cochrane review on screening for breast cancer with mammography [published erra­tum appears in Lancet 2006;367:474]. PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:Act Class - review SemanticType:[idcn] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Preposition For SemanticType:[qlco] PreferredName:Publishing SemanticType:[ocac] PreferredName:Mammography SemanticType:[diap] PreferredName:Tums SemanticType:[inch, phsu] PreferredName:ESRRA gene SemanticType:[gngm] PreferredName:Lancet SemanticType:[medd] PreferredName:Appearance SemanticType:[qlco] POS:NNP POS:NN POS:IN POS:NN POS:IN POS:NN POS:NN POS:IN POS:NN POS:NN POS:VBN POS:NN POS:VBZ POS:IN POS:NNP POS:CD POS:: POS:CD POS:: POS:CD POS:NN POS:. 
[sentNum: 401]<Annotation Id="19169" Type="Sentence" StartNode="41528" EndNode="41553">Lancet 2001;358:	 1340&#x2013;2. PreferredName:Lancet SemanticType:[medd] POS:NNP POS:CD POS:: POS:CD POS:: POS:CD POS:NN POS:CD POS:. 
[sentNum: 402]<Annotation Id="19170" Type="Sentence" StartNode="41554" EndNode="41565">(Level III) PreferredName:Level III SemanticType:[inpr] POS:NN POS:NN POS:CD POS:NN 
[sentNum: 403]<Annotation Id="19171" Type="Sentence" StartNode="41570" EndNode="41573">22.	POS:CD POS:. 
[sentNum: 404]<Annotation Id="19172" Type="Sentence" StartNode="41577" EndNode="41652">Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE. PreferredName:HPS4 gene SemanticType:[gngm] PreferredName:Iodides SemanticType:[inch] POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:. 
[sentNum: 405]<Annotation Id="19173" Type="Sentence" StartNode="41653" EndNode="41799">Long-term effects of mam­mography screening: updated overview of the Swedish randomised trials [published erratum appears in Lancet 2002;360:724]. PreferredName:Mammography SemanticType:[diap] PreferredName:Longterm Effects SemanticType:[phpr] PreferredName:Update SemanticType:[tmco] PreferredName:Trial Screening SemanticType:[resa] PreferredName:Swedish SemanticType:[popg] PreferredName:overview SemanticType:[inpr] PreferredName:Published Erratum SemanticType:[inpr] PreferredName:Clinical Trials SemanticType:[resa] PreferredName:Lancet SemanticType:[medd] PreferredName:Appearance SemanticType:[qlco] POS:JJ POS:NNS POS:IN POS:NN POS:NN POS:: POS:VBN POS:NN POS:IN POS:DT POS:JJ POS:JJ POS:NNS POS:VBP POS:VBN POS:NN POS:VBZ POS:IN POS:NNP POS:CD POS:: POS:CD POS:: POS:CD POS:NN POS:. 
[sentNum: 406]<Annotation Id="19174" Type="Sentence" StartNode="41800" EndNode="41823">Lancet 2002;359:909&#x2013;19. PreferredName:Lancet SemanticType:[medd] POS:NNP POS:CD POS:: POS:CD POS:: POS:CD POS:CD POS:CD POS:. 
[sentNum: 407]<Annotation Id="19175" Type="Sentence" StartNode="41824" EndNode="41835">(Level III) PreferredName:Level III SemanticType:[inpr] POS:NN POS:NN POS:CD POS:NN 
[sentNum: 408]<Annotation Id="19176" Type="Sentence" StartNode="41840" EndNode="41843">23.	PreferredName:Arabic numeral 23 SemanticType:[qnco] POS:CD POS:. 
[sentNum: 409]<Annotation Id="19177" Type="Sentence" StartNode="41847" EndNode="41937">Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. PreferredName:Screening for malignant neoplasm of breast SemanticType:[topp] PreferredName:Preventive service healthcare SemanticType:[hlca] PreferredName:United States SemanticType:[geoa] PreferredName:Recommendation SemanticType:[idcn] PreferredName:Advisory Committees SemanticType:[gora] PreferredName:Statement SemanticType:[idcn] POS:VBG POS:IN POS:NN POS:NN POS:: POS:NNP POS:. POS:NN POS:. POS:NNP POS:NNPS POS:NNP POS:NNP POS:NN POS:NN POS:. 
[sentNum: 410]<Annotation Id="19178" Type="Sentence" StartNode="41938" EndNode="42062">US Preventive Services Task Force [published errata appear in Ann Intern Med 2010;152:199&#x2013;200; Ann Intern Med 2010;152:688]. PreferredName:Preventive service healthcare SemanticType:[hlca] PreferredName:Published Erratum SemanticType:[inpr] PreferredName:Advisory Committees SemanticType:[gora] PreferredName:Intern SemanticType:[prog] PreferredName:Appearance SemanticType:[qlco] PreferredName:Intern SemanticType:[prog] PreferredName:2010s SemanticType:[tmco] PreferredName:2010s SemanticType:[tmco] POS:NNP POS:NNP POS:NNPS POS:NNP POS:NNP POS:NN POS:VBN POS:NNS POS:VBP POS:IN POS:NNP POS:NNP POS:NNP POS:CD POS:: POS:CD POS:: POS:CD POS:NN POS:CD POS:: POS:NNP POS:NNP POS:NNP POS:CD POS:: POS:CD POS:: POS:CD POS:NN POS:. 
[sentNum: 411]<Annotation Id="19179" Type="Sentence" StartNode="42063" EndNode="42100">Ann Intern Med 2009;151:716&#x2013;26;W-236. PreferredName:Intern SemanticType:[prog] POS:NNP POS:NNP POS:NNP POS:CD POS:: POS:CD POS:: POS:CD POS:CD POS:CD POS:: POS:NN POS:CD POS:. 
[sentNum: 412]<Annotation Id="19180" Type="Sentence" StartNode="42101" EndNode="42112">(Level III) PreferredName:Level III SemanticType:[inpr] POS:NN POS:NN POS:CD POS:NN 
[sentNum: 413]<Annotation Id="19181" Type="Sentence" StartNode="42117" EndNode="42120">24.	POS:CD POS:. 
[sentNum: 414]<Annotation Id="19182" Type="Sentence" StartNode="42124" EndNode="42328">Mandelblatt J, Saha S, Teutsch S, Hoerger T, Siu AL, Atkins D, et al. The cost-effectiveness of screening mam­mography beyond age 65 years: a systematic review for the U.S. Preventive Services Task Force. PreferredName:Vorinostat SemanticType:[orch, phsu] PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:Cost Effectiveness SemanticType:[qnco] PreferredName:Age-Years SemanticType:[tmco] PreferredName:Mammography SemanticType:[diap] PreferredName:Review, Systematic SemanticType:[inpr] PreferredName:Arabic numeral 65 SemanticType:[inpr] PreferredName:Preventive service healthcare SemanticType:[hlca] PreferredName:United States SemanticType:[geoa] PreferredName:Advisory Committees SemanticType:[gora] POS:NNP POS:NNP POS:, POS:NNP POS:NN POS:, POS:NNP POS:NN POS:, POS:NNP POS:NN POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:FW POS:FW POS:. POS:DT POS:NN POS:IN POS:VBG POS:NN POS:IN POS:NN POS:CD POS:NNS POS:: POS:DT POS:JJ POS:NN POS:IN POS:DT POS:NNP POS:. POS:NN POS:. POS:NNP POS:NNPS POS:NNP POS:NNP POS:. 
[sentNum: 415]<Annotation Id="19183" Type="Sentence" StartNode="42329" EndNode="42388">Cost Work Group of the U.S. Preventive Services Task Force. PreferredName:Financial cost SemanticType:[qnco] PreferredName:Groups SemanticType:[idcn] PreferredName:Work SemanticType:[ocac] PreferredName:Preventive service healthcare SemanticType:[hlca] PreferredName:United States SemanticType:[geoa] PreferredName:Advisory Committees SemanticType:[gora] POS:NN POS:NNP POS:NNP POS:IN POS:DT POS:NNP POS:. POS:NN POS:. POS:NNP POS:NNPS POS:NNP POS:NNP POS:. 
[sentNum: 416]<Annotation Id="19184" Type="Sentence" StartNode="42389" EndNode="42420">Ann Intern Med 2003;139:835&#x2013;42. PreferredName:Intern SemanticType:[prog] POS:NNP POS:NNP POS:NNP POS:CD POS:: POS:CD POS:: POS:CD POS:CD POS:CD POS:. 
[sentNum: 417]<Annotation Id="19185" Type="Sentence" StartNode="42421" EndNode="42432">(Level III) PreferredName:Level III SemanticType:[inpr] POS:NN POS:NN POS:CD POS:NN 
[sentNum: 418]<Annotation Id="19186" Type="Sentence" StartNode="42437" EndNode="42440">25.	POS:CD POS:. 
[sentNum: 419]<Annotation Id="19187" Type="Sentence" StartNode="42444" EndNode="42603">Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD, et al. American Cancer Society guidelines forbreast screening withMRI as an adjunct to mammog­raphy. PreferredName:Morphology Findings Domain SemanticType:[idcn] PreferredName:Guideline [Publication Type] SemanticType:[inpr] PreferredName:American Cancer Society SemanticType:[pros] PreferredName:Aspects of disease screening SemanticType:[ftcn] POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:VBZ POS:NN POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:FW POS:FW POS:. POS:NNP POS:NNP POS:NNP POS:NNS POS:JJ POS:NN POS:NN POS:IN POS:DT POS:NN POS:TO POS:NN POS:. 
[sentNum: 420]<Annotation Id="19188" Type="Sentence" StartNode="42604" EndNode="42744">American Cancer Society Breast Cancer Advisory Group [published erratum appears in CA Cancer J Clin 2007;57:185].CACancerJClin2007;57:75&#x2013;89.(PreferredName:American Cancer Society SemanticType:[pros] PreferredName:Groups SemanticType:[idcn] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Appearance SemanticType:[qlco] PreferredName:Published Erratum SemanticType:[inpr] PreferredName:CLIN SemanticType:[inpr] PreferredName:Malignant Neoplasms SemanticType:[neop] POS:NNP POS:NNP POS:NNP POS:NN POS:NN POS:NNP POS:NNP POS:CD POS:VBN POS:NN POS:VBZ POS:IN POS:NNP POS:NNP POS:NNP POS:NNP POS:CD POS:: POS:CD POS:: POS:CD POS:NN POS:. POS:NN POS:CD POS:: POS:CD POS:: POS:CD POS:CD POS:CD POS:. 
[sentNum: 421]<Annotation Id="19189" Type="Sentence" StartNode="42744" EndNode="42754">(LevelIII) POS:NN POS:NN POS:CD 
[sentNum: 422]<Annotation Id="19190" Type="Sentence" StartNode="42759" EndNode="42762">26.	POS:CD POS:. 
[sentNum: 423]<Annotation Id="19191" Type="Sentence" StartNode="42766" EndNode="42872">Pisano ED, Gatsonis C, Hendrick E, Yaffe M, Baum JK,	 Acharyya S, et al. Diagnostic performance of digital PreferredName:M NOS ANTIBODY SemanticType:[aapp, imft] PreferredName:Endocrine System Findings Domain SemanticType:[idcn] PreferredName:Diagnostic SemanticType:[ftcn] PreferredName:SLC14A1 gene SemanticType:[gngm] PreferredName:Digital SemanticType:[qlco] PreferredName:performance - action SemanticType:[acty] POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NN POS:, POS:FW POS:FW POS:. POS:JJ POS:NN POS:IN POS:JJ 
[sentNum: 424]<Annotation Id="19192" Type="Sentence" StartNode="42879" EndNode="42932">versus film mammography for breast-cancer screen­ing. PreferredName:Screening for malignant neoplasm of breast SemanticType:[topp] PreferredName:Film Mammography SemanticType:[diap] POS:CC POS:NN POS:NN POS:IN POS:JJ POS:NN POS:. 
[sentNum: 425]<Annotation Id="19193" Type="Sentence" StartNode="42933" EndNode="43064">Digital Mammographic Imaging Screening Trial (DMIST) Investigators Group [published erratum appears in N Engl J Med 2006;355:1840]. PreferredName:Mammography SemanticType:[diap] PreferredName:digital imaging SemanticType:[mcha] PreferredName:Research Personnel SemanticType:[prog] PreferredName:Screening Study SemanticType:[resa] PreferredName:Published Erratum SemanticType:[inpr] PreferredName:User Group SemanticType:[popg] PreferredName:EXOG gene SemanticType:[gngm] PreferredName:Appearance SemanticType:[qlco] PreferredName:1840s SemanticType:[tmco] POS:NNP POS:NNP POS:NNP POS:NNP POS:NNP POS:CD POS:NNP POS:CD POS:NNS POS:NNP POS:CD POS:VBN POS:NN POS:VBZ POS:IN POS:NN POS:NNP POS:NNP POS:VBD POS:CD POS:: POS:CD POS:: POS:CD POS:CD POS:. 
[sentNum: 426]<Annotation Id="19194" Type="Sentence" StartNode="43065" EndNode="43097">N Engl J Med 2005;	 353:1773&#x2013;83. PreferredName:N+ (tumor staging) SemanticType:[inpr] PreferredName:EXOG gene SemanticType:[gngm] POS:NN POS:NNP POS:NNP POS:VBD POS:CD POS:: POS:CD POS:: POS:CD POS:CD POS:CD POS:. 
[sentNum: 427]<Annotation Id="19195" Type="Sentence" StartNode="43098" EndNode="43110">(Level II-3) PreferredName:Level 3 SemanticType:[inpr] POS:NN POS:NN POS:NN POS:CD POS:NN 
[sentNum: 428]<Annotation Id="19196" Type="Sentence" StartNode="43113" EndNode="43116">27.	POS:CD POS:. 
[sentNum: 429]<Annotation Id="19197" Type="Sentence" StartNode="43120" EndNode="43331">Skaane P, Hofvind S, Skjennald A. Randomized trial of screen-film versus full-field digital mammography with soft-copy reading in population-based screening program: follow-up and final results of Oslo II study. PreferredName:Screening - procedure intent SemanticType:[ftcn] PreferredName:Clinical Trials, Randomized SemanticType:[inpr, resa] PreferredName:Full field SemanticType:[spco] PreferredName:film (photographic) SemanticType:[mnob] PreferredName:Soft SemanticType:[qlco] PreferredName:Digital Mammography SemanticType:[diap] PreferredName:Reading (activity) SemanticType:[dora] PreferredName:Copy (object) SemanticType:[mnob] PreferredName:Base - General Qualifier SemanticType:[idcn] PreferredName:Population Programs SemanticType:[hlca] PreferredName:follow-up SemanticType:[hlca] PreferredName:Disease Screening SemanticType:[diap] PreferredName:research outcome SemanticType:[fndg] PreferredName:Diagnosis Type - Final SemanticType:[idcn] POS:NN POS:NN POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:. POS:NNP POS:NN POS:IN POS:NN POS:CC POS:JJ POS:JJ POS:NN POS:IN POS:JJ POS:NN POS:IN POS:JJ POS:NN POS:NN POS:: POS:NN POS:CC POS:JJ POS:NNS POS:IN POS:NNP POS:NNP POS:NN POS:. 
[sentNum: 430]<Annotation Id="19198" Type="Sentence" StartNode="43332" EndNode="43358">Radiology 2007;244:708&#x2013;17. PreferredName:Radiology studies SemanticType:[diap] POS:NNP POS:CD POS:: POS:CD POS:: POS:CD POS:CD POS:CD POS:. 
[sentNum: 431]<Annotation Id="19199" Type="Sentence" StartNode="43359" EndNode="43367">(LevelI) POS:NN POS:NN POS:CD 
[sentNum: 432]<Annotation Id="19200" Type="Sentence" StartNode="43372" EndNode="43375">28.	POS:CD POS:. 
[sentNum: 433]<Annotation Id="19201" Type="Sentence" StartNode="43379" EndNode="43456">VinnicombeS,PintoPereiraSM,McCormackVA,ShielS,	 Perry N, Dos Santos Silva IM. PreferredName:C19orf26 gene SemanticType:[gngm] PreferredName:Immune System Findings Domain SemanticType:[idcn] PreferredName:Silvan SemanticType:[orch] POS:NNP POS:, POS:NNP POS:, POS:NNP POS:, POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:NNP POS:NNP POS:. 
[sentNum: 434]<Annotation Id="19202" Type="Sentence" StartNode="43457" EndNode="43599">Full-field digital versus screen-film mammography: comparison within the UK breast screening program and systematic review of pub­lished data. PreferredName:Digital SemanticType:[qlco] PreferredName:Full field SemanticType:[spco] PreferredName:Film Mammography SemanticType:[diap] PreferredName:Screening - procedure intent SemanticType:[ftcn] PreferredName:Entire breast SemanticType:[bpoc] PreferredName:Comparison SemanticType:[acty] PreferredName:Program SemanticType:[phsu] PreferredName:Disease Screening SemanticType:[diap] PreferredName:Taverns SemanticType:[mnob] PreferredName:Review, Systematic SemanticType:[inpr] PreferredName:Data SemanticType:[idcn] POS:JJ POS:JJ POS:CC POS:JJ POS:NN POS:: POS:NN POS:IN POS:DT POS:NNP POS:NN POS:NN POS:NN POS:CC POS:JJ POS:NN POS:IN POS:JJ POS:NNS POS:. 
[sentNum: 435]<Annotation Id="19203" Type="Sentence" StartNode="43600" EndNode="43626">Radiology 2009;251:347&#x2013;58. PreferredName:Radiology studies SemanticType:[diap] POS:NNP POS:CD POS:: POS:CD POS:: POS:CD POS:CD POS:CD POS:. 
[sentNum: 436]<Annotation Id="19204" Type="Sentence" StartNode="43627" EndNode="43638">(Level III) PreferredName:Level III SemanticType:[inpr] POS:NN POS:NN POS:CD POS:NN 
[sentNum: 437]<Annotation Id="19205" Type="Sentence" StartNode="43643" EndNode="43646">29.	POS:CD POS:. 
[sentNum: 438]<Annotation Id="19206" Type="Sentence" StartNode="43650" EndNode="43879">Coates RJ, Uhler RJ, Brogan DJ, Gammon MD, Malone KE, Swanson CA, et al. Patterns and predictors of the breast cancer detection methods in women under age 45 yearsofage (United States).CCC cancer causes&amp;control 2001;12(5):431&#x2013;42. PreferredName:Djibouti SemanticType:[geoa] PreferredName:Kenya SemanticType:[geoa] PreferredName:Gammon SemanticType:[food] PreferredName:Predictor SemanticType:[idcn] PreferredName:Patterns SemanticType:[spco] PreferredName:Method of detection SemanticType:[inpr] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Age SemanticType:[orga] PreferredName:Woman SemanticType:[popg] PreferredName:Cancer Control SemanticType:[hlca] PreferredName:United States SemanticType:[geoa] PreferredName:Integer +5 SemanticType:[qnco] PreferredName:Etiology SemanticType:[ftcn] POS:NNP POS:NN POS:, POS:NNP POS:NN POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:FW POS:FW POS:. POS:NN POS:CC POS:NNS POS:IN POS:DT POS:NN POS:NN POS:NN POS:NNS POS:IN POS:NNS POS:IN POS:NN POS:CD POS:NN POS:CD POS:NNP POS:NNPS POS:NN POS:. POS:NN POS:NN POS:VBZ POS:CC POS:NN POS:CD POS:: POS:CD POS:CD POS:CD POS:NN POS:: POS:CD POS:CD POS:CD POS:. 
[sentNum: 439]<Annotation Id="19207" Type="Sentence" StartNode="43880" EndNode="43892">(Level II-2) PreferredName:Level 2 SemanticType:[inpr] POS:NN POS:NN POS:NN POS:CD POS:CD 
[sentNum: 440]<Annotation Id="19208" Type="Sentence" StartNode="43897" EndNode="43900">30.	POS:CD POS:. 
[sentNum: 441]<Annotation Id="19209" Type="Sentence" StartNode="43904" EndNode="44030">Newcomer L, Newcomb P, Trentham-Dietz A, Storer B, Yasui Y, Daling J, et al. Detection method and breast car­cinoma histology. PreferredName:newcomer SemanticType:[popg] PreferredName:Entire breast SemanticType:[bpoc] PreferredName:Method of detection SemanticType:[inpr] PreferredName:Histology SemanticType:[bmod] PreferredName:Automobiles SemanticType:[mnob] POS:NN POS:NN POS:, POS:NNP POS:NN POS:, POS:NNP POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NN POS:, POS:VBG POS:NN POS:, POS:FW POS:FW POS:. POS:NN POS:NN POS:CC POS:NN POS:NN POS:NN POS:. 
[sentNum: 442]<Annotation Id="19210" Type="Sentence" StartNode="44031" EndNode="44055">Cancer 2002;95(3):470&#x2013;7. PreferredName:&lt;3 (qualifier value) SemanticType:[qnco] PreferredName:Primary malignant neoplasm SemanticType:[neop] POS:NN POS:CD POS:: POS:CD POS:CD POS:CD POS:NN POS:: POS:CD POS:NN POS:CD POS:. 
[sentNum: 443]<Annotation Id="19211" Type="Sentence" StartNode="44056" EndNode="44068">(Level II-3) PreferredName:Level 3 SemanticType:[inpr] POS:NN POS:NN POS:NN POS:CD POS:NN 
[sentNum: 444]<Annotation Id="19212" Type="Sentence" StartNode="44073" EndNode="44076">31.	PreferredName:Arabic numeral 31 SemanticType:[inpr] POS:CD POS:. 
[sentNum: 445]<Annotation Id="19213" Type="Sentence" StartNode="44080" EndNode="44202">Auvinen A, Elovainio L, Hakama M. Breast self-exam­ination and survival from breast cancer: a prospective follow-up study. PreferredName:Breast Self-Examination SemanticType:[diap] PreferredName:M+ (tumor staging) SemanticType:[inpr] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Continuance of life SemanticType:[acty] PreferredName:Follow-Up Studies SemanticType:[resa] PreferredName:Longitudinal Studies SemanticType:[resa] POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NN POS:. POS:NN POS:NN POS:CC POS:NN POS:IN POS:NN POS:NN POS:: POS:DT POS:JJ POS:JJ POS:NN POS:. 
[sentNum: 446]<Annotation Id="19214" Type="Sentence" StartNode="44203" EndNode="44241">Breast Cancer Res Treat 1996;38:161&#x2013;8. PreferredName:Observation Result SemanticType:[fndg] PreferredName:Malignant neoplasm of breast SemanticType:[neop] PreferredName:Treatment intent SemanticType:[ftcn] POS:NN POS:NN POS:NNP POS:NNP POS:CD POS:: POS:CD POS:: POS:CD POS:CD POS:CD POS:. 
[sentNum: 447]<Annotation Id="19215" Type="Sentence" StartNode="44242" EndNode="44254">(Level II-2) PreferredName:Level 2 SemanticType:[inpr] POS:NN POS:NN POS:NN POS:CD POS:CD 
[sentNum: 448]<Annotation Id="19216" Type="Sentence" StartNode="44259" EndNode="44262">32.	POS:CD POS:. 
[sentNum: 449]<Annotation Id="19217" Type="Sentence" StartNode="44266" EndNode="44403">Thomas DB, Gao DL, Ray RM, Wang WW, Allison CJ,	 Chen FL, et al. Randomized trial of breast self-examina­tion in Shanghai: final results. PreferredName:Radiation SemanticType:[npop] PreferredName:Per Deciliter SemanticType:[qnco] PreferredName:EAR WAX, WET/DRY SemanticType:[dsyn] PreferredName:Rostromedial auditory cortex SemanticType:[blor] PreferredName:Clinical Trials, Randomized SemanticType:[inpr, resa] PreferredName:Chen SemanticType:[bird] PreferredName:Self SemanticType:[idcn] PreferredName:Entire breast SemanticType:[bpoc] PreferredName:Experimental Result SemanticType:[fndg] PreferredName:Diagnosis Type - Final SemanticType:[idcn] POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NN POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NN POS:, POS:FW POS:FW POS:. POS:VBN POS:NN POS:IN POS:NN POS:NN POS:IN POS:NNP POS:: POS:JJ POS:NNS POS:. 
[sentNum: 450]<Annotation Id="19218" Type="Sentence" StartNode="44404" EndNode="44441">J Natl Cancer Inst 2002;	 94:1445&#x2013;57. PreferredName:Primary malignant neoplasm SemanticType:[neop] POS:NNP POS:NNP POS:NNP POS:NNP POS:CD POS:: POS:CD POS:: POS:CD POS:CD POS:CD POS:. 
[sentNum: 451]<Annotation Id="19219" Type="Sentence" StartNode="44442" EndNode="44450">(LevelI) POS:NN POS:NN POS:CD 
[sentNum: 452]<Annotation Id="19220" Type="Sentence" StartNode="44455" EndNode="44458">33.	POS:CD POS:. 
[sentNum: 453]<Annotation Id="19221" Type="Sentence" StartNode="44462" EndNode="44486">Kosters JP, Gotzsche PC. PreferredName:PROC wt Allele SemanticType:[gngm] POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:. 
[sentNum: 454]<Annotation Id="19222" Type="Sentence" StartNode="44487" EndNode="44574">Regular self-examination or clinical examination for early detection of breast can­cer. PreferredName:Self-Examination SemanticType:[diap] PreferredName:Regular SemanticType:[qlco] PreferredName:Examination of breast SemanticType:[diap] PreferredName:Clinical SemanticType:[qlco] PreferredName:CER tumor staging notation SemanticType:[inpr] PreferredName:Early Diagnosis SemanticType:[diap] POS:JJ POS:NN POS:CC POS:JJ POS:NN POS:IN POS:JJ POS:NN POS:IN POS:NN POS:NN POS:. 
[sentNum: 455]<Annotation Id="19223" Type="Sentence" StartNode="44575" EndNode="44629">Cochrane Database of Systematic Reviews 2003, Issue 2. PreferredName:Review, Systematic SemanticType:[inpr] PreferredName:Databases SemanticType:[inpr] PreferredName:Problem SemanticType:[fndg] POS:NNP POS:NNP POS:IN POS:NNP POS:NNP POS:CD POS:, POS:NN POS:CD POS:. 
[sentNum: 456]<Annotation Id="19224" Type="Sentence" StartNode="44630" EndNode="44634">Art. PreferredName:Arts SemanticType:[ocdi] POS:NNP POS:. 
[sentNum: 457]<Annotation Id="19225" Type="Sentence" StartNode="44635" EndNode="44638">No.:POS:DT POS:. 
[sentNum: 458]<Annotation Id="19226" Type="Sentence" StartNode="44638" EndNode="44649">: CD003373. POS:: POS:NNP POS:CD POS:. 
[sentNum: 459]<Annotation Id="19227" Type="Sentence" StartNode="44650" EndNode="44672">DOI: 10.1002/14651858. PreferredName:Digital Object Identifier SemanticType:[clas] POS:NNP POS:: POS:CD POS:. POS:CD POS:: POS:CD POS:. 
[sentNum: 460]<Annotation Id="19228" Type="Sentence" StartNode="44673" EndNode="44682">CD003373. POS:NNP POS:CD POS:. 
[sentNum: 461]<Annotation Id="19229" Type="Sentence" StartNode="44683" EndNode="44698">(Meta-analysis) PreferredName:Meta Analysis (statistical procedure) SemanticType:[resa] POS:NN POS:NN POS:CD 
[sentNum: 462]<Annotation Id="19230" Type="Sentence" StartNode="44703" EndNode="44706">34.	POS:CD POS:. 
[sentNum: 463]<Annotation Id="19231" Type="Sentence" StartNode="44710" EndNode="44835">Baxter N. Preventive health care, 2001 update: should womenberoutinelytaughtbreastself-examinationtoscreen for breast cancer? PreferredName:Update SemanticType:[tmco] PreferredName:preventive health care SemanticType:[topp] PreferredName:Malignant neoplasm of breast SemanticType:[neop] POS:NNP POS:NNP POS:. POS:NNP POS:NN POS:NN POS:, POS:CD POS:VBP POS:: POS:MD POS:VB POS:IN POS:NN POS:NN POS:. 
[sentNum: 464]<Annotation Id="19232" Type="Sentence" StartNode="44836" EndNode="44902">Canadian Task Force on Preventive HealthCare.CMAJ2001;164:1837&#x2013;46.(PreferredName:CANADIAN SemanticType:[fndg] PreferredName:preventive health care SemanticType:[topp] PreferredName:Advisory Committees SemanticType:[gora] POS:JJ POS:NNP POS:NNP POS:IN POS:NNP POS:NNP POS:. POS:NNP POS:CD POS:: POS:CD POS:: POS:CD POS:CD POS:CD POS:. 
[sentNum: 465]<Annotation Id="19233" Type="Sentence" StartNode="44902" EndNode="44912">(LevelIII) POS:NN POS:NN POS:CD 
[sentNum: 466]<Annotation Id="19234" Type="Sentence" StartNode="44917" EndNode="44920">35.	POS:CD POS:. 
[sentNum: 467]<Annotation Id="19235" Type="Sentence" StartNode="44924" EndNode="44951">Bobo JK, Lee NC, Thames SF. PreferredName:North Carolina SemanticType:[geoa] PreferredName:SLC14A1 gene SemanticType:[gngm] POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:. 
[sentNum: 468]<Annotation Id="19236" Type="Sentence" StartNode="44952" EndNode="45100">Findings from 752,081 clinical breast examinations reported to a national screen­ing program from 1995 through 1998.JNatl Cancer Inst 2000;92:971&#x2013;6. PreferredName:Clinical Breast Examination SemanticType:[topp] PreferredName:Procedure findings:Finding:Point in time:^Patient:Narrative SemanticType:[clna] PreferredName:National citizen SemanticType:[inpr] PreferredName:Reporting SemanticType:[hlca] PreferredName:Program SemanticType:[phsu] PreferredName:Screening procedure SemanticType:[hlca] PreferredName:Primary malignant neoplasm SemanticType:[neop] PreferredName:From SemanticType:[qlco] PreferredName:2000s SemanticType:[tmco] POS:NNS POS:IN POS:CD POS:, POS:CD POS:JJ POS:NN POS:NNS POS:VBD POS:TO POS:DT POS:JJ POS:VBG POS:NN POS:IN POS:CD POS:IN POS:CD POS:. POS:NN POS:NN POS:JJ POS:CD POS:: POS:CD POS:: POS:CD POS:CD POS:CD POS:. 
[sentNum: 469]<Annotation Id="19237" Type="Sentence" StartNode="45101" EndNode="45113">(Level II-3) PreferredName:Level 3 SemanticType:[inpr] POS:NN POS:NN POS:NN POS:CD POS:NN 
[sentNum: 470]<Annotation Id="19238" Type="Sentence" StartNode="45118" EndNode="45121">36.	POS:CD POS:. 
[sentNum: 471]<Annotation Id="19239" Type="Sentence" StartNode="45125" EndNode="45270">Shen Y, Zelen M. Screening sensitivity and sojourn time from breast cancer early detection clinical trials: mammograms and physical examinations. PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:M NOS ANTIBODY SemanticType:[aapp, imft] PreferredName:Sojourn SemanticType:[orch, phsu] PreferredName:Statistical sensitivity SemanticType:[qnco] PreferredName:Screening for malignant neoplasm of breast SemanticType:[topp] PreferredName:Time SemanticType:[tmco] PreferredName:Mammography SemanticType:[diap] PreferredName:Clinical Trial [Publication Type] SemanticType:[inpr] PreferredName:Physical Examination SemanticType:[hlca] POS:VBN POS:NN POS:, POS:NNP POS:NN POS:. POS:NN POS:NN POS:CC POS:NN POS:NN POS:IN POS:NN POS:NN POS:JJ POS:NN POS:JJ POS:NNS POS:: POS:NNS POS:CC POS:JJ POS:NNS POS:. 
[sentNum: 472]<Annotation Id="19240" Type="Sentence" StartNode="45271" EndNode="45299">J Clin Oncol 2001;19:3490&#x2013;9. PreferredName:CLIN SemanticType:[inpr] POS:NNP POS:NNP POS:NNP POS:CD POS:: POS:CD POS:: POS:CD POS:CD POS:CD POS:. 
[sentNum: 473]<Annotation Id="19241" Type="Sentence" StartNode="45300" EndNode="45311">(Level III) PreferredName:Level III SemanticType:[inpr] POS:NN POS:NN POS:CD POS:NN 
[sentNum: 474]<Annotation Id="19242" Type="Sentence" StartNode="45316" EndNode="45319">37.	POS:CD POS:. 
[sentNum: 475]<Annotation Id="19243" Type="Sentence" StartNode="45323" EndNode="45356">Jatoi I. Breast cancer screening. PreferredName:Iodides SemanticType:[inch] PreferredName:Screening for malignant neoplasm of breast SemanticType:[topp] POS:NNP POS:PRP POS:. POS:NN POS:NN POS:NN POS:. 
[sentNum: 476]<Annotation Id="19244" Type="Sentence" StartNode="45357" EndNode="45385">Am J Surg 1999;177:	 518&#x2013;24. PreferredName:Surg SemanticType:[tmco] POS:VBP POS:NN POS:NN POS:CD POS:: POS:CD POS:: POS:CD POS:CD POS:CD POS:. 
[sentNum: 477]<Annotation Id="19245" Type="Sentence" StartNode="45386" EndNode="45397">(Level III) PreferredName:Level III SemanticType:[inpr] POS:NN POS:NN POS:CD POS:NN 
[sentNum: 478]<Annotation Id="19246" Type="Sentence" StartNode="45402" EndNode="45405">38.	POS:CD POS:. 
[sentNum: 479]<Annotation Id="19247" Type="Sentence" StartNode="45409" EndNode="45485">Primic-Zakelj M. Screening mammography for early detection of breast cancer. PreferredName:M+ (tumor staging) SemanticType:[inpr] PreferredName:Screening for malignant neoplasm of breast SemanticType:[topp] PreferredName:Screening mammography SemanticType:[topp] POS:JJ POS:NN POS:NN POS:. POS:VBG POS:NN POS:IN POS:JJ POS:NN POS:IN POS:NN POS:NN POS:. 
[sentNum: 480]<Annotation Id="19248" Type="Sentence" StartNode="45486" EndNode="45519">Ann Oncol 1999;10(suppl 6):121&#x2013;7. POS:NNP POS:NNP POS:CD POS:: POS:CD POS:CD POS:NN POS:CD POS:NN POS:: POS:CD POS:NN POS:CD POS:. 
[sentNum: 481]<Annotation Id="19249" Type="Sentence" StartNode="45520" EndNode="45531">(Level III) PreferredName:Level III SemanticType:[inpr] POS:NN POS:NN POS:CD POS:NN 
[sentNum: 482]<Annotation Id="19250" Type="Sentence" StartNode="45536" EndNode="45539">39.	POS:CD POS:. 
[sentNum: 483]<Annotation Id="19251" Type="Sentence" StartNode="45543" EndNode="45665">Fletcher SW, Black W, Harris R, Rimer BK, Shapiro S.	 Report of the International Workshop on Screening for Breast Cancer. PreferredName:fletchers' SemanticType:[phsu] PreferredName:African race SemanticType:[popg] PreferredName:BLOOD GROUP--SWANN SYSTEM SemanticType:[bdsy] PreferredName:KNG1 gene SemanticType:[gngm] PreferredName:Right SemanticType:[spco] PreferredName:International SemanticType:[idcn] PreferredName:Report (document) SemanticType:[inpr] PreferredName:On (qualifier value) SemanticType:[inpr] PreferredName:Educational workshop SemanticType:[edac] PreferredName:Screening for malignant neoplasm of breast SemanticType:[topp] POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NN POS:. POS:NNP POS:IN POS:DT POS:NNP POS:NNP POS:IN POS:NNP POS:IN POS:NN POS:NN POS:. 
[sentNum: 484]<Annotation Id="19252" Type="Sentence" StartNode="45666" EndNode="45701">J Natl Cancer Inst 1993;85:1644&#x2013;56. PreferredName:Primary malignant neoplasm SemanticType:[neop] POS:NNP POS:NNP POS:NNP POS:NNP POS:CD POS:: POS:CD POS:: POS:CD POS:CD POS:CD POS:. 
[sentNum: 485]<Annotation Id="19253" Type="Sentence" StartNode="45702" EndNode="45713">(Level III) PreferredName:Level III SemanticType:[inpr] POS:NN POS:NN POS:CD POS:NN 
[sentNum: 486]<Annotation Id="19254" Type="Sentence" StartNode="45718" EndNode="45721">40.	PreferredName:/40 SemanticType:[tmco] POS:CD POS:. 
[sentNum: 487]<Annotation Id="19255" Type="Sentence" StartNode="45725" EndNode="45833">Miller AB, To T, Baines CJ, Wall C. Canadian national breast screening study-2: 13-year results of a random-PreferredName:T prime SemanticType:[clna] PreferredName:Miller SemanticType:[prog] PreferredName:CANADIAN SemanticType:[fndg] PreferredName:Walls of a building SemanticType:[mnob] PreferredName:Entire breast SemanticType:[bpoc] PreferredName:National citizen SemanticType:[inpr] PreferredName:per year SemanticType:[tmco] PreferredName:Screening Study SemanticType:[resa] PreferredName:Randomization SemanticType:[resa] PreferredName:Experimental Result SemanticType:[fndg] POS:NNP POS:NNP POS:, POS:TO POS:NN POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:. POS:NNP POS:JJ POS:NN POS:NN POS:NN POS:CD POS:: POS:CD POS:: POS:NN POS:NNS POS:IN POS:DT POS:JJ 
[sentNum: 488]<Annotation Id="19256" Type="Sentence" StartNode="45841" EndNode="45911">ized trial in women aged 50&#x2013;59 years.JNatl Cancer Inst 2000;92:1490&#x2013;9. PreferredName:Woman SemanticType:[popg] PreferredName:Clinical Trials SemanticType:[resa] PreferredName:year SemanticType:[tmco] PreferredName:Elderly (population group) SemanticType:[popg] PreferredName:2000s SemanticType:[tmco] PreferredName:Primary malignant neoplasm SemanticType:[neop] POS:VBN POS:NN POS:IN POS:NNS POS:JJ POS:CD POS:CD POS:CD POS:NNS POS:. POS:NN POS:NN POS:JJ POS:CD POS:: POS:CD POS:: POS:CD POS:CD POS:CD POS:. 
[sentNum: 489]<Annotation Id="19257" Type="Sentence" StartNode="45912" EndNode="45920">(LevelI) POS:NN POS:NN POS:CD 
[sentNum: 490]<Annotation Id="19258" Type="Sentence" StartNode="45923" EndNode="45926">41.	POS:CD POS:. 
[sentNum: 491]<Annotation Id="19259" Type="Sentence" StartNode="45930" EndNode="46106">ChiarelliAM,MajpruzV,BrownP,TheriaultM,ShumakR,	 Mai V. The contribution of clinical breast examination to the accuracyof breast screening.JNatl Cancer Inst 2009;	 101:1236&#x2013;43. PreferredName:Contribution SemanticType:[acty] PreferredName:Mycobacterium avium Complex SemanticType:[bact] PreferredName:Examination of breast SemanticType:[diap] PreferredName:Clinical SemanticType:[qlco] PreferredName:Screening for malignant neoplasm of breast SemanticType:[topp] POS:NNP POS:, POS:NN POS:, POS:NN POS:, POS:NN POS:, POS:NN POS:, POS:NNP POS:NNP POS:. POS:DT POS:NN POS:IN POS:JJ POS:NN POS:NN POS:TO POS:DT POS:JJ POS:NN POS:NN POS:. POS:NN POS:NN POS:JJ POS:CD POS:: POS:CD POS:: POS:CD POS:CD POS:CD POS:. 
[sentNum: 492]<Annotation Id="19260" Type="Sentence" StartNode="46107" EndNode="46119">(Level II-2) PreferredName:Level 2 SemanticType:[inpr] POS:NN POS:NN POS:NN POS:CD POS:CD 
[sentNum: 493]<Annotation Id="19261" Type="Sentence" StartNode="46124" EndNode="46127">42.	POS:CD POS:. 
[sentNum: 494]<Annotation Id="19262" Type="Sentence" StartNode="46131" EndNode="46586">SmithRA,SaslowD,SawyerKA,BurkeW,CostanzaME, EvansWP3rd, etal.AmericanCancerSocietyguidelines forbreastcancerscreening:update2003.AmericanCancer SocietyHigh-RiskWorkGroup;AmericanCancerSociety Screening Older Women Work Group; American Cancer Society Mammography Work Group; American Cancer Society Physical Examination Work Group; American CancerSocietyNewTechnologiesWorkGroup;American CancerSocietyBreastCancerAdvisoryGroup.CACancer JClin2003;53:141&#x2013;69.(PreferredName:Older Population SemanticType:[popg] PreferredName:Aspects of disease screening SemanticType:[ftcn] PreferredName:American Cancer Society SemanticType:[pros] PreferredName:Women, Working SemanticType:[popg] PreferredName:Work SemanticType:[ocac] PreferredName:Mammography SemanticType:[diap] PreferredName:American Cancer Society SemanticType:[pros] PreferredName:User Group SemanticType:[popg] PreferredName:Work SemanticType:[ocac] PreferredName:Physical Examination SemanticType:[hlca] PreferredName:American SemanticType:[popg] PreferredName:User Group SemanticType:[popg] PreferredName:Arabic numeral 69 SemanticType:[inpr] PreferredName:American SemanticType:[popg] POS:NN POS:, POS:NN POS:, POS:NN POS:, POS:NN POS:, POS:NN POS:, POS:NN POS:NN POS:, POS:NN POS:. POS:NNS POS:VBG POS:: POS:VB POS:CD POS:. POS:NN POS:NN POS:: POS:NNP POS:NNP POS:NNP POS:NNP POS:NNP POS:NNP POS:: POS:NNP POS:NNP POS:NNP POS:NN POS:NNP POS:NNP POS:: POS:NNP POS:NNP POS:NNP POS:NNP POS:NNP POS:NNP POS:NNP POS:: POS:NNP POS:NNP POS:: POS:NNP POS:NNP POS:. POS:NN POS:NN POS:CD POS:: POS:CD POS:: POS:CD POS:CD POS:CD POS:. 
[sentNum: 495]<Annotation Id="19263" Type="Sentence" StartNode="46586" EndNode="46596">(LevelIII) POS:NN POS:NN POS:CD 
[sentNum: 496]<Annotation Id="19264" Type="Sentence" StartNode="46601" EndNode="46604">43.	POS:CD POS:. 
[sentNum: 497]<Annotation Id="19265" Type="Sentence" StartNode="46608" EndNode="46646">National Comprehensive Cancer Network. PreferredName:National Comprehensive Cancer Network SemanticType:[hcro] POS:NNP POS:NNP POS:NNP POS:NNP POS:. 
[sentNum: 498]<Annotation Id="19266" Type="Sentence" StartNode="46647" EndNode="46711">NCCN Clinical Practice Guidelines in OncologyTM: breast can­cer. PreferredName:National Comprehensive Cancer Network SemanticType:[hcro] PreferredName:Entire breast SemanticType:[bpoc] PreferredName:Clinical Practice Guideline SemanticType:[inpr] PreferredName:CER tumor staging notation SemanticType:[inpr] POS:NNP POS:JJ POS:NNP POS:NNS POS:IN POS:NN POS:: POS:NN POS:NN POS:. 
[sentNum: 499]<Annotation Id="19267" Type="Sentence" StartNode="46712" EndNode="46745">Fort Washington (PA): NCCN; 2011. PreferredName:Washington state SemanticType:[geoa] PreferredName:National Comprehensive Cancer Network SemanticType:[hcro] PreferredName:Pairing Events Domain SemanticType:[idcn] POS:NNP POS:NNP POS:CD POS:NN POS:CD POS:: POS:NN POS:: POS:CD POS:. 
[sentNum: 500]<Annotation Id="19268" Type="Sentence" StartNode="46746" EndNode="46757">(Level III) PreferredName:Level III SemanticType:[inpr] POS:NN POS:NN POS:CD POS:NN 
[sentNum: 501]<Annotation Id="19269" Type="Sentence" StartNode="46762" EndNode="46765">44.	POS:CD POS:. 
[sentNum: 502]<Annotation Id="19270" Type="Sentence" StartNode="46769" EndNode="46832">Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW. PreferredName:POLK gene SemanticType:[gngm] PreferredName:BLOOD GROUP--SWANN SYSTEM SemanticType:[bdsy] PreferredName:fletchers' SemanticType:[phsu] POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NN POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:. 
[sentNum: 503]<Annotation Id="19271" Type="Sentence" StartNode="46833" EndNode="46947">Ten-year risk of false positive screening mammograms and clinical breast examinations.NEnglJ Med 1998;338:1089&#x2013;96. PreferredName:per year SemanticType:[tmco] PreferredName:Toxic Epidermal Necrolysis SemanticType:[dsyn] PreferredName:False Positive SemanticType:[lbtr] PreferredName:Risk SemanticType:[qlco] PreferredName:Clinical Breast Examination SemanticType:[topp] PreferredName:Screening mammography SemanticType:[topp] POS:JJ POS:NN POS:IN POS:JJ POS:JJ POS:NN POS:NNS POS:CC POS:JJ POS:NN POS:NNS POS:. POS:NN POS:VBD POS:CD POS:: POS:CD POS:: POS:CD POS:CD POS:CD POS:. 
[sentNum: 504]<Annotation Id="19272" Type="Sentence" StartNode="46948" EndNode="46960">(Level II-3) PreferredName:Level 3 SemanticType:[inpr] POS:NN POS:NN POS:NN POS:CD POS:NN 
[sentNum: 505]<Annotation Id="19273" Type="Sentence" StartNode="46965" EndNode="46968">45.	POS:CD POS:. 
[sentNum: 506]<Annotation Id="19274" Type="Sentence" StartNode="46972" EndNode="47028">Armstrong K, Moye E, Williams S, Berlin JA, Reynolds EE. PreferredName:Potassium Ion SemanticType:[elii, phsu] PreferredName:City of Berlin SemanticType:[geoa] POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NN POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:. 
[sentNum: 507]<Annotation Id="19275" Type="Sentence" StartNode="47029" EndNode="47142">Screening mammography in women 40 to 49 years of age: a systematic review for the American College of Physicians. PreferredName:Screening mammography SemanticType:[topp] PreferredName:/40 SemanticType:[tmco] PreferredName:Woman SemanticType:[popg] PreferredName:Age-Years SemanticType:[tmco] PreferredName:To SemanticType:[qlco] PreferredName:American College of Physicians SemanticType:[prog] PreferredName:Review, Systematic SemanticType:[inpr] POS:VBG POS:NN POS:IN POS:NNS POS:CD POS:TO POS:CD POS:NNS POS:IN POS:NN POS:: POS:DT POS:JJ POS:NN POS:IN POS:DT POS:NNP POS:NNP POS:IN POS:NNP POS:. 
[sentNum: 508]<Annotation Id="19276" Type="Sentence" StartNode="47143" EndNode="47174">Ann Intern Med 2007;146:516&#x2013;26. PreferredName:Intern SemanticType:[prog] POS:NNP POS:NNP POS:NNP POS:CD POS:: POS:CD POS:: POS:CD POS:CD POS:CD POS:. 
[sentNum: 509]<Annotation Id="19277" Type="Sentence" StartNode="47175" EndNode="47186">(Level III) PreferredName:Level III SemanticType:[inpr] POS:NN POS:NN POS:CD POS:NN 
[sentNum: 510]<Annotation Id="19278" Type="Sentence" StartNode="47191" EndNode="47194">46.	POS:CD POS:. 
[sentNum: 511]<Annotation Id="19279" Type="Sentence" StartNode="47198" EndNode="47276">Harris R. Variation of benefits and harms of breast cancer screening with age. PreferredName:Variant SemanticType:[qlco] PreferredName:Right SemanticType:[spco] PreferredName:Screening for malignant neoplasm of breast SemanticType:[topp] PreferredName:Benefits SemanticType:[qnco] PreferredName:Age SemanticType:[orga] POS:NNP POS:NNP POS:. POS:NN POS:IN POS:NNS POS:CC POS:NNS POS:IN POS:NN POS:NN POS:NN POS:IN POS:NN POS:. 
[sentNum: 512]<Annotation Id="19280" Type="Sentence" StartNode="47277" EndNode="47320">J Natl Cancer Inst Monogr 1997;(22):139&#x2013;43. PreferredName:Primary malignant neoplasm SemanticType:[neop] POS:NNP POS:NNP POS:NNP POS:NNP POS:NNP POS:CD POS:: POS:CD POS:CD POS:NN POS:: POS:CD POS:CD POS:CD POS:. 
[sentNum: 513]<Annotation Id="19281" Type="Sentence" StartNode="47321" EndNode="47332">(Level III) PreferredName:Level III SemanticType:[inpr] POS:NN POS:NN POS:CD POS:NN 
[sentNum: 514]<Annotation Id="19282" Type="Sentence" StartNode="47337" EndNode="47340">47.	POS:CD POS:. 
[sentNum: 515]<Annotation Id="19283" Type="Sentence" StartNode="47344" EndNode="47364">Rimer BK, Bluman LG. PreferredName:KNG1 gene SemanticType:[gngm] POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:. 
[sentNum: 516]<Annotation Id="19284" Type="Sentence" StartNode="47365" EndNode="47411">The psychosocial conse­quences of mammography. PreferredName:Mammography SemanticType:[diap] PreferredName:Psychosocial SemanticType:[ftcn] POS:DT POS:JJ POS:NNS POS:IN POS:NN POS:. 
[sentNum: 517]<Annotation Id="19285" Type="Sentence" StartNode="47412" EndNode="47454">J Natl Cancer Inst Monogr 1997;(22):131&#x2013;8. PreferredName:Primary malignant neoplasm SemanticType:[neop] POS:NNP POS:NNP POS:NNP POS:NNP POS:NNP POS:CD POS:: POS:CD POS:CD POS:NN POS:: POS:CD POS:CD POS:CD POS:. 
[sentNum: 518]<Annotation Id="19286" Type="Sentence" StartNode="47455" EndNode="47466">(Level III) PreferredName:Level III SemanticType:[inpr] POS:NN POS:NN POS:CD POS:NN 
[sentNum: 519]<Annotation Id="19287" Type="Sentence" StartNode="47471" EndNode="47474">48.	POS:CD POS:. 
[sentNum: 520]<Annotation Id="19288" Type="Sentence" StartNode="47478" EndNode="47539">Lerman C, Trock B, Rimer BK, Boyce A, Jepson C,	 Engstrom PF. PreferredName:KNG1 gene SemanticType:[gngm] POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NNP POS:. 
[sentNum: 521]<Annotation Id="19289" Type="Sentence" StartNode="47540" EndNode="47606">Psychological and behavioral implica­tions of abnormal mammograms. PreferredName:Psychiatric problem SemanticType:[mobd] PreferredName:Mammography abnormal SemanticType:[fndg] PreferredName:Behavior SemanticType:[inbe] POS:JJ POS:CC POS:JJ POS:NNS POS:IN POS:JJ POS:NNS POS:. 
[sentNum: 522]<Annotation Id="19290" Type="Sentence" StartNode="47607" EndNode="47640">Ann Intern Med 1991;	 114:657&#x2013;61. PreferredName:Intern SemanticType:[prog] POS:NNP POS:NNP POS:NNP POS:CD POS:: POS:CD POS:: POS:CD POS:CD POS:CD POS:. 
[sentNum: 523]<Annotation Id="19291" Type="Sentence" StartNode="47641" EndNode="47652">(Level III) PreferredName:Level III SemanticType:[inpr] POS:NN POS:NN POS:CD POS:NN 
[sentNum: 524]<Annotation Id="19292" Type="Sentence" StartNode="47657" EndNode="47660">49.	POS:CD POS:. 
[sentNum: 525]<Annotation Id="19293" Type="Sentence" StartNode="47664" EndNode="47710">BrettJ,BankheadC,HendersonB,WatsonE,AustokerJ.	POS:NNP POS:, POS:NNP POS:, POS:NN POS:, POS:NN POS:, POS:NN POS:. 
[sentNum: 526]<Annotation Id="19294" Type="Sentence" StartNode="47712" EndNode="47763">The psychological impact of mammographic screening. PreferredName:Screening mammography SemanticType:[topp] PreferredName:Psychological Impact SemanticType:[clna] POS:DT POS:JJ POS:NN POS:IN POS:JJ POS:NN POS:. 
[sentNum: 527]<Annotation Id="19295" Type="Sentence" StartNode="47764" EndNode="47784">A systematic review. PreferredName:Review, Systematic SemanticType:[inpr] POS:DT POS:JJ POS:NN POS:. 
[sentNum: 528]<Annotation Id="19296" Type="Sentence" StartNode="47785" EndNode="47815">Psychooncology 2005;14:917&#x2013;38. POS:JJ POS:CD POS:: POS:CD POS:: POS:CD POS:CD POS:CD POS:. 
[sentNum: 529]<Annotation Id="19297" Type="Sentence" StartNode="47816" EndNode="47827">(Level III) PreferredName:Level III SemanticType:[inpr] POS:NN POS:NN POS:CD POS:NN 
[sentNum: 530]<Annotation Id="19298" Type="Sentence" StartNode="47832" EndNode="47835">50.	POS:CD POS:. 
[sentNum: 531]<Annotation Id="19299" Type="Sentence" StartNode="47839" EndNode="47868">Brewer NT, Salz T, Lillie SE. PreferredName:Nuchal Translucency Screen SemanticType:[diap] PreferredName:Brewer SemanticType:[prog] POS:NNP POS:NNP POS:, POS:NNP POS:NN POS:, POS:NNP POS:NN POS:. 
[sentNum: 532]<Annotation Id="19300" Type="Sentence" StartNode="47869" EndNode="47939">Systematic review: the long-term effects of false-positive mammograms. PreferredName:Longterm Effects SemanticType:[phpr] PreferredName:Review, Systematic SemanticType:[inpr] PreferredName:Mammography SemanticType:[diap] PreferredName:False Positive SemanticType:[lbtr] POS:JJ POS:NN POS:: POS:DT POS:JJ POS:NNS POS:IN POS:JJ POS:NNS POS:. 
[sentNum: 533]<Annotation Id="19301" Type="Sentence" StartNode="47940" EndNode="47943">Ann POS:NNP 
[sentNum: 534]<Annotation Id="19302" Type="Sentence" StartNode="47948" EndNode="47975">Intern Med 2007;146:502&#x2013;10. PreferredName:Intern SemanticType:[prog] POS:NNP POS:NNP POS:CD POS:: POS:CD POS:: POS:CD POS:CD POS:CD POS:. 
[sentNum: 535]<Annotation Id="19303" Type="Sentence" StartNode="47976" EndNode="47991">(Meta-analysis) PreferredName:Meta Analysis (statistical procedure) SemanticType:[resa] POS:NN POS:NN POS:CD 
[sentNum: 536]<Annotation Id="19304" Type="Sentence" StartNode="47996" EndNode="47999">51.	POS:CD POS:. 
[sentNum: 537]<Annotation Id="19305" Type="Sentence" StartNode="48003" EndNode="48049">SchwartzLM,WoloshinS,SoxHC,FischhoffB,WelchHG.	POS:NNP POS:, POS:NNP POS:, POS:NNP POS:, POS:NNP POS:, POS:NNP POS:. 
[sentNum: 538]<Annotation Id="19306" Type="Sentence" StartNode="48051" EndNode="48176">US women&#x2019;s attitudes to false positive mammography results and detection of ductal carcinoma in situ: cross sectional survey. PreferredName:Attitude SemanticType:[menp] PreferredName:Woman SemanticType:[popg] PreferredName:Mammography SemanticType:[diap] PreferredName:False Positive SemanticType:[lbtr] PreferredName:Noninfiltrating Intraductal Carcinoma SemanticType:[neop] PreferredName:Detection SemanticType:[topp] PreferredName:Cross-Sectional Studies SemanticType:[resa] POS:NNP POS:NNS POS:VBP POS:NNS POS:NNS POS:TO POS:JJ POS:JJ POS:NN POS:NNS POS:CC POS:NN POS:IN POS:JJ POS:NN POS:FW POS:FW POS:: POS:VB POS:JJ POS:NN POS:. 
[sentNum: 539]<Annotation Id="19307" Type="Sentence" StartNode="48177" EndNode="48198">BMJ 2000;320:1635&#x2013;40. PreferredName:2000s SemanticType:[tmco] PreferredName:/40 SemanticType:[tmco] POS:NNP POS:CD POS:: POS:CD POS:: POS:CD POS:CD POS:CD POS:. 
[sentNum: 540]<Annotation Id="19308" Type="Sentence" StartNode="48199" EndNode="48210">(Level III) PreferredName:Level III SemanticType:[inpr] POS:NN POS:NN POS:CD POS:NN 
[sentNum: 541]<Annotation Id="19309" Type="Sentence" StartNode="48215" EndNode="48218">52.	POS:CD POS:. 
[sentNum: 542]<Annotation Id="19310" Type="Sentence" StartNode="48222" EndNode="48259">Overmoyer B. Breast cancer screening. PreferredName:Screening for malignant neoplasm of breast SemanticType:[topp] POS:NN POS:NN POS:. POS:NN POS:NN POS:NN POS:. 
[sentNum: 543]<Annotation Id="19311" Type="Sentence" StartNode="48260" EndNode="48301">Med Clin North Am 1999;83:1443&#x2013;66;vi&#x2013;vii. PreferredName:CLIN SemanticType:[inpr] PreferredName:Roman numeral VII SemanticType:[inpr] PreferredName:North SemanticType:[spco] POS:VBD POS:NNP POS:NNP POS:VBP POS:CD POS:: POS:CD POS:: POS:CD POS:CD POS:CD POS:: POS:NNS POS:. 
[sentNum: 544]<Annotation Id="19312" Type="Sentence" StartNode="48302" EndNode="48313">(Level III) PreferredName:Level III SemanticType:[inpr] POS:NN POS:NN POS:CD POS:NN 
[sentNum: 545]<Annotation Id="19313" Type="Sentence" StartNode="48318" EndNode="48321">53.	POS:CD POS:. 
[sentNum: 546]<Annotation Id="19314" Type="Sentence" StartNode="48325" EndNode="48368">Agency for Healthcare Research and Quality. PreferredName:United States Agency for Healthcare Research and Quality SemanticType:[hcro] POS:NNP POS:IN POS:NNP POS:NNP POS:CC POS:NNP POS:. 
[sentNum: 547]<Annotation Id="19315" Type="Sentence" StartNode="48369" EndNode="48463">Diagnosis andmanagementofspecificbreastabnormalities.Evidence Report/Technology Assessment 33. PreferredName:Evidence of SemanticType:[ftcn] PreferredName:Diagnosis Study SemanticType:[resa] PreferredName:Technology SemanticType:[ocdi] PreferredName:Evaluation Report SemanticType:[inpr, resa] POS:NN POS:NNS POS:. POS:NN POS:NNP POS:: POS:NNP POS:NNP POS:CD POS:. 
[sentNum: 548]<Annotation Id="19316" Type="Sentence" StartNode="48464" EndNode="48509">Rockville (MD): AHRQ;2001.AHRQpublication no.01PreferredName:United States Agency for Healthcare Research and Quality SemanticType:[hcro] POS:NNP POS:CD POS:NN POS:CD POS:: POS:NNP POS:: POS:CD POS:. POS:NN POS:DT POS:. 
[sentNum: 549]<Annotation Id="19317" Type="Sentence" StartNode="48509" EndNode="48517">01-E046.(POS:SYM POS:: POS:NN POS:CD POS:. 
[sentNum: 550]<Annotation Id="19318" Type="Sentence" StartNode="48517" EndNode="48527">(LevelIII) POS:NN POS:NN POS:CD 
[sentNum: 551]<Annotation Id="19319" Type="Sentence" StartNode="48532" EndNode="48535">54.	POS:CD POS:. 
[sentNum: 552]<Annotation Id="19320" Type="Sentence" StartNode="48539" EndNode="48730">Kerlikowske K, Salzmann P, Phillips KA, Cauley JA, Cummings SR. Continuing screening mammography in women aged70to79years:impact onlife expectancy and cost-effectiveness.JAMA1999;282:2156&#x2013;63.(PreferredName:Potassium Ion SemanticType:[elii, phsu] PreferredName:Screening mammography SemanticType:[topp] PreferredName:Continuous SemanticType:[idcn] PreferredName:IMPACT gene SemanticType:[gngm] PreferredName:Woman SemanticType:[popg] PreferredName:Cost Effectiveness SemanticType:[qnco] PreferredName:Expectation SemanticType:[idcn] POS:NNP POS:NNP POS:, POS:NNP POS:NN POS:, POS:NNP POS:NN POS:, POS:NNP POS:NNP POS:, POS:NNP POS:NN POS:. POS:VBG POS:JJ POS:NN POS:IN POS:NNS POS:JJ POS:CD POS:TO POS:CD POS:NNS POS:: POS:NN POS:JJ POS:NN POS:CC POS:NN POS:. POS:NN POS:CD POS:: POS:CD POS:: POS:CD POS:CD POS:CD POS:. 
[sentNum: 553]<Annotation Id="19321" Type="Sentence" StartNode="48730" EndNode="48740">(LevelIII) POS:NN POS:NN POS:CD 
[sentNum: 554]<Annotation Id="19322" Type="Sentence" StartNode="48747" EndNode="49004">The MEDLINE database, the Cochrane Library, and the American College of Obstetricians and Gynecologists&#x2019; own internal resources and documents were used to con­duct a literature search to locate relevant articles published between January 1990&#x2013;February 2011. PreferredName:Databases SemanticType:[inpr] PreferredName:MEDLINE SemanticType:[inpr] PreferredName:American College of Obstetricians and Gynecologists SemanticType:[pros] PreferredName:Libraries SemanticType:[mnob, orgt] PreferredName:Resources SemanticType:[idcn] PreferredName:Internal - CodeSystemType SemanticType:[inpr] PreferredName:Used by SemanticType:[fndg] PreferredName:Documents SemanticType:[inpr] PreferredName:Publications SemanticType:[inpr, mnob] PreferredName:Entire duct SemanticType:[bpoc] PreferredName:To SemanticType:[qlco] PreferredName:Search - action SemanticType:[acty] PreferredName:Article SemanticType:[inpr] PreferredName:Relevance SemanticType:[qlco] PreferredName:1990s SemanticType:[tmco] PreferredName:Scientific Publication SemanticType:[inpr] POS:DT POS:NN POS:NN POS:, POS:DT POS:NNP POS:NNP POS:, POS:CC POS:DT POS:NNP POS:NNP POS:IN POS:NNPS POS:CC POS:NNPS POS:CD POS:JJ POS:JJ POS:NNS POS:CC POS:NNS POS:VBD POS:VBN POS:TO POS:VB POS:DT POS:NN POS:NN POS:TO POS:VB POS:JJ POS:NNS POS:VBN POS:IN POS:NNP POS:CD POS:CD POS:NNP POS:CD POS:. 
[sentNum: 555]<Annotation Id="19323" Type="Sentence" StartNode="49005" EndNode="49077">The search was restricted to articles published in the English language. PreferredName:Restricted SemanticType:[ftcn] PreferredName:Search - action SemanticType:[acty] PreferredName:Scientific Publication SemanticType:[inpr] PreferredName:Article SemanticType:[inpr] PreferredName:English Language SemanticType:[lang] POS:DT POS:NN POS:VBD POS:JJ POS:TO POS:NNS POS:VBN POS:IN POS:DT POS:NNP POS:NN POS:. 
[sentNum: 556]<Annotation Id="19324" Type="Sentence" StartNode="49078" EndNode="49342">Priority was given to articles reporting results of original research, although review articles and commentaries also were consulted.Abstracts of researchpresented at sympo­sia and scientific conferences were not considered adequate for inclusion in this document. PreferredName:Priority SemanticType:[tmco] PreferredName:Article SemanticType:[inpr] PreferredName:Entity Name Part Type - given SemanticType:[idcn] PreferredName:Original SemanticType:[idcn] PreferredName:Reporting SemanticType:[hlca] PreferredName:Review [Publication Type] SemanticType:[inpr] PreferredName:research outcome SemanticType:[fndg] PreferredName:Published Comment SemanticType:[inpr] PreferredName:Article SemanticType:[inpr] PreferredName:Abstract Summary SemanticType:[inpr] PreferredName:Consultation SemanticType:[hlca] PreferredName:Science SemanticType:[ocdi] PreferredName:Sia SemanticType:[euka] PreferredName:Negation SemanticType:[ftcn] PreferredName:Conferences SemanticType:[hcpp] PreferredName:Sufficient SemanticType:[qlco] PreferredName:consider SemanticType:[idcn] PreferredName:Documents SemanticType:[inpr] PreferredName:Inclusion SemanticType:[qlco] POS:NN POS:VBD POS:VBN POS:TO POS:NNS POS:VBG POS:NNS POS:IN POS:JJ POS:NN POS:, POS:IN POS:NN POS:NNS POS:CC POS:NNS POS:RB POS:VBD POS:VBN POS:. POS:NNS POS:IN POS:JJ POS:IN POS:NN POS:CC POS:JJ POS:NNS POS:VBD POS:RB POS:VBN POS:JJ POS:IN POS:NN POS:IN POS:DT POS:NN POS:. 
[sentNum: 557]<Annotation Id="19325" Type="Sentence" StartNode="49343" EndNode="49598">Guidelines published by organizations orinstitutions such as theNationalInstitutes of Health and the American College of Obstetricians and Gynecologists were reviewed, and additional studies were located by reviewing bibliographies of identified articles. PreferredName:Scientific Publication SemanticType:[inpr] PreferredName:Guideline [Publication Type] SemanticType:[inpr] PreferredName:Health SemanticType:[idcn] PreferredName:Organization administrative structures SemanticType:[orgt] PreferredName:Review [Publication Type] SemanticType:[inpr] PreferredName:American College of Obstetricians and Gynecologists SemanticType:[pros] PreferredName:Scientific Study SemanticType:[lbpr] PreferredName:Additional SemanticType:[ftcn] PreferredName:Bibliography SemanticType:[inpr, mnob] PreferredName:Review [Publication Type] SemanticType:[inpr] PreferredName:Article SemanticType:[inpr] PreferredName:Identified SemanticType:[qlco] POS:NNS POS:VBN POS:IN POS:NNS POS:NNS POS:JJ POS:IN POS:NNS POS:IN POS:NNP POS:CC POS:DT POS:NNP POS:NNP POS:IN POS:NNPS POS:CC POS:NNPS POS:VBD POS:VBN POS:, POS:CC POS:JJ POS:NNS POS:VBD POS:VBN POS:IN POS:VBG POS:NNS POS:IN POS:VBN POS:NNS POS:. 
[sentNum: 558]<Annotation Id="19326" Type="Sentence" StartNode="49599" EndNode="49699">When reliable research was not available, expert opinions from obstetrician&#x2013;gynecologists were used. PreferredName:Research Activities SemanticType:[resa] PreferredName:Reliability (characteristic) SemanticType:[qnco] PreferredName:Expert Opinion SemanticType:[cnce] PreferredName:Not available SemanticType:[idcn] PreferredName:Used by SemanticType:[fndg] PreferredName:Obstetrician and gynecologist SemanticType:[prog] POS:WRB POS:JJ POS:NN POS:VBD POS:RB POS:JJ POS:, POS:JJ POS:NNS POS:IN POS:NNS POS:VBD POS:VBN POS:. 
[sentNum: 559]<Annotation Id="19327" Type="Sentence" StartNode="49702" EndNode="49826">Studies were reviewed and evaluated for quality according to the method outlined by the U.S. Preventive Services Task Force: PreferredName:Review [Publication Type] SemanticType:[inpr] PreferredName:Scientific Study SemanticType:[lbpr] PreferredName:Quality SemanticType:[qlco] PreferredName:Evaluation SemanticType:[ftcn] PreferredName:United States SemanticType:[geoa] PreferredName:Methods SemanticType:[inpr] PreferredName:Advisory Committees SemanticType:[gora] PreferredName:Preventive service healthcare SemanticType:[hlca] POS:NNS POS:VBD POS:VBN POS:CC POS:VBN POS:IN POS:NN POS:VBG POS:TO POS:DT POS:NN POS:VBN POS:IN POS:DT POS:NNP POS:. POS:NN POS:. POS:NNP POS:NNPS POS:NNP POS:NNP POS:: 
[sentNum: 560]<Annotation Id="19328" Type="Sentence" StartNode="49829" EndNode="49912">I Evidence obtained from at least one properly	 designedrandomized controlledtrial. PreferredName:Evidence of SemanticType:[ftcn] PreferredName:Iodides SemanticType:[inch] PreferredName:Smaller SemanticType:[qlco] PreferredName:Obtain SemanticType:[ftcn] PreferredName:One SemanticType:[qnco] POS:PRP POS:NN POS:VBN POS:IN POS:IN POS:JJS POS:CD POS:RB POS:VBN POS:NN POS:. 
[sentNum: 561]<Annotation Id="19329" Type="Sentence" StartNode="49913" EndNode="49994">II-1 Evidence obtained from well-designed controlled trials withoutrandomization. PreferredName:Evidence of SemanticType:[ftcn] PreferredName:Good SemanticType:[qlco] PreferredName:Obtain SemanticType:[ftcn] PreferredName:CDISC Trial Design Class SemanticType:[inpr] PreferredName:Control function SemanticType:[ftcn] POS:NN POS:CD POS:NN POS:VBN POS:IN POS:JJ POS:JJ POS:NNS POS:NN POS:. 
[sentNum: 562]<Annotation Id="19330" Type="Sentence" StartNode="49997" EndNode="50132">II-2 Evidence obtained from well-designed cohort or case&#x2013;control analytic studies,preferablyfrom more than one center or researchgroup. PreferredName:Obtain SemanticType:[ftcn] PreferredName:Evidence of SemanticType:[ftcn] PreferredName:Design SemanticType:[acty] PreferredName:Good SemanticType:[qlco] PreferredName:Clinical Study Case SemanticType:[cnce] PreferredName:Cohort SemanticType:[popg] PreferredName:Scientific Study SemanticType:[lbpr] PreferredName:control aspects SemanticType:[qlco] PreferredName:Central SemanticType:[spco] PreferredName:One SemanticType:[qnco] POS:NN POS:CD POS:NN POS:VBN POS:IN POS:JJ POS:NN POS:CC POS:JJ POS:JJ POS:NNS POS:, POS:NN POS:JJR POS:IN POS:CD POS:NN POS:CC POS:NN POS:. 
[sentNum: 563]<Annotation Id="19331" Type="Sentence" StartNode="50135" EndNode="50301">II-3 Evidenceobtainedfrommultipletimeserieswithor withouttheintervention.Dramatic resultsin uncon­trolled experiments also could be regarded as this type of evidence. PreferredName:Type - attribute SemanticType:[qlco] PreferredName:research study SemanticType:[resa] PreferredName:Evidence of SemanticType:[ftcn] POS:NN POS:CD POS:NN POS:NN POS:. POS:JJ POS:NN POS:JJ POS:NNS POS:RB POS:MD POS:VB POS:VBN POS:IN POS:DT POS:NN POS:IN POS:NN POS:. 
[sentNum: 564]<Annotation Id="19332" Type="Sentence" StartNode="50304" EndNode="50422">III	 Opinionsofrespected authorities,based onclinical experience,descriptive studies, or reports of expert committees. PreferredName:III (suffix) SemanticType:[qlco] PreferredName:Base - General Qualifier SemanticType:[idcn] PreferredName:Authority SemanticType:[socb] PreferredName:Description SemanticType:[idcn] PreferredName:Practice Experience SemanticType:[menp] PreferredName:Report (document) SemanticType:[inpr] PreferredName:Scientific Study SemanticType:[lbpr] PreferredName:Committee SemanticType:[grup] POS:NNP POS:NNP POS:NNS POS:, POS:VBN POS:JJ POS:NN POS:, POS:JJ POS:NNS POS:, POS:CC POS:NNS POS:IN POS:NN POS:NNS POS:. 
[sentNum: 565]<Annotation Id="19333" Type="Sentence" StartNode="50425" EndNode="50561">Based on the highest level of evidence found in the data, recommendations are provided and graded according to the following categories: PreferredName:Base - General Qualifier SemanticType:[idcn] PreferredName:Levels of Evidence SemanticType:[fndg] PreferredName:Highest SemanticType:[qlco] PreferredName:Recommendation SemanticType:[idcn] PreferredName:Data found SemanticType:[idcn] PreferredName:Grade SemanticType:[clas] PreferredName:Providing (action) SemanticType:[acty] PreferredName:Followed by SemanticType:[tmco] PreferredName:Agreement SemanticType:[socb] PreferredName:Categories SemanticType:[inpr] POS:VBN POS:IN POS:DT POS:JJS POS:NN POS:IN POS:NN POS:VBN POS:IN POS:DT POS:NNS POS:, POS:NNS POS:VBP POS:VBN POS:CC POS:VBN POS:VBG POS:TO POS:DT POS:VBG POS:NNS POS:: 
[sentNum: 566]<Annotation Id="19334" Type="Sentence" StartNode="50564" EndNode="50614">Level A&#x2014;Recommendations are based on good and con­PreferredName:Levels (qualifier value) SemanticType:[qlco] PreferredName:Base - General Qualifier SemanticType:[idcn] PreferredName:Recommendation SemanticType:[idcn] PreferredName:Good SemanticType:[qlco] POS:NN POS:NNS POS:VBP POS:VBN POS:IN POS:JJ POS:CC POS:NN 
[sentNum: 567]<Annotation Id="19335" Type="Sentence" StartNode="50616" EndNode="50644">sistent scientific evidence. PreferredName:Science SemanticType:[ocdi] PreferredName:Evidence of SemanticType:[ftcn] POS:JJ POS:JJ POS:NN POS:. 
[sentNum: 568]<Annotation Id="19336" Type="Sentence" StartNode="50646" EndNode="50728">Level B&#x2014;Recommendations are based on limited or incon­sistent scientific evidence. PreferredName:Levels (qualifier value) SemanticType:[qlco] PreferredName:Base - General Qualifier SemanticType:[idcn] PreferredName:Recommendation SemanticType:[idcn] PreferredName:Science SemanticType:[ocdi] PreferredName:Limited (extensiveness) SemanticType:[ftcn] PreferredName:Evidence of SemanticType:[ftcn] POS:NN POS:NNS POS:VBP POS:VBN POS:IN POS:JJ POS:CC POS:JJ POS:JJ POS:NN POS:. 
[sentNum: 569]<Annotation Id="19337" Type="Sentence" StartNode="50732" EndNode="50809">Level C&#x2014;Recommendations are based primarily on con­sensus and expert opinion. PreferredName:Levels (qualifier value) SemanticType:[qlco] PreferredName:Base - General Qualifier SemanticType:[idcn] PreferredName:Recommendation SemanticType:[idcn] PreferredName:Expert Opinion SemanticType:[cnce] POS:NN POS:NNS POS:VBP POS:VBN POS:RB POS:IN POS:NN POS:CC POS:NN POS:NN POS:. 
[sentNum: 570]<Annotation Id="19338" Type="Sentence" StartNode="50812" EndNode="51171">Copyright August 2011 by the American College of Obstet-	 ricians andGynecologists.All rights reserved.Nopart of this publication may be reproduced, stored in a retrieval system, posted on the Internet, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording, or	 otherwise, withoutprior writtenpermissionfromthepublisher. PreferredName:Html Link Type - copyright SemanticType:[idcn] PreferredName:College SemanticType:[mnob] PreferredName:American SemanticType:[popg] PreferredName:Reservation (action) SemanticType:[acty] PreferredName:Rights SemanticType:[qlco] PreferredName:Storage SemanticType:[ftcn] PreferredName:Publications SemanticType:[inpr, mnob] PreferredName:System SemanticType:[ftcn] PreferredName:Retrieval SemanticType:[hlca] PreferredName:Internet SemanticType:[mnob] PreferredName:Post SemanticType:[tmco] PreferredName:Manufactured form SemanticType:[mnob] PreferredName:Transmitted by SemanticType:[ftcn] PreferredName:Authorization Mode - Electronic SemanticType:[idcn] PreferredName:Means SemanticType:[cnce] PreferredName:Photocopying SemanticType:[mcha] PreferredName:Mechanical Methods SemanticType:[ftcn] PreferredName:Records SemanticType:[inpr] POS:NN POS:NNP POS:CD POS:IN POS:DT POS:NNP POS:NNP POS:IN POS:JJ POS:NNS POS:NNS POS:. POS:DT POS:NNS POS:VBN POS:. POS:NN POS:IN POS:DT POS:NN POS:MD POS:VB POS:VBN POS:, POS:VBN POS:IN POS:DT POS:NN POS:NN POS:, POS:VBD POS:IN POS:DT POS:NN POS:, POS:CC POS:VBN POS:, POS:IN POS:DT POS:NN POS:CC POS:IN POS:DT POS:NNS POS:, POS:JJ POS:, POS:JJ POS:, POS:VBG POS:, POS:VBG POS:, POS:CC POS:RB POS:, POS:NN POS:NN POS:. 
[sentNum: 571]<Annotation Id="19339" Type="Sentence" StartNode="51174" EndNode="51325">Requests for authorization to make photocopies should be directed to Copyright Clearance Center, 222 Rosewood Drive, Danvers, MA 01923, (978) 750-8400. PreferredName:Request for SemanticType:[ftcn] PreferredName:Make - Instruction Imperative SemanticType:[ftcn] PreferredName:Authorization documentation SemanticType:[inpr] PreferredName:Direct type of relationship SemanticType:[qlco] PreferredName:Photocopying SemanticType:[mcha] PreferredName:Clearance [PK] SemanticType:[npop] PreferredName:Html Link Type - copyright SemanticType:[idcn] PreferredName:Intrinsic drive SemanticType:[menp] PreferredName:Central SemanticType:[spco] POS:NNS POS:IN POS:NN POS:TO POS:VB POS:NNS POS:MD POS:VB POS:VBN POS:TO POS:NN POS:NNP POS:NNP POS:, POS:CD POS:NNP POS:NNP POS:, POS:NNP POS:, POS:NNP POS:CD POS:, POS:CD POS:CD POS:NN POS:CD POS:: POS:CD POS:. 
[sentNum: 572]<Annotation Id="19340" Type="Sentence" StartNode="51328" EndNode="51444">The American College of Obstetricians and Gynecologists 409 12th Street, SW, PO Box 96920, Washington, DC 20090-6920 PreferredName:Street address SemanticType:[fndg] PreferredName:American College of Obstetricians and Gynecologists SemanticType:[pros] PreferredName:Oral SemanticType:[spco] PreferredName:BLOOD GROUP--SWANN SYSTEM SemanticType:[bdsy] PreferredName:Washington state SemanticType:[geoa] PreferredName:Box SemanticType:[mnob] POS:DT POS:NNP POS:NNP POS:IN POS:NNPS POS:CC POS:NNPS POS:CD POS:JJ POS:NNP POS:, POS:NNP POS:, POS:NNP POS:NNP POS:CD POS:, POS:NNP POS:, POS:NNP POS:CD POS:: POS:CD 
[sentNum: 573]<Annotation Id="19341" Type="Sentence" StartNode="51447" EndNode="51471">Breast cancer screening. PreferredName:Screening for malignant neoplasm of breast SemanticType:[topp] POS:NN POS:NN POS:NN POS:. 
[sentNum: 574]<Annotation Id="19342" Type="Sentence" StartNode="51472" EndNode="51493">Practice Bulletin No. PreferredName:Practice Experience SemanticType:[menp] POS:VB POS:NNP POS:NNP POS:. 
[sentNum: 575]<Annotation Id="19343" Type="Sentence" StartNode="51494" EndNode="51498">122. POS:CD POS:. 
[sentNum: 576]<Annotation Id="19344" Type="Sentence" StartNode="51499" EndNode="51551">American College of Obstetricians and Gynecologists. PreferredName:American College of Obstetricians and Gynecologists SemanticType:[pros] POS:NNP POS:NNP POS:IN POS:NNPS POS:CC POS:NNPS POS:. 
[sentNum: 577]<Annotation Id="19345" Type="Sentence" StartNode="51552" EndNode="51585">Obstet Gynecol 2011;118:	 372&#x2013;82. POS:NNP POS:NNP POS:CD POS:: POS:CD POS:: POS:CD POS:CD POS:CD POS:. 
